<SEC-DOCUMENT>0000049071-25-000004.txt : 20250211
<SEC-HEADER>0000049071-25-000004.hdr.sgml : 20250211
<ACCEPTANCE-DATETIME>20250211064121
ACCESSION NUMBER:		0000049071-25-000004
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		21
CONFORMED PERIOD OF REPORT:	20250211
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
FILED AS OF DATE:		20250211
DATE AS OF CHANGE:		20250211

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HUMANA INC
		CENTRAL INDEX KEY:			0000049071
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		ORGANIZATION NAME:           	02 Finance
		IRS NUMBER:				610647538
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-05975
		FILM NUMBER:		25607632

	BUSINESS ADDRESS:	
		STREET 1:		500 W MAIN ST
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40202
		BUSINESS PHONE:		5025801000

	MAIL ADDRESS:	
		STREET 1:		500 W. MAIN ST
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXTENDICARE INC
		DATE OF NAME CHANGE:	19740404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HERITAGE HOUSE OF AMERICA INC
		DATE OF NAME CHANGE:	19671129
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>hum-20250211.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:009e4717-ec41-4801-ab4f-36ee5ab4fc59,g:ed3e948d-78e3-4427-a7bf-36efb002053c,d:169bcb2531f14a5a976b9212ff45d2e9-->
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>hum-20250211</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0000049071</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-22">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="hum-20250211.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-11</xbrli:startDate><xbrli:endDate>2025-02-11</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i169bcb2531f14a5a976b9212ff45d2e9_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.861%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, DC&#160;20549</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.527%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.527%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported):&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">February 11, 2025</ix:nonNumeric> (February 11, 2025)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.472%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Humana Inc.</ix:nonNumeric> </span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.194%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Exact name of registrant as specified in its charter)</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.750%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">1-5975</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">61-0647538</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">500 West Main Street</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Louisville</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-9">KY</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">40202</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">502</ix:nonNumeric>-<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">580-1000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.472%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General Instruction A.2. below):</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.150%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17&#160;CFR&#160;230.425)</span></td></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.150%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.150%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17&#160;CFR&#160;240.14d-2(b))</span></td></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.150%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17&#160;CFR&#160;240.13e-4(c))</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:36.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.592%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">HUM</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-20">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i169bcb2531f14a5a976b9212ff45d2e9_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2.02&#160;&#160;&#160;&#160;Results of Operations and Financial Condition.</span></div><div id="i169bcb2531f14a5a976b9212ff45d2e9_10"></div><div style="-sec-extract:summary;margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item&#160;7.01&#160;&#160;&#160;&#160;Regulation FD Disclosure.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Inc. (the "Company") issued a press release this morning reporting financial results for the quarter ended December 31, 2024, and posted a detailed earnings release related to the same period to the Investor Relations portion of the Company&#8217;s website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.humana.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;A copy of each release is attached hereto as Exhibit 99.1 and Exhibit 99.2, respectively, and each release is incorporated herein by reference. Additionally, a copy of management's prepared remarks on the Company's 2024 financial results and expectations for future earnings, is attached hereto as Exhibit 99.3, and incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i169bcb2531f14a5a976b9212ff45d2e9_13"></div><div style="-sec-extract:summary;margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Exhibits:</span></div><div style="margin-bottom:1pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:6.084%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:58.137%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.612%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;No.</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="hum-2024q48kxex99x1brief.htm">Press Release</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="hum-2024q48kxex99x2detailed.htm">Earnings Release and Statistical Pages</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a4q2024humanaincpostedrema.htm">Prepared Management Remarks</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="6" style="padding:2px 1pt 2px 28pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i169bcb2531f14a5a976b9212ff45d2e9_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:1pt;margin-top:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.456%"><tr><td style="width:1.0%"/><td style="width:13.149%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:84.651%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">HUMANA INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BY:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">/s/ John-Paul W. Felter</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John-Paul W. Felter</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Vice President, Chief Accounting Officer &amp; Controller</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Principal Accounting Officer)</span></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: February 11, 2025</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>hum-2024q48kxex99x1brief.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ia72680a000294cbe94b5c1fd11988e54_1"></div><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.150%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:15pt;font-weight:700;line-height:100%">n e w s</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:15pt;font-weight:400;line-height:100%">  r e l e a s e</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 99.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Humana Inc.</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">500 West Main Street</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">P.O. Box 1438</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Louisville, KY 40202</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">http&#58;&#47;&#47;www.humana.com</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FOR MORE INFORMATION CONTACT&#58;</font></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.817%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lisa Stoner<br>Humana Investor Relations<br>(502) 580-2652<br>e-mail&#58; LStamper&#64;humana.com</font></td><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img alt="humanalogoa05b.jpg" src="humanalogoa05b.jpg" style="height:65px;margin-bottom:5pt;vertical-align:text-bottom;width:217px"></div></td></tr></table></div><div style="margin-top:7pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Mark Taylor</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Humana Corporate Communications</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(317) 753-0345</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e-mail&#58; MTaylor108&#64;humana.com</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#5c9a1b;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Humana Reports Fourth Quarter 2024 Financial Results&#59; </font></div><div style="text-align:center"><font style="color:#5c9a1b;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Provides Full Year 2025 Financial Guidance</font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Reports 4Q24 net loss per share of $5.76</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on a GAAP basis,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted net loss per share of $2.16&#59; reports FY 2024 earnings per share (EPS) of $9.98 on a GAAP basis, $16.21  on an Adjusted basis</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">4Q24 Insurance segment Adjusted benefit ratio of 91.9 percent, which includes a 20-basis point increase related to  incremental Star Ratings investments, was consistent with expectations</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Affirms previous commentary of Adjusted FY 2025 EPS guidance to be 'at least in line with 2024 results'&#59; anticipating GAAP EPS of approximately $15.88, or approximately $16.25 on an Adjusted basis, inclusive of incremental investments to support operational excellence</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Expects individual Medicare Advantage annual membership decline of approximately 550,000, or approximately 10 percent, from 2024, inclusive of the company's decision to exit certain unprofitable plans and counties</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Continuing to advance Medicaid and CenterWell strategies&#59; expected to drive increased earnings contribution over the mid and longer term</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Publishes prepared management remarks to Investor Relations page of www.humana.com ahead of this morning's 9&#58;00 a.m. ET question and answer session to discuss its financial results for the quarter and expectations for future earnings</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">LOUISVILLE, KY (February 11, 2025)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> &#8211; Humana Inc. (NYSE&#58; HUM) today reported consolidated pretax results and net (loss) earnings per share for the quarter ended December 31, 2024 (4Q24) versus the quarter ended December 31, 2023 (4Q23) and for the year ended December 31, 2024 (FY 2024) versus the year ended December 31, 2023 (FY 2023) as noted in the tables below.</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.638%"><tr><td style="width:1.0%"></td><td style="width:44.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated (loss) income before income taxes and equity in net losses (pretax results) </font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">In millions</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4Q24 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4Q23 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FY 2024&#160;(a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FY 2023&#160;(a)</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Generally Accepted Accounting Principles (GAAP)</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($862)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($591)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,721</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,383&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization associated with identifiable intangibles</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">60</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Put&#47;call valuation adjustments associated with the company's non-consolidating minority interest investments</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">155</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">296</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">144</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value creation initiatives</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">130</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">281</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">200</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">200</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction and integration costs</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued charge related to certain anticipated litigation expenses</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair market value of publicly-traded equity securities</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($296)</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$79&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,702</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,369&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="margin-top:12pt;padding-left:31.5pt;padding-right:31.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.638%"><tr><td style="width:1.0%"></td><td style="width:44.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Net loss per share) EPS</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4Q24 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4Q23 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FY 2024&#160;(a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FY 2023&#160;(a)</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($5.76)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($4.42)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$9.98</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20.00&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization associated with identifiable intangibles</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.12</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.50</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.54&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Put&#47;call valuation adjustments associated with the company's non-consolidating minority interest investments</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.29</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.45</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.57&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.55</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.19</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value creation initiatives</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.08</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.33</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.66</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.74&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.65</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.73&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction and integration costs</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.38)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued charge related to certain anticipated litigation expenses</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.84&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair market value of publicly-traded equity securities</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative net tax impact of non-GAAP adjustments</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.10)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.16)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.89)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.83)</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($2.16)</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($0.11)</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$16.21</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$26.09&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:4.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Refer to the &#34;Footnotes&#34; section included herein for further explanation of disclosures for Adjusted (non-GAAP) financial measures, as well as additional reconciliations.</font></div><div style="margin-top:7pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Please refer to the tables above, as well as the consolidated and segment highlight sections in the detailed earnings release for additional discussion of the factors impacting the year-over-comparisons.</font></div><div style="margin-top:7pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;We were pleased with Humana&#8217;s solid finish to the year, while also reaffirming our outlook for 2025,&#8221; said Jim Rechtin, Humana&#8217;s President and Chief Executive Officer.  &#8220;We are confident in our long-term strategy and 2025 will be a critical step in returning to compelling, normalized margins.</font><font style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font></div><div id="ia72680a000294cbe94b5c1fd11988e54_4"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">FY 2025 Earnings Guidance</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Humana provides its GAAP EPS guidance for the year ending December 31, 2025 (FY 2025) of approximately $15.88, or approximately $16.25 on an Adjusted basis.</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.833%"><tr><td style="width:1.0%"></td><td style="width:67.885%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><font style="font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><br></font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Diluted earnings per share</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FY 2025<br>&#160;Guidance</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FY 2024 (a)</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP </font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">approximately <br>$15.88</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9.98&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization associated with identifiable intangibles</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.49&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Put&#47;call valuation adjustments associated with the company's non-consolidating minority interest investments</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.45&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.19&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value creation initiatives</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.33&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative net tax impact of non-GAAP adjustments</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.89)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP) &#8211; FY 2025 projected (b)&#59; FY 2024 Reported</font></td><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">approximately <br>$16.25</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.21&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Refer to the &#34;Footnotes&#34; section included herein for further explanation of disclosures for Adjusted (non-GAAP) financial measures, as well</font></div><div style="padding-left:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:107%">as additional reconciliations.</font></div><div id="ia72680a000294cbe94b5c1fd11988e54_7"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Detailed Press Release</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Humana&#8217;s full earnings press release, including the statistical pages, has been posted to the company&#8217;s Investor Relations site and may be accessed at https&#58;&#47;&#47;humana.gcs-web.com&#47; or via a current report on Form 8-K filed by the company with the Securities and Exchange Commission this morning (available at www.sec.gov or on the company&#8217;s website).</font></div><div id="ia72680a000294cbe94b5c1fd11988e54_10"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Conference Call</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">Humana will host a live question and answer session for analysts at 9&#58;00 a.m. Eastern time today to discuss its financial results for the quarter and the company&#8217;s expectations for future earnings. In advance of the question and answer session, Humana will post prepared management remarks to the Quarterly Results section of its Investor Relations page (https&#58;&#47;&#47;humana.gcs-web.com&#47;financial-information&#47;quarterly-results).</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">To participate via phone, please register in advance at this link - https&#58;&#47;&#47;register.vevent.com&#47;register&#47;BIe3b4c275f3cf421383fa6ac8a142593b.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique registrant ID that can be used to access the call.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">A webcast of the 4Q24 earnings call may also be accessed via Humana&#8217;s Investor Relations page at humana.com.&#160;The company suggests participants for both the conference call and those listening via the web dial in or sign on at least 15 minutes in advance of the call. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For those </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">unable to participate in the live event, the archive will be available in the Historical Webcasts and Presentations section of the Investor Relations page (https&#58;&#47;&#47;humana.gcs-web.com&#47;events-and-presentations), approximately two hours following the live webcast.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div id="ia72680a000294cbe94b5c1fd11988e54_13"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Footnotes</font></div><div style="margin-top:7pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company has included financial measures throughout this earnings release that are not in accordance with GAAP. Management believes that these measures, when presented in conjunction with the corresponding GAAP measures, provide a comprehensive perspective to more accurately compare and analyze the company&#8217;s core operating performance over time. Consequently, management uses these non-GAAP (Adjusted) financial measures as consistent and uniform indicators of the company&#8217;s core business operations from period to period, as well as for planning and decision-making purposes and in determination of incentive compensation. Non-GAAP (Adjusted) financial measures should be considered in addition to, but not as a substitute for, or superior to, financial measures prepared in accordance with GAAP. All financial measures in this earnings release are in accordance with GAAP unless otherwise indicated. Please refer to the footnotes for a detailed description of each item adjusted out of GAAP financial measures to arrive at non-GAAP (Adjusted) financial measures.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) For the periods covered in this earnings release, the following items are excluded from the non-GAAP financial</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measures described above, as applicable&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Amortization associated with identifiable intangibles -</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Since amortization varies based on the size and timing of acquisition activity, management believes this exclusion provides a more consistent and uniform indicator of performance from period to period. For all periods shown within this earnings release, </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GAAP measures affected include consolidated pretax results, (net loss per share) EPS, and Insurance and CenterWell segments income from operations. The table below discloses respective period amortization expense for each segment&#58;</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.527%"><tr><td style="width:1.0%"></td><td style="width:35.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.794%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q23</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2023</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance segment</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$4</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$17</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CenterWell segment</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$10</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$11</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$43</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$45</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Put&#47;call valuation adjustments </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">associated with the company&#8217;s non-consolidating minority interest investments - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amounts are the result of fair value measurements associated with the company's Primary Care Organization strategic partnership and are unrelated to the company's core business operations. For all periods shown within this earnings release, GAAP measures affected include consolidated pretax results and </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(net loss per share) EPS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:13.02pt">I</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">mpact of exit of employer group commercial medical products business - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amounts relate to activity from the exit of the employer group commercial medical products business as announced by Humana on February 23, 2023.  For all periods shown within this</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">earnings release, GAAP measures affected include consolidated pretax results, </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(net loss per share) EPS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, consolidated revenues, consolidated benefit ratio, consolidated operating cost ratio, Insurance segment revenues, Insurance segment benefit ratio, Insurance segment operating cost ratio, and Insurance segment income from operations.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Value creation initiatives - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These charges relate to the company's ongoing initiative to drive additional value for the enterprise through cost saving, productivity initiatives, and value creation from previous investments, and primarily consist of asset impairment and severance charges. These charges were recorded at the corporate level and not allocated to the segments. For all periods shown within this earnings release, GAAP measures affected in this release include consolidated pretax results, </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(net loss per share) EPS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and the consolidated operating cost ratio.</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Impairment charges -</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The company recognized non-cash impairment charges in 4Q24 and 4Q23 related to certain indefinite-lived intangible assets based on the company's estimate of future financial performance in certain state markets. Additionally, in 4Q23 the company recognized non-cash impairment charges related to minority ownership investments that were deemed to be unrecoverable based on investment performance. These charges were recorded at the corporate level and not allocated to the segments. For all periods, GAAP measures affected include consolidated pretax results, </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(net loss per share) EPS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and the consolidated operating cost ratio.  For 4Q23 and FY 20023, consolidated revenues (specifically investment income) were also affected.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Transaction and integration costs -</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The transaction and integration costs primarily related to the acquisition of Kindred at Home in 2021 and the subsequent divestiture of majority ownership of Gentiva (formerly Kindred) Hospice in 2022.  For FY 2023, GAAP measures affected include consolidated pretax results, </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(net loss per share) EPS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and the consolidated operating cost ratio.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Accrued charge related to certain anticipated</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">litigation expenses - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This charge related to certain anticipated expenses the company accrued in connection with a legal matter.  For FY 2023, GAAP measures affected include consolidated pretax results, </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(net loss per share) EPS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the consolidated and Insurance segment operating cost ratios, and Insurance segment income from operations.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Change in fair market value of publicly-traded equity securities - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These gains are a result of market and economic conditions that are unrelated to the company's core business operations.  For FY 2023, GAAP measures affected include consolidated pretax results, EPS, and consolidated revenues (specifically investment income).</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Cumulative net tax impact of non-GAAP adjustments - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This adjustment represents the cumulative net impact of the corresponding tax benefit or expense related to the aforementioned items excluded from the applicable GAAP measures.  For all periods presented in this earnings release, </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(net loss per share) EPS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is the sole GAAP measure affected. </font></div><div style="margin-top:3pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the reconciliations shown on</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">page 2</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of this release, the following are reconciliations of GAAP to Adjusted (non-GAAP) measures described above and disclosed within this earnings release&#58;</font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3pt;text-align:justify;text-indent:4.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Revenues</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:43.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Revenues - CONSOLIDATED<br>(in millions)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q23</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2023</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$29,213</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$26,462</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$117,761</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$106,374</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair market value of publicly-traded equity securities</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(764)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(551)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,764)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$29,199</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25,734</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$117,210</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$102,645</font></td></tr></table></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"></td><td style="width:43.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.730%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Revenues - INSURANCE SEGMENT<br>(in millions)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q23</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2023</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$28,170</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25,565</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$113,764</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$102,854</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(764)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(551)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,764)</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$28,156</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$24,801</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$113,213</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$99,090</font></td></tr></table></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Benefit Ratio </font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:44.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.608%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Benefit ratio - CONSOLIDATED</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q23</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2023</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.7&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.3&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.2)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.5&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.750%"><tr><td style="width:1.0%"></td><td style="width:44.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Benefit ratio - INSURANCE SEGMENT</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q23</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2023</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.5&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.0&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.2)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.4&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.0&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Operating Cost Ratio </font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:44.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.608%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Operating cost ratio - CONSOLIDATED</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q23</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2023</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value creation initiatives</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.5)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.2)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued charge related to certain anticipated litigation expenses</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.7)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.2)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:43.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Operating cost ratio - INSURANCE SEGMENT</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q23</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2023</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.0</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued charge related to certain anticipated litigation expenses</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.0</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Insurance Segment - (Loss) Income from Operations</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:43.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.690%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(Loss) income from operations - INSURANCE SEGMENT <br>(in millions)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q23</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2023</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($646)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($426)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,289</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,654</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization associated with identifiable intangibles</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">177</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued charge related to certain anticipated litigation expenses</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($575)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($361)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,483</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,897</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">b) FY 2025 projected Adjusted results exclude the future impact of items that cannot be estimated at this time.</font></div><div id="ia72680a000294cbe94b5c1fd11988e54_16"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Cautionary Statement</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This news release includes forward-looking statements regarding Humana within the meaning of the Private Securities Litigation Reform Act of 1995. When used in investor presentations, press releases, Securities and Exchange Commission (SEC) filings, and in oral statements made by or with the approval of one of Humana&#8217;s executive officers, the words or phrases like &#8220;expects,&#8221; &#8220;believes,&#8221; &#8220;anticipates,&#8221; &#8220;assumes,&#8221; &#8220;intends,&#8221; &#8220;likely will result,&#8221; &#8220;estimates,&#8221; &#8220;projects&#8221; or variations of such words and similar expressions are intended to identify such forward-looking statements.  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions, including, among other things, information set forth in the &#8220;Risk Factors&#8221; section of the company&#8217;s SEC filings, a summary of which includes but is not limited to the following&#58;  </font></div><div style="margin-bottom:2.4pt;padding-left:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">If Humana does not design and price its products properly and competitively, if the premiums Humana receives are insufficient to cover the cost of healthcare services delivered to its members, if the company is unable to implement clinical initiatives to provide a better healthcare experience for its members, lower costs and appropriately document the risk profile of its members, or if its estimates of benefits expense are inadequate, Humana&#8217;s profitability could be materially adversely affected. Humana estimates the costs of its benefit expense payments, and designs and prices its products accordingly, using actuarial methods and assumptions based upon, among other relevant factors, claim payment patterns, medical cost inflation, and historical developments such as claim inventory levels and claim receipt patterns. The company continually reviews estimates of future payments relating to benefit expenses for services incurred in the current and prior periods and makes necessary adjustments to its reserves, including premium deficiency reserves, where appropriate. These estimates involve extensive judgment, and have considerable inherent variability because they are extremely sensitive to changes in claim payment patterns and medical cost trends. Accordingly, Humana's reserves may be insufficient.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">If Humana fails to effectively implement its operational and strategic initiatives, including its Medicare initiatives, which are of particular importance given the concentration of the company's revenues in these products, state-based contract strategy, the growth of its CenterWell business, and its integrated care delivery model, the company&#8217;s business may be materially adversely affected.  </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.53pt">The number of Humana&#8217;s Medicare Advantage plans rated 4-star or higher will significantly decline in 2025.  Humana has filed a lawsuit seeking to set aside and vacate the 2025 Star Ratings of its Medicare Advantage plans, but there is no assurance that the company will prevail in this lawsuit. If the company is not successful, the decline in Star Ratings will negatively impact its 2026 quality bonus payments from CMS and may also significantly adversely affect the company&#8217;s revenues, operating results, and cash flows. In addition, there can be no assurances the company will be successful in maintaining or improving its Star Ratings in future years. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">If Humana, or the third-party service providers on which it relies, fails to properly maintain the integrity of its data, to strategically maintain existing or implement new information systems, to protect Humana&#8217;s proprietary rights to its systems, or to defend against cyber-security attacks, contain such attacks when they occur, or prevent other privacy or data security incidents that result in security breaches that disrupt the company's operations or in the unintentional dissemination of sensitive personal information or proprietary or confidential information, the company&#8217;s business may be materially adversely affected.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Humana is involved in various legal actions, or disputes that could lead to legal actions (such as, among other things, provider contract disputes and qui tam litigation brought by individuals on behalf of the government), governmental and internal investigations, and routine internal review of business processes any of which, if resolved unfavorably to the company, could result in substantial monetary damages or changes in its business practices. Increased litigation and negative publicity could also increase the company&#8217;s cost of doing business.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">As a government contractor, Humana is exposed to risks that may materially adversely affect its business or its willingness or ability to participate in government healthcare programs including, among other things, loss of material government contracts&#59; governmental audits and investigations&#59; potential inadequacy of government determined payment rates&#59; potential restrictions on profitability, including by comparison of profitability of the company&#8217;s Medicare Advantage business to non-Medicare Advantage business&#59; or other changes in the governmental programs in which Humana participates. Changes to the risk-adjustment model utilized by CMS to adjust premiums paid to Medicare Advantage plans or retrospective recovery by CMS of previously paid premiums as a result of the final rule related to the risk adjustment data validation audit methodology published by CMS on January 30, 2023 (Final RADV Rule), which Humana believes fails to address adequately the statutory requirement of actuarial equivalence and violates the Administrative Procedure Act due to its failure to include a &#34;Fee for Service Adjuster&#34; could have a material adverse effect on the company's operating results, financial position and cash flows. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Humana's business activities are subject to substantial government regulation.  New laws or regulations, or legislative, judicial, or regulatory changes in existing laws or regulations or their manner of application could increase the company's cost of doing business and have a material adverse effect on Humana&#8217;s results of operations (including restricting revenue, enrollment and premium growth in certain products and market segments, restricting the company&#8217;s ability to expand into new markets, increasing the company&#8217;s medical and operating costs by, among other things, requiring a minimum benefit ratio on insured products, lowering the company&#8217;s Medicare payment rates and increasing the company&#8217;s expenses associated with a non-deductible health insurance industry fee and other assessments)&#59; the company&#8217;s financial position (including the company&#8217;s ability to maintain the value of its goodwill)&#59; and the company&#8217;s cash flows.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Humana&#8217;s failure to manage acquisitions, divestitures and other significant transactions successfully may have a material adverse effect on the company&#8217;s results of operations, financial position, and cash flows. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">If Humana fails to develop and maintain satisfactory relationships with the providers of care to its members, the company&#8217;s business may be adversely affected.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;padding-left:12.53pt">Humana faces significant competition in attracting and retaining talented employees. Further, managing succession for, and retention of, key executives is critical to the Company&#8217;s success, and its failure to do so could adversely affect the Company&#8217;s businesses, operating results and&#47;or future performance.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Humana&#8217;s pharmacy business is highly competitive and subjects it to regulations and supply chain risks in addition to those the company faces with its core health benefits businesses.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Changes in the prescription drug industry pricing benchmarks may adversely affect Humana&#8217;s financial performance.  </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Humana&#8217;s ability to obtain funds from certain of its licensed subsidiaries is restricted by state insurance regulations.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Downgrades in Humana&#8217;s debt ratings, should they occur, may adversely affect its business, results of operations, and financial condition.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Volatility or disruption in the securities and credit markets may significantly and adversely affect the value of our investment portfolio and the investment income that we derive from this portfolio.    </font></div><div style="padding-left:36pt;text-align:justify;text-indent:4.5pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In making forward-looking statements, Humana is not undertaking to address or update them in future filings or communications regarding its business or results. In light of these risks, uncertainties, and assumptions, the forward-looking events discussed herein may or may not occur. There also may be other risks that the company is unable to predict at this time. Any of these risks and uncertainties may cause actual results to differ materially from the results discussed in the forward-looking statements.  </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Humana advises investors to read the following documents as filed by the company with the SEC for further discussion both of the risks it faces and its historical performance&#58; </font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Form 10-K for the year ended December&#160;31, 2023&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Form 10-Qs for the quarters ended March 31, 2024, June 30, 2024, and September 30, 2024&#59; and </font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Form 8-Ks filed during 2024 and 2025. </font></div><div><font><br></font></div><div id="ia72680a000294cbe94b5c1fd11988e54_19"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">About Humana </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Humana Inc. is committed to putting health first &#8211; for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health &#8211; delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.  </font></div><div style="margin-top:12pt"><font><br></font></div><div style="margin-top:12pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>hum-2024q48kxex99x2detailed.htm
<DESCRIPTION>EX-99.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_1"></div><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:22.083%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">n e w s  r e l e a s e</font></td><td colspan="3" style="display:none"></td></tr></table><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:1pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.555%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"><font style="font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><br></font></td></tr></table><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Exhibit 99.2</font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:125.25pt"><tr><td style="width:1.0pt"></td><td style="width:123.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:60pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Humana Inc.</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">500 West Main Street</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">P.O. Box 1438</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Louisville, KY 40202</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">http&#58;&#47;&#47;www.humana.com</font></div></td></tr></table></div><div style="margin-top:7pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FOR MORE INFORMATION CONTACT&#58;</font></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.817%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lisa Stoner<br>Humana Investor Relations<br>(502) 580-2652<br>e-mail&#58; LStamper&#64;humana.com</font></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="humanalogoa051.jpg" src="humanalogoa051.jpg" style="height:65px;margin-bottom:5pt;vertical-align:text-bottom;width:217px"></div></td></tr></table></div><div style="margin-top:7pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Mark Taylor</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Humana Corporate Communications</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(317) 753-0345</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">e-mail&#58; MTaylor108&#64;humana.com</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#5c9a1b;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Humana Reports Fourth Quarter 2024 Financial Results&#59; </font></div><div style="text-align:center"><font style="color:#5c9a1b;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Provides Full Year 2025 Financial Guidance </font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Reports 4Q24 net loss per share of $5.76 on a GAAP basis, Adjusted net loss per share of $2.16&#59; reports FY 2024 earnings per share (EPS) of $9.98 on a GAAP basis, $16.21 on an Adjusted basis</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">4Q24 Insurance segment Adjusted benefit ratio of 91.9 percent, which includes a 20-basis point increase related to  incremental Star Ratings investments, was consistent with expectations</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Affirms previous commentary of Adjusted FY 2025 EPS guidance to be 'at least in line with 2024 results'&#59; anticipating GAAP EPS of approximately $15.88, or approximately $16.25 on an Adjusted basis, inclusive of incremental investments to support operational excellence</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Expects individual Medicare Advantage annual membership decline of approximately 550,000, or approximately 10 percent, from 2024, inclusive of the company's decision to exit certain unprofitable plans and counties</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Continuing to advance Medicaid and CenterWell strategies&#59; expected to drive increased earnings contribution over the mid and longer term</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Publishes prepared management remarks to Investor Relations page of www.humana.com ahead of this morning's 9&#58;00 a.m. ET question and answer session to discuss its financial results for the quarter and expectations for future earnings</font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">LOUISVILLE, KY (February 11, 2025)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> &#8211; Humana Inc. (NYSE&#58; HUM) today reported consolidated pretax results and net (loss) earnings per share for the quarter ended December 31, 2024 (4Q24) versus the quarter ended December 31, 2023 (4Q23) and for the year ended December 31, 2024 (FY 2024) versus the year ended December 31, 2023 (FY 2023) as noted in the tables below.</font></div><div style="text-align:center"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.638%"><tr><td style="width:1.0%"></td><td style="width:44.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated (loss) income before income taxes and equity in net losses (pretax results) </font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">In millions</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4Q24 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4Q23 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FY 2024&#160;(a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FY 2023&#160;(a)</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Generally Accepted Accounting Principles (GAAP)</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($862)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($591)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,721</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,383&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization associated with identifiable intangibles</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">60</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Put&#47;call valuation adjustments associated with the company's non-consolidating minority interest investments</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">155</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">296</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">144</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value creation initiatives</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">130</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">281</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">200</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">200</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction and integration costs</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued charge related to certain anticipated litigation expenses</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair market value of publicly-traded equity securities</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($296)</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$79&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,702</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,369&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.638%"><tr><td style="width:1.0%"></td><td style="width:44.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Net loss per share) EPS</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4Q24 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4Q23 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FY 2024&#160;(a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FY 2023&#160;(a)</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($5.76)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($4.42)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$9.98</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20.00&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization associated with identifiable intangibles</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.12</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.50</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.54&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Put&#47;call valuation adjustments associated with the company's non-consolidating minority interest investments</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.29</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.45</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.57&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.55</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.19</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value creation initiatives</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.08</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.33</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.66</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.74&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.65</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.73&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction and integration costs</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.38)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued charge related to certain anticipated litigation expenses</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.84&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair market value of publicly-traded equity securities</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative net tax impact of non-GAAP adjustments</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.10)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.16)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.89)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.83)</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($2.16)</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($0.11)</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$16.21</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$26.09&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:4.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Refer to the &#34;Footnotes&#34; section included herein for further explanation of disclosures for Adjusted (non-GAAP) financial measures, as well as additional reconciliations.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Please refer to the tables above, as well as the consolidated and segment highlight sections that follow for additional discussion of the factors impacting the year-over-year comparisons. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8220;We were pleased with Humana&#8217;s solid finish to the year, while also reaffirming our outlook for 2025,&#8221; said Jim Rechtin, Humana&#8217;s President and Chief Executive Officer.  &#8220;We are confident in our long-term strategy and 2025 will be a critical step in returning to compelling, normalized margins.</font><font style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;</font></div><div style="margin-top:12pt;text-align:justify"><font><br></font></div><div style="margin-top:12pt;text-align:justify"><font><br></font></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_7"></div><div style="text-align:center"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div></div></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_13"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">FY 2025 Earnings Guidance</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Humana provides its GAAP EPS guidance for the year ending December 31, 2025 (FY 2025) of approximately $15.88, or approximately $16.25 on an Adjusted basis.</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Additional FY 2025 guidance points are included on page 14 of this earnings release.</font></div><div style="padding-right:-11.25pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.833%"><tr><td style="width:1.0%"></td><td style="width:67.885%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><font style="font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><br></font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Diluted earnings per share</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FY 2025<br>&#160;Guidance</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FY 2024 (a)</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP </font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">approximately <br>$15.88</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9.98&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization associated with identifiable intangibles</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.49&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Put&#47;call valuation adjustments associated with the company's non-consolidating minority interest investments</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.45&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.19&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value creation initiatives</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.33&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative net tax impact of non-GAAP adjustments</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.89)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP) &#8211; FY 2025 projected (b)&#59; FY 2024 Reported</font></td><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">approximately <br>$16.25</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.21&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><div style="padding-left:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:107%">Refer to the &#34;Footnotes&#34; section included herein for further explanation of disclosures for Adjusted (non-GAAP) financial measures, as well</font></div><div style="padding-left:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:107%">as additional reconciliations.</font></div><div><font><br></font></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_19"></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Humana Consolidated Highlights</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:43.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Humana Inc. Summary of Results<br></font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($ in millions, except per share amounts)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4Q24 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4Q23 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FY 2024 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FY  2023 (a)</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revenues </font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$29,213</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$26,462</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$117,761</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$106,374</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revenues - Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$29,199</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$25,734</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$117,210</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$102,645</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pretax results</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">($862)</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">($591)</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$1,721</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$3,383</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pretax results - Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">($296)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$79</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$2,702</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$4,369</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Net loss per share) EPS</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">($5.76)</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">($4.42)</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$9.98</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$20.00</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Net loss per share) EPS - Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">($2.16)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">($0.11)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$16.21</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$26.09</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Benefits expense ratio</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">91.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">90.7&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">89.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">87.3&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Benefits expense ratio - Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">91.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">90.5&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">89.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">87.2&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating cost ratio</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">14.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14.6&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">11.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12.5&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating cost ratio - Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">13.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12.9&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">11.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.7&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating cash flows </font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$2,966</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$3,981</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Parent company cash and short term investments</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$562</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$510</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Debt-to-total capitalization</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">41.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">41.8&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Days in Claims Payable (DCP)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">37.8</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">41.4</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Refer to the &#34;Footnotes&#34; section included herein for further explanation of disclosures for Adjusted (non-GAAP) financial measures, as well as reconciliations.</font></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_25"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Consolidated Revenues</font></div><div style="margin-top:7pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">favorable</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> year-over-year quarter and FY GAAP consolidated revenues comparisons were primarily driven by the following factors&#58;</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">higher per member</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Medicare premiums, and </font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Medicare Advantage and state-based contracts membership growth.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These factors were partially offset by the continued decline in stand-alone PDP membership, as well as a decline in  membership in the group commercial medical business as a result of the company's decision to exit the business.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Refer to the &#34;Footnotes&#34; section included herein for a reconciliation of GAAP to Adjusted (non-GAAP) consolidated revenues for the respective periods. </font></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_31"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Consolidated Benefit Ratio</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The year-over-year quarterly and FY increases in the GAAP consolidated benefit ratio primarily reflected the following items&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">continued impact of elevated Medicare Advantage and state-based contracts medical cost trends in 4Q24 and FY 2024, and</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.53pt">lower favorable prior period medical claims reserve development.</font></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">These factors were partially offset by t</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">he impact of the pricing and benefit design of the company's 2024 Medicare Advantage products, which included a reduction in benefits in response to the net impact of the 2024 final rate notice and the initial emergence of increased medical cost trends in 2023.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Furthermore, the year-over-year comparisons continue to reflect a shift in line of business mix, with growth in Medicare Advantage and state-based contracts and other membership, which can carry a higher benefit ratio.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Refer to the &#34;Footnotes&#34; section included herein for a reconciliation of GAAP to Adjusted (non-GAAP) consolidated benefit ratios for the respective periods. </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Prior Period Medical Claims Reserve Development (Prior Period Development)</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.166%"><tr><td style="width:1.0%"></td><td style="width:17.947%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.947%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.947%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.283%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.167%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#5c9a1b;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Consolidated Favorable Prior Period Development</font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">$ in millions</font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Basis points (bps)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">First<br>Quarter</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Second<br>Quarter</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Third<br>Quarter</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Fourth<br>Quarter</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FY</font></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Prior Period Development from prior years recognized in 2024 </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c) </font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$535</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$134</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$24</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$8</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$701</font></td></tr><tr><td colspan="9" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Decrease to GAAP benefit ratio</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(190 bps)</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(50 bps)</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(10 bps)</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(0 bps)</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(60 bps)</font></td></tr><tr><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Prior Period Development from prior years recognized in 2023 </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$522</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$232</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$4</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$114</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$872</font></td></tr><tr><td colspan="9" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Decrease to GAAP benefit ratio</font></td><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(200 bps)</font></td><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(90 bps)</font></td><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(0 bps)</font></td><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(50 bps)</font></td><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(90 bps)</font></td></tr></table></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_37"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Consolidated Operating Cost Ratio</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The year-over-year quarterly and FY decreases in the GAAP consolidated operating cost ratio from the respective 2023 periods primarily reflected the following&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">scale efficiencies associated with growth in the company's Medicare Advantage membership, </font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">administrative cost efficiencies resulting from the company's value creation initiatives, </font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">a lesser impact from commission expense for brokers in 2024 compared to 2023 as a result of the significant individual Medicare Advantage membership growth in 2023, and </font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">a lesser impact of value creation initiative charges</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in 4Q24 and FY 2024 compared to the prior year periods&#59; these charges were recorded at the corporate level and not allocated to the segments. </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The year-over-year FY comparison was further impacted by the accrued charge related to certain anticipated litigation expenses included in FY 2023 results.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These factors were partially offset by the following items&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">impact of significantly reduced compensation accruals in 4Q23 and FY 2023 related to the annual incentive plan offered to employees across all levels of the company as the company's 2023 performance was negatively impacted by higher-than-anticipated Medicare Advantage utilization trends, and</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">higher impairment costs in 4Q24 and FY 2024. </font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Refer to the &#34;Footnotes&#34; section included herein for a reconciliation of GAAP to Adjusted (non-GAAP) consolidated operating cost ratios for the respective periods. </font></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_43"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Balance sheet</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Days in claims payable (DCP) of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">37.8</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> days at December 31, 2024 represented a </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">decrease</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of 2.9 days</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">from 40.7 days at September 30, 2024 and a decrease of 3.6</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">days from 41.4 days at December 31, 2023. </font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The 2.9</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">days sequential decrease was primarily driven by a 2.6-day impact related to a lesser processed claims inventory as of December 31, 2024 compared to September 30, 2024.  </font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">The 3.6 days year-over-year decrease was primarily driven by lower reserve requirements in provider-capitation accruals due to lower performance-based payment expectations and a lesser processed claims inventory.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:107%"> </font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;padding-left:12.53pt">Humana's debt-to-total capitalization at December 31</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">, 2024 </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">decreased 40 basis points to 41.9 percent fro</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">m 42.3 p</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">ercent at </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">September 30, 2024 </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">primarily driven by repayment of senior note and commercial paper debt, partially offset by the impact of the 4Q24 net loss. </font></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_49"></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Operating cash flows</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">The year-over-year decline in FY GAAP operating cash flows primarily reflected lower earnings in 2024, partially offset by the favorable impact of working capital items.</font></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_64"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Humana&#8217;s Insurance Segment</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This segment is comprised of insurance products serving Medicare and state-based contract beneficiaries, as well as individuals and employers. The segment also includes the company's Pharmacy Benefit Manager, or PBM, business.   </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.027%"><tr><td style="width:1.0%"></td><td style="width:45.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.365%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Insurance Segment Results<br></font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($ in millions)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q24 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q23 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2024 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY  2023 (a)</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$28,170</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$25,565</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$113,764</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$102,854</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revenues - Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$28,156</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$24,801</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$113,213</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$99,090</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Benefits expense ratio</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">92.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">91.5&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">90.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">88.0&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Benefits expense ratio - Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">91.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">91.4&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">90.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">88.0&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating cost ratio</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">11.0</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.1&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">9.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.2&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating cost ratio - Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">11.0</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.9&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">9.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.8&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Loss) income from operations</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">($646)</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">($426)</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$1,289</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$2,654</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Loss) income from operations - Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">($575)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">($361)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$1,483</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$2,897</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Refer to the &#34;Footnotes&#34; section included herein for further explanation of disclosures for Adjusted (non-GAAP) financial measures, as well as recalculations.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Insurance Segment Revenues</font></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The year-over-year quarter and FY </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">increases</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in GAAP segment revenues from the respective 2023 periods primarily reflected the following items&#58; </font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">higher per member</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Medicare premiums, and </font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Medicare Advantage and state-based contracts membership growth.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These factors were partially offset by the continued decline in stand-alone PDP membership, as well as a decline in  membership in the group commercial medical business as a result of the company's decision to exit the business.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Refer to the &#34;Footnotes&#34; section included herein for a reconciliation of GAAP to Adjusted (non-GAAP) Insurance segment revenues for the respective periods. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Insurance Segment Benefit Ratio</font></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The year-over-year quarter and FY </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">increases </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">in the GAAP segment benefit ratio primarily reflected the following items&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.53pt">continued impact of elevated Medicare Advantage and state-based contracts medical cost trends in 4Q24 and FY 2024, and</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.53pt">lower favorable prior period medical claims reserve development.</font></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">These factors were partially offset by t</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">he impact of the pricing and benefit design of the company's 2024 Medicare Advantage products, which included a reduction in benefits in response to the net impact of the 2024 final rate notice and the initial emergence of increased medical cost trends in 2023.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Furthermore, the year-over-year comparisons continue to reflect a shift in line of business mix, with growth in Medicare Advantage and state-based contracts and other membership, which can carry a higher benefit ratio.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Refer to the &#34;Footnotes&#34; section included herein for a reconciliation of GAAP to Adjusted (non-GAAP) Insurance segment benefit ratios for the respective periods.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%"> </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Insurance Segment Operating Cost Ratio</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The year-over-year quarter and FY decreases in the GAAP segment operating cost ratio from the respective 2023 periods primarily related to the following&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">scale efficiencies associated with growth in the company's Medicare Advantage membership, </font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">administrative cost efficiencies resulting from the company's value creation initiatives, and</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">a lesser impact from commission expense for brokers in 2024 compared to 2023 as a result of the significant individual Medicare Advantage membership growth in 2023.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The year-over-year FY comparison was further impacted by the accrued charge related to certain anticipated litigation expenses included in FY 2023 results.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These factors were partially offset by the impact of significantly reduced compensation accruals in 4Q23 and FY 2023.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Refer to the &#34;Footnotes&#34; section included herein for a reconciliation of GAAP to Adjusted (non-GAAP) Insurance segment operating cost ratios for the respective periods. </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">January 2025 Ending Membership</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">January 2025 individual Medicare Advantage membership approximated 5,217,000, down approximately 444,800, or 8 percent, from December 31, 2024.  The decrease reflects net membership losses during the recently completed 2025 Annual Election (AEP) period, inclusive of the company's decision to exit certain unprofitable plans and counties, which impacted approximately 560,000 members.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Included within the Individual Medicare Advantage membership are approximately 814,000 Dual Eligible Special Need Plans (D-SNP) members, a decrease of 123,100, or 13 percent, from December 31, 2024. The D-SNP membership decrease was driven in part by delayed redeterminations as a result of the Change Healthcare disruption in 2024.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">January 2025 group Medicare Advantage membership approximated 576,000, up approximately 30,300, or 6 percent, from December 31, 2024, reflecting net membership additions during the 2025 selling season.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">January 2025 stand-alone PDP membership approximated 2,465,000, up approximately 176,800, or 8 percent, from December 31, 2024, reflecting net membership additions during the recently completed 2025 AEP.</font></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_76"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Humana&#8217;s CenterWell Segment</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This segment includes pharmacy (excluding the PBM operations), primary care, and home solutions.  The segment also includes the impact of non-consolidating minority interest investments related to the company's strategic partnerships with Welsh, Carson, Anderson &#38; Stowe (WCAS) to develop and operate senior-focused, payor-agnostic, primary care centers, as well as the</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gentiva (formerly Kindred) Hospice</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">operations</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Services offered by this segment are designed to enhance the overall healthcare experience. These services may lead to lower utilization associated with improved member health and&#47;or lower drug costs.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:43.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CenterWell Segment Results<br></font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($ in millions)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q23</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2023</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$5,130</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,710</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$19,936</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18,405</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.2&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$327</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$387</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,329</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,404</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations - Adjusted (non-GAAP) (d)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$385</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$445</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,553</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,614</font></td></tr></table></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Refer to the &#34;Footnotes&#34; section included herein for further explanation of disclosures for Adjusted (non-GAAP) financial measures, as well as reconciliations.  </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">CenterWell Segment Revenues</font></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The favorable year-over-year quarter and FY CenterWell segment revenues comparisons were primarily impacted by the following </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">factors&#58; </font></div><div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">greater intersegment revenues associated with the Home Solutions business in 2024 as compared to respective periods in 2023 as a result of the expansion of services to Humana members under value-based contracts,  </font></div><div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">an increase in Pharmacy Solutions revenues resulting from growth in the specialty pharmacy business, driven by increased penetration of Humana health plan members, as well as payor agnostic consumers,  and </font></div><div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">higher revenues associated with growth in the company's Primary Care business, partially offset by the impact of the v28 risk model revision.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">CenterWell Segment Operating Cost Ratio</font></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The year-over-year</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> quarterly and FY increases i</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">n the segment's operating cost ratio primarily resulted from the following&#58;</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">unfavorable impact of the v28 risk model revision to the company's Primary Care business, and</font></div><div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">the impact of significantly reduced compensation accruals in 4Q23 and FY 2023. </font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This impact was partially offset by the following factors&#58;</font></div><div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">administrative cost efficiencies resulting from the company's value creation initiatives, and</font></div><div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">positive prior period medical claims development within the Primary Care Organization</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">See additional operational metrics for the CenterWell segment on pages S-13 through S-15 of the statistical supplement included in this earnings release.</font></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_82"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Conference Call</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">Humana will host a live question and answer session for analysts at 9&#58;00 a.m. Eastern time today to discuss its financial results for the quarter and the company&#8217;s expectations for future earnings. In advance of the question and answer session, Humana will post prepared management remarks to the Quarterly Results section of its Investor Relations page (https&#58;&#47;&#47;humana.gcs-web.com&#47;financial-information&#47;quarterly-results).</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">To participate via phone, please register in advance at this link - https&#58;&#47;&#47;register.vevent.com&#47;register&#47;BIe3b4c275f3cf421383fa6ac8a142593b.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique registrant ID that can be used to access the call.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">A webcast of the 4Q24 earnings call may also be accessed via Humana&#8217;s Investor Relations page at humana.com.&#160;The company suggests participants for both the conference call and those listening via the web dial in or sign on at least 15 minutes in advance of the call. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For those </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">unable to participate in the live event, the archive will be available in the Historical Webcasts and Presentations section of the Investor Relations page (https&#58;&#47;&#47;humana.gcs-web.com&#47;events-and-presentations), approximately two hours following the live webcast.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_85"></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Footnotes</font></div><div style="margin-top:7pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company has included financial measures throughout this earnings release that are not in accordance with GAAP. Management believes that these measures, when presented in conjunction with the corresponding GAAP measures, provide a comprehensive perspective to more accurately compare and analyze the company&#8217;s core operating performance over time. Consequently, management uses these non-GAAP (Adjusted) financial measures as consistent and uniform indicators of the company&#8217;s core business operations from period to period, as well as for planning and decision-making purposes and in determination of incentive compensation. Non-GAAP (Adjusted) financial measures should be considered in addition to, but not as a substitute for, or superior to, financial measures prepared in accordance with GAAP. All financial measures in this earnings release are in accordance with GAAP unless otherwise indicated. Please refer to the footnotes for a detailed description of each item adjusted out of GAAP financial measures to arrive at non-GAAP (Adjusted) financial measures.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) For the periods covered in this earnings release, the following items are excluded from the non-GAAP financial</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measures described above, as applicable&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Amortization associated with identifiable intangibles -</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Since amortization varies based on the size and timing of acquisition activity, management believes this exclusion provides a more consistent and uniform indicator of performance from period to period. For all periods shown within this earnings release, </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GAAP measures affected include consolidated pretax results, (net loss per share) EPS, and Insurance and CenterWell segments income from operations. The table below discloses respective period amortization expense for each segment&#58;</font></div><div style="text-align:center"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.527%"><tr><td style="width:1.0%"></td><td style="width:35.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.794%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q23</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2023</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance segment</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$4</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$17</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CenterWell segment</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$10</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$11</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$43</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$45</font></td></tr></table></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Put&#47;call valuation adjustments </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">associated with the company&#8217;s non-consolidating minority interest investments - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amounts are the result of fair value measurements associated with the company's Primary Care Organization strategic partnership and are unrelated to the company's core business operations. For all periods shown within this earnings release, GAAP measures affected include consolidated pretax results and </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(net loss per share) EPS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:13.02pt">I</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">mpact of exit of employer group commercial medical products business - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amounts relate to activity from the exit of the employer group commercial medical products business as announced by Humana on February 23, 2023.  For all periods shown within this</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">earnings release, GAAP measures affected include consolidated pretax results, </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(net loss per share) EPS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, consolidated revenues, consolidated benefit ratio, consolidated operating cost ratio, Insurance segment revenues, Insurance segment benefit ratio, Insurance segment operating cost ratio, and Insurance segment income from operations.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Value creation initiatives - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These charges relate to the company's ongoing initiative to drive additional value for the enterprise through cost saving, productivity initiatives, and value creation from previous investments, and primarily consist of asset impairment and severance charges. These charges were recorded at the corporate level and not allocated to the segments. For all periods shown within this earnings release, GAAP measures affected in this release include consolidated pretax results, </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(net loss per share) EPS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and the consolidated operating cost ratio.</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Impairment charges -</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The company recognized non-cash impairment charges in 4Q24 and 4Q23 related to certain indefinite-lived intangible assets based on the company's estimate of future financial performance in certain state markets. Additionally, in 4Q23 the company recognized non-cash impairment charges related to minority ownership investments that were deemed to be unrecoverable based on investment performance. These charges were recorded at the corporate level and not allocated to the segments. For all periods, GAAP measures affected include consolidated pretax results, </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(net loss per share) EPS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and the consolidated operating cost ratio.  For 4Q23 and FY 20023, consolidated revenues (specifically investment income) were also affected.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Transaction and integration costs -</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The transaction and integration costs primarily related to the acquisition of Kindred at Home in 2021 and the subsequent divestiture of majority ownership of Gentiva (formerly Kindred) Hospice in 2022.  For FY 2023, GAAP measures affected include consolidated pretax results, </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(net loss per share) EPS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and the consolidated operating cost ratio.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Accrued charge related to certain anticipated</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">litigation expenses - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This charge related to certain anticipated expenses the company accrued in connection with a legal matter.  For FY 2023, GAAP measures affected include consolidated pretax results, </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(net loss per share) EPS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the consolidated and Insurance segment operating cost ratios, and Insurance segment income from operations.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Change in fair market value of publicly-traded equity securities - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These gains are a result of market and economic conditions that are unrelated to the company's core business operations.  For FY 2023, GAAP measures affected include consolidated pretax results, EPS, and consolidated revenues (specifically investment income).</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Cumulative net tax impact of non-GAAP adjustments - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This adjustment represents the cumulative net impact of the corresponding tax benefit or expense related to the aforementioned items excluded from the applicable GAAP measures.  For all periods presented in this earnings release, </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(net loss per share) EPS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is the sole GAAP measure affected.  </font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the reconciliations shown on</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">page 2</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of this release, the following are reconciliations of GAAP to Adjusted (non-GAAP) measures described above and disclosed within this earnings release&#58;</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:4.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Revenues</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:43.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Revenues - CONSOLIDATED</font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q23</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2023</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$29,213</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$26,462</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$117,761</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$106,374</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair market value of publicly-traded equity securities</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(764)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(551)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,764)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$29,199</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25,734</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$117,210</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$102,645</font></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"></td><td style="width:43.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.730%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Revenues - INSURANCE SEGMENT</font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q23</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2023</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$28,170</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25,565</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$113,764</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$102,854</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(764)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(551)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,764)</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$28,156</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$24,801</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$113,213</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$99,090</font></td></tr></table></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><font><br></font></div><div style="text-align:justify;text-indent:4.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:115%;text-decoration:underline">Benefit Ratio </font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:44.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.608%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Benefit ratio - CONSOLIDATED</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q23</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2023</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.7&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.3&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.2)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.5&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.750%"><tr><td style="width:1.0%"></td><td style="width:44.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.546%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Benefit ratio - INSURANCE SEGMENT</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q23</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2023</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.5&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.0&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.2)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.4&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.0&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:4.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Operating Cost Ratio </font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:44.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.608%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Operating cost ratio - CONSOLIDATED</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q23</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2023</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value creation initiatives</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.5)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.2)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued charge related to certain anticipated litigation expenses</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.7)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.2)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:43.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.570%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Operating cost ratio - INSURANCE SEGMENT</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q23</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2023</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.0</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued charge related to certain anticipated litigation expenses</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.0</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Insurance Segment - (Loss) Income from Operations</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:43.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.690%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(Loss) income from operations - INSURANCE SEGMENT </font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q23</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2023</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($646)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($426)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,289</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,654</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization associated with identifiable intangibles</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">177</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued charge related to certain anticipated litigation expenses</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($575)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($361)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,483</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,897</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">b) FY 2025 projected Adjusted results exclude the future impact of items that cannot be estimated at this time.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(c) Prior Period Development related to the employer group commercial medical products business&#58;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.416%"><tr><td style="width:1.0%"></td><td style="width:51.156%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.798%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.490%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Favorable (Unfavorable) Prior Period Development</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Quarter</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Second<br>Quarter</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Third Quarter</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fourth<br>Quarter</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FY</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Prior Period Development from prior years recognized in 2024 </font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$34</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($9)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($1)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($3)</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$21</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior Period Development from prior years recognized in 2023 </font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$23</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($20)</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($2)</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(d) The CenterWell segment Adjusted income from operations includes an adjustment to add back depreciation and amortization expense to the segment's GAAP income from operations since such an adjustment is commonly utilized for valuation purposes within the healthcare delivery industry. </font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:115%">  </font></div><div style="margin-bottom:12pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:43.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.690%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Income from operations  - CENTERWELL SEGMENT</font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4Q23</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FY 2023</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$327</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$387</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,329</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,404</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">224</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$385</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$445&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,553</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,614&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_97"></div><div style="margin-top:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Cautionary Statement</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This news release includes forward-looking statements regarding Humana within the meaning of the Private Securities Litigation Reform Act of 1995. When used in investor presentations, press releases, Securities and Exchange Commission (SEC) filings, and in oral statements made by or with the approval of one of Humana&#8217;s executive officers, the words or phrases like &#8220;expects,&#8221; &#8220;believes,&#8221; &#8220;anticipates,&#8221; &#8220;assumes,&#8221; &#8220;intends,&#8221; &#8220;likely will result,&#8221; &#8220;estimates,&#8221; &#8220;projects&#8221; or variations of such words and similar expressions are intended to identify such forward-looking statements.  </font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions, including, among other things, information set forth in the &#8220;Risk Factors&#8221; section of the company&#8217;s SEC filings, a summary of which includes but is not limited to the following&#58;  </font></div><div style="margin-bottom:2.4pt;padding-left:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">If Humana does not design and price its products properly and competitively, if the premiums Humana receives are insufficient to cover the cost of healthcare services delivered to its members, if the company is unable to implement clinical initiatives to provide a better healthcare experience for its members, lower costs and appropriately document the risk profile of its members, or if its estimates of benefits expense are inadequate, Humana&#8217;s profitability could be materially adversely affected. Humana estimates the costs of its benefit expense payments, and designs and prices its products accordingly, using actuarial methods and assumptions based upon, among other relevant factors, claim payment patterns, medical cost inflation, and historical developments such as claim inventory levels and claim receipt patterns. The company continually reviews estimates of future payments relating to benefit </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">expenses for services incurred in the current and prior periods and makes necessary adjustments to its reserves, including premium deficiency reserves, where appropriate. These estimates involve extensive judgment, and have considerable inherent variability because they are extremely sensitive to changes in claim payment patterns and medical cost trends. Accordingly, Humana's reserves may be insufficient.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">If Humana fails to effectively implement its operational and strategic initiatives, including its Medicare initiatives, which are of particular importance given the concentration of the company's revenues in these products, state-based contract strategy, the growth of its CenterWell business, and its integrated care delivery model, the company&#8217;s business may be materially adversely affected.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.53pt">The number of Humana&#8217;s Medicare Advantage plans rated 4-star or higher will significantly decline in 2025.  Humana has filed a lawsuit seeking to set aside and vacate the 2025 Star Ratings of its Medicare Advantage plans, but there is no assurance that the company will prevail in this lawsuit. If the company is not successful, the decline in Star Ratings will negatively impact its 2026 quality bonus payments from CMS and may also significantly adversely affect the company&#8217;s revenues, operating results, and cash flows. In addition, there can be no assurances the company will be successful in maintaining or improving its Star Ratings in future years. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">If Humana, or the third-party service providers on which it relies, fails to properly maintain the integrity of its data, to strategically maintain existing or implement new information systems, to protect Humana&#8217;s proprietary rights to its systems, or to defend against cyber-security attacks, contain such attacks when they occur, or prevent other privacy or data security incidents that result in security breaches that disrupt the company's operations or in the unintentional dissemination of sensitive personal information or proprietary or confidential information, the company&#8217;s business may be materially adversely affected.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Humana is involved in various legal actions, or disputes that could lead to legal actions (such as, among other things, provider contract disputes and qui tam litigation brought by individuals on behalf of the government), governmental and internal investigations, and routine internal review of business processes any of which, if resolved unfavorably to the company, could result in substantial monetary damages or changes in its business practices. Increased litigation and negative publicity could also increase the company&#8217;s cost of doing business.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">As a government contractor, Humana is exposed to risks that may materially adversely affect its business or its willingness or ability to participate in government healthcare programs including, among other things, loss of material government contracts&#59; governmental audits and investigations&#59; potential inadequacy of government determined payment rates&#59; potential restrictions on profitability, including by comparison of profitability of the company&#8217;s Medicare Advantage business to non-Medicare Advantage business&#59; or other changes in the governmental programs in which Humana participates. Changes to the risk-adjustment model utilized by CMS to adjust premiums paid to Medicare Advantage plans or retrospective recovery by CMS of previously paid premiums as a result of the final rule related to the risk adjustment data validation audit methodology published by CMS on January 30, 2023 (Final RADV Rule), which Humana believes fails to address adequately the statutory requirement of actuarial equivalence and violates the Administrative Procedure Act due to its failure to include a &#34;Fee for Service Adjuster&#34; could have a material adverse effect on the company's operating results, financial position and cash flows. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Humana's business activities are subject to substantial government regulation.  New laws or regulations, or legislative, judicial, or regulatory changes in existing laws or regulations or their manner of application could increase the company's cost of doing business and have a material adverse effect on Humana&#8217;s results of operations (including restricting revenue, enrollment and premium growth in certain products and market segments, restricting the company&#8217;s ability to expand into new markets, increasing the company&#8217;s medical and operating costs by, among other things, requiring a minimum benefit ratio on insured products, lowering the company&#8217;s Medicare payment rates and increasing the company&#8217;s expenses associated with a non-deductible health insurance industry fee and other assessments)&#59; the company&#8217;s financial position (including the company&#8217;s ability to maintain the value of its goodwill)&#59; and the company&#8217;s cash flows.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Humana&#8217;s failure to manage acquisitions, divestitures and other significant transactions successfully may have a material adverse effect on the company&#8217;s results of operations, financial position, and cash flows. </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">If Humana fails to develop and maintain satisfactory relationships with the providers of care to its members, the company&#8217;s business may be adversely affected.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;padding-left:12.53pt">Humana faces significant competition in attracting and retaining talented employees. Further, managing succession for, and retention of, key executives is critical to the Company&#8217;s success, and its failure to do so could adversely affect the Company&#8217;s businesses, operating results and&#47;or future performance.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Humana&#8217;s pharmacy business is highly competitive and subjects it to regulations and supply chain risks in addition to those the company faces with its core health benefits businesses.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Changes in the prescription drug industry pricing benchmarks may adversely affect Humana&#8217;s financial performance.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Humana&#8217;s ability to obtain funds from certain of its licensed subsidiaries is restricted by state insurance regulations.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Downgrades in Humana&#8217;s debt ratings, should they occur, may adversely affect its business, results of operations, and financial condition.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Volatility or disruption in the securities and credit markets may significantly and adversely affect the value of our investment portfolio and the investment income that we derive from this portfolio.    </font></div><div style="padding-left:36pt;text-align:justify;text-indent:4.5pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In making forward-looking statements, Humana is not undertaking to address or update them in future filings or communications regarding its business or results. In light of these risks, uncertainties, and assumptions, the forward-looking events discussed herein may or may not occur. There also may be other risks that the company is unable to predict at this time. Any of these risks and uncertainties may cause actual results to differ materially from the results discussed in the forward-looking statements.  </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Humana advises investors to read the following documents as filed by the company with the SEC for further discussion both of the risks it faces and its historical performance&#58; </font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Form 10-K for the year ended December&#160;31, 2023&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Form 10-Qs for the quarters ended March 31, 2024, June 30, 2024, and September 30, 2024&#59; and </font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Form 8-Ks filed during 2024 and 2025. </font></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_100"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">About Humana </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Humana Inc. is committed to putting health first &#8211; for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health &#8211; delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.  </font></div><div style="margin-top:12pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.388%"><tr><td style="width:1.0%"></td><td style="width:29.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.807%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:29.447%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%;text-decoration:underline">Humana Inc. Full Year 2025 Projections - As of February 11, 2025</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Diluted earnings per common share</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">approximately $15.88</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-GAAP&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> approximately $16.25</font></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Total Revenues</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> $126 billion to $128 billion</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Consolidated and segment level revenue projections include expected investment income.<br>Segment level revenues include amounts that eliminate in consolidation.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance segment</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$121 billion to $123 billion</font></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CenterWell segment</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20.5 billion to $21.5 billion</font></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Change in year-end medical membership from prior year-end</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decline of approximately 550,000</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relatively flat</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Growth of approximately 200,000</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State-based contracts</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Growth within 175,000 to 250,000 range</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">State-based contracts guidance includes membership in Florida, Illinois, Indiana, Kentucky, Louisiana, Ohio, Oklahoma, South Carolina, Virginia, and Wisconsin.</font></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Ratio</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Insurance segment</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> 90.1% to 90.5%</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ratio calculation&#58; benefits expense as a percent of premiums revenues.</font></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Cost Ratio </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">            Consolidated</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3% to 11.7%</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ratio calculation&#58; operating costs excluding depreciation and amortization as a percent of revenues excluding investment income.</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Segment Results</font></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance segment income from operations</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.5 billion to $2.0 billion</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;<br></font><font style="font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">CenterWell segment Non-GAAP income from operations excludes the projected impact of segment depreciation and amortization.</font></td></tr><tr style="height:26pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CenterWell segment income from operations</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> $1.0 billion to $1.5 billion</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-GAAP&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> $1.2 billion to $1.7 billion</font></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effective Tax Rate</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  approximately 25.0%</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Avg. Share Count for Diluted EPS</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">approximately 121.5 million</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operations</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> $2.4 billion to $2.9 billion</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capital expenditures</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">approximately $650 million</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">14</font></div></div></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_106"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:40pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:40pt;font-weight:400;line-height:120%">Statistical Schedules</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:40pt;font-weight:400;line-height:120%">and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:40pt;font-weight:400;line-height:120%">Supplementary Information</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:40pt;font-weight:400;line-height:120%">4Q24 Earnings Release</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-1</font></div></div></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_109"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:center;text-indent:-36pt"><font><br></font></div><div style="text-align:center;text-indent:-36pt"><font><br></font></div><div style="text-align:center;text-indent:-36pt"><font><br></font></div><div style="text-align:center;text-indent:-36pt"><font><br></font></div><div style="text-align:center;text-indent:-36pt"><font><br></font></div><div style="text-align:center;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.833%"><tr><td style="width:1.0%"></td><td style="width:23.108%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Humana Inc.<br>Statistical Schedules and Supplementary Information <br>4Q24 Earnings Release </font></td></tr><tr style="height:5pt"><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(S-3)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Summary of Results - Consolidated and Segment Quarter and FY</font></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(S-4)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Consolidated Statements of Income - Quarter and FY</font></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(S-5)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Consolidated Balance Sheets</font></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(S-6)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Consolidated Statements of Cash Flows - FY</font></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(S-7) - (S-8)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Consolidating Statements of Income - Quarter</font></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(S-9) - (S-10)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Consolidating Statements of Income - FY</font></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(S-11)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Membership Detail</font></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(S-12)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Premiums and Services Revenue Detail</font></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(S-13) - (S-15)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CenterWell Segment - Pharmacy Solutions, Primary Care, &#38; Home Solutions</font></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(S-16)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Footnotes</font></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-2</font></div></div></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_115"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.062%"><tr><td style="width:1.0%"></td><td style="width:45.454%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.263%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Humana Inc. Summary of Results<br></font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($ in millions, except per share amounts)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4Q24 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4Q23 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FY 2024 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FY  2023 (a)</font></td></tr><tr><td colspan="15" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONSOLIDATED</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues </font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$29,213</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$26,462</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$117,761</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$106,374</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues - Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$29,199</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25,734</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$117,210</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$102,645</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pretax results</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($862)</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($591)</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,721</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,383</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pretax results - Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($296)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$79</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,702</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,369</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Net loss per share) EPS</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($5.76)</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($4.42)</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$9.98</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20.00</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Net loss per share) EPS - Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($2.16)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($0.11)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$16.21</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$26.09</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits expense ratio</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.7&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.3&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits expense ratio - Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.5&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio - Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows </font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,966</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,981</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Parent company cash and short term investments</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$562</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$510</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt-to-total capitalization</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.8&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Days in Claims Payable (DCP)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37.8</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.4</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="15" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INSURANCE SEGMENT</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$28,170</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25,565</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$113,764</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$102,854</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues - Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$28,156</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$24,801</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$113,213</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$99,090</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits expense ratio</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.5&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.0&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits expense ratio - Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.4&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.0&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.0</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio - Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.0</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from operations</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($646)</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($426)</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,289</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,654</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from operations - Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($575)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($361)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,483</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,897</font></td></tr><tr><td colspan="15" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CENTERWELL SEGMENT</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$5,130</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,710</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$19,936</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18,405</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.2&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$327</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$387</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,329</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,404</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations - Adjusted (non-GAAP) (d)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$385</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$445</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,553</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,614</font></td></tr></table></div><div style="padding-left:90pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Refer to the &#34;Footnotes&#34; section included in the previous narrative portion of this release (beginning on page 8) for further explanation of disclosures for Adjusted (non-GAAP) financial measures, as well as reconciliations.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Consolidated Statements of Income (Unaudited)</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Dollars in millions, except per common share results</font></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.916%"><tr><td style="width:1.0%"></td><td style="width:43.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.413%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">For&#160;the&#160;three&#160;months&#160;ended&#160;<br>December 31,</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">For&#160;the&#160;year ended <br>December 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revenues&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Premiums</font></td><td style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">27,750</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25,128&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">112,104</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">101,272&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Services</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1,166</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,040&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4,431</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,033&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Investment income</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">297</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">294&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1,226</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,069&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Total revenues</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">29,213</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">26,462&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">117,761</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">106,374&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Benefits</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">25,381</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">22,782&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">100,664</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">88,394&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating costs</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4,167</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,827&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">13,696</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13,188&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">208</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">201&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">839</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">779&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Total operating expenses</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">29,756</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">26,810&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">115,199</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">102,361&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(Loss) income from operations</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(543)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(348)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2,562</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,013&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">164</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">146&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">660</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">493&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other expense, net</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">155</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">97&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">181</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">137&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(Loss) income before income taxes and equity in net losses</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(862)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(591)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1,721</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,383&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Benefit) provision from income taxes</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(216)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(75)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">413</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">836&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Equity in net losses (A)</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(37)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(24)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(94)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(63)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Net (loss) income</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(683)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(540)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1,214</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,484&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(10)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(7)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Net (loss) income attributable to Humana</font></td><td style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(693)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(541)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1,207</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,489&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Basic (loss) earnings per common share</font></td><td style="border-left:1pt solid #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(5.76)</font></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(4.42)</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-left:1pt solid #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">10.01</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20.09&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Diluted (loss) earnings per common share</font></td><td style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(5.76)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(4.42)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">9.98</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20.00&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing basic earnings per common share (000&#8217;s)</font></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">120,455</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,461&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">120,571</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,866&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing diluted earnings (loss) per common share (000&#8217;s)</font></td><td colspan="2" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">120,455</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,461&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">120,869</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,441&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-4</font></div></div></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_121"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Balance Sheets (Unaudited)</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Dollars in millions, except share amounts</font></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.062%"><tr><td style="width:1.0%"></td><td style="width:72.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.023%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December&#160;31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,221</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,694&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment securities</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18,214</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,626&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receivables, net</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,704</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,035&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,676</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,631&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current assets</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">29,815</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,986&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,532</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,030&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term investment securities</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">421</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">382&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity method investments</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">697</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">740&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,631</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,550&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term assets</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,383</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,377&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</font></td><td style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">46,479</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47,065&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities and Stockholders&#8217; Equity</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Benefits payable</font></td><td style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,440</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,241&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade accounts payable and accrued expenses</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,259</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,569&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Book overdraft</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">403</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">353&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unearned revenues</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">260</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">266&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term debt</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">577</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,443&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current liabilities</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,939</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,872&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11,144</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,213&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,951</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,662&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">30,034</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,747&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commitments and contingencies</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stockholders&#8217; equity&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred stock, $1 par&#59; 10,000,000 shares authorized, none issued</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock, $0.16 2&#47;3 par&#59; 300,000,000 shares authorized&#59; 198,718,810 issued at December 31, 2024</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">33</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capital in excess of par value</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,463</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,346&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained earnings</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">28,317</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,540&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,067)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(999)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock, at cost, 78,077,195 shares at December 31, 2024</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14,371)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,658)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders&#8217; equity</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,375</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,262&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncontrolling interests</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">70</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total equity</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,445</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,318&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities and equity</font></td><td style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">46,479</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47,065&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt-to-total capitalization ratio</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">41.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41.8&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-5</font></div></div></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_124"></div><hr style="page-break-after:always"><div style="min-height:31.5pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Inc. </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Cash Flows (Unaudited) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Dollars in millions </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.979%"><tr><td style="width:1.0%"></td><td style="width:66.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.965%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For&#160;the&#160;year ended December 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from operating activities</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$1,214</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$2,484</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Gain) loss on investment securities, net</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(24)</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity in net losses</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">94</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">207</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">175</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairment of indefinite-lived intangible assets</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">200</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">908</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">850</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">60</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairment of property and equipment</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">237</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">206</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(192)</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(167)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of effect of businesses acquired and disposed&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receivables</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(669)</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(337)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,003</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,318)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Benefits payable</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">199</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">915</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other liabilities</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(373)</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">841</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unearned revenues</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(6)</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(20)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, net</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">108</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">113</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash provided by operating activities</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,966</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,981</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from investing activities</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisitions, net of cash and cash equivalents acquired</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(89)</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(233)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(575)</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,004)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of property and equipment</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">210</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in securities lending collateral receivable</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(418)</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of investment securities</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(8,185)</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,552)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturities of investment securities</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,982</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,292</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sales of investment securities</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,376</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,795</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(50)</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash used in investing activities</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,952)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,492)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from financing activities</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Payments) receipts from contract deposits, net</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,933)</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">828</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of senior notes, net</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,232</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,544</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayments of senior notes</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,107)</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,832)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Repayments) proceeds from issuance of commercial paper, net</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(907)</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">211</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayments of short-term borrowings</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(100)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment of term loan</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(500)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt issue costs</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(7)</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in book overdraft</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">50</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock repurchases</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(817)</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,573)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends paid</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(431)</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(431)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in securities lending payable</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">418</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in rebate factor payable</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">123</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, net </font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(108)</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(151)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash used in financing activities</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,487)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(856)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Decrease in cash and cash equivalents</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,473)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(367)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,694</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,061</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of period </font></td><td colspan="3" style="border-bottom:3pt double #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$2,221</font></td><td colspan="3" style="border-bottom:3pt double #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$4,694</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-6</font></div></div></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_130"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Consolidating Statements of Income&#8212;For the three months ended December 31, 2024 (Unaudited)</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In millions </font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font></div><div><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.625%"><tr><td style="width:1.0%"></td><td style="width:44.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Insurance</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CenterWell</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations&#47;<br>Corporate</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues&#8212;external customers Premiums&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,500&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,500&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,891&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,891&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicare</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,119&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,119&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State-based contracts and other</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,159&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,159&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial fully-insured</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty benefits</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Medicare Supplement</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total premiums</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,750&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,750&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Services revenue&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Primary care</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy solutions</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Military services and other</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial ASO </font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total services revenue</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues&#8212;external customers</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,001&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,916&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,215&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,216)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,170&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,130&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,087)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,213&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,547&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,381&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,089&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,745&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,667)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,167&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,816&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,803&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,863)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,756&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Loss) income from operations</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(646)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(543)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit ratio</font></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.1&#160;</font></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.5&#160;</font></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating cost ratio</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Consolidating Statements of Income&#8212;For the three months ended December 31, 2023 (Unaudited)</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In millions</font></div><div><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.625%"><tr><td style="width:1.0%"></td><td style="width:44.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Insurance</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CenterWell</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations&#47;<br>Corporate</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues&#8212;external customers Premiums&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,642&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,642&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicare</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,831&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,831&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State-based contracts and other </font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial fully-insured</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty benefits</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24.75pt;text-indent:-9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total premiums</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,128&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,128&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Services revenue&#58;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Primary care</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy solutions</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Military services and other</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial ASO</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total services revenue</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,040&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues&#8212;external customers</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,398&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,168&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,940&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,941)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,565&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,710&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,813)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,462&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,004&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(222)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,782&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,811&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,265&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,249)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,827&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,991&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,323&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,504)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,810&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Loss) income from operations</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(426)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(309)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(348)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit ratio</font></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.5&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.7&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating cost ratio</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:1pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Consolidating Statements of Income&#8212;For the year ended December 31, 2024 (Unaudited)</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In millions</font></div><div style="margin-bottom:1pt;text-align:center;text-indent:-31.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.625%"><tr><td style="width:1.0%"></td><td style="width:44.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Insurance</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CenterWell</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations&#47;<br>Corporate</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues&#8212;external customers Premiums&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,019&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,019&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,731&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,731&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,137&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,137&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicare</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,887&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,887&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State-based contracts and other</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,915&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,915&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial fully-insured</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty benefits </font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total premiums</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,104&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,104&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Services revenue&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions </font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Primary care</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,248&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,248&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy solutions </font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Military services and other</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial ASO</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total services revenue</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,465&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,431&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues&#8212;external customers</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,070&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,465&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,535&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,471&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,475)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,764&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,936&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,939)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,761&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,299&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(635)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,664&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,443&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,383&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,130)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,696&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">733&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,475&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,607&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,883)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,199&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from operations</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,289&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,562&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit ratio</font></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.4&#160;</font></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.8&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating cost ratio</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:1pt;text-align:center;text-indent:-31.5pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:1pt"><font><br></font></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Consolidating Statements of Income&#8212;For the year ended December 31, 2023 (Unaudited)</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In millions</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.145%"><tr><td style="width:1.0%"></td><td style="width:44.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.784%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.784%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.784%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Insurance</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CenterWell</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations&#47;<br>Corporate</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues&#8212;external customers Premiums&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,837&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,837&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,869&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,869&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,189&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,189&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicare</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,895&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,895&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State-based contracts and other</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,108&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,108&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial fully-insured</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,527&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,527&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty benefits</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,007&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,007&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total premiums</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,272&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,272&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Services revenue&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,342&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,342&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Primary care</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy solutions</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Military services and other</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial ASO</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total services revenue</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,033&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,033&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues&#8212;external customers</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,272&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,033&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,305&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,372&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,403)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,069&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,854&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,405&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,885)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,374&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,100&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(706)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,394&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,408&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,791&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,011)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,188&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,200&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,001&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,840)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,361&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from operations</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,654&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,013&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit ratio</font></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.0&#160;</font></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.3&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating cost ratio</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-10</font></div></div></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_136"></div><hr style="page-break-after:always"><div style="min-height:42.7pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Membership Detail  (Unaudited)     </font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">In thousands</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.453%"><tr><td style="width:1.0%"></td><td style="width:36.123%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.199%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.199%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.199%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.204%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average 4Q24</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Membership&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Individual Medicare Advantage*</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,661.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,670.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,408.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,659.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Group Medicare Advantage</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">545.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">546.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">509.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">546.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Medicare Advantage</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,207.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,216.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,918.5&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,205.9&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,288.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,297.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,849.1&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,315.7&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Medicare</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,495.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,513.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,767.6&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,521.6&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicare Supplement</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">377.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">370.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">307.2&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">357.3&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State-based contracts and other</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,459.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,455.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,228.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,446.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Military services</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,009.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,995.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,960.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,984.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total excluding employer group commercial medical</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,342.0</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,334.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,263.8&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,309.8&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fully-insured commercial medical</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">338.7&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.9&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASO commercial</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">255.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total employer group commercial medical</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5.1</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13.0</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">594.0&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48.3&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Medical Membership</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,347.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,347.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,857.8&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,358.1&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Membership&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dental&#8212;fully-insured (B)</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,054.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,058.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,205.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,070.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dental&#8212;ASO</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">301.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">301.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">307.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">291.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Dental</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,355.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,359.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,512.0&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,361.9&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vision</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,843.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,842.0</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,971.4&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,846.5&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other supplemental benefits</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">362.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">360.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">384.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">358.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Specialty Membership</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,562.0</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,561.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,868.3&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,566.8&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Member Mix<br>December 31, 2024</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2023</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Member Mix<br>December 31, 2023</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Individual Medicare Advantage Membership</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HMO</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,857.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">50</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,853.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PPO&#47;PFFS</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,804.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">50</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,555.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Individual Medicare Advantage</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,661.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">100</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,408.9&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Individual Medicare Advantage Membership</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shared Risk (C)</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,114.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">38</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,917.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Path to Risk (D)</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,879.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">33</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,847.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Value-based</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,994.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">71</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,764.3&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,667.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">29</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,644.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Individual Medicare Advantage</font></td><td colspan="2" style="border-bottom:3pt double #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,661.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:3pt double #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">100</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,408.9&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Individual Medicare Advantage membership includes</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> 937,100 </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Dual Eligible Special Need Plans (D-SNP) members as of December 31, 2024, a net increase of 65,800, or 8 percent, from 871,300 as of December 31, 2023, and down 2,500, or </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">less than 1 percent</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, from 939,600 as of September 30, 2024</font></div><div style="height:40.27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-11</font></div></div></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_139"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_145"></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Humana Inc. </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Premiums and Services Revenue Detail (Unaudited)</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dollars in millions, except per member per month&#59; includes intersegment revenues </font></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.562%"><tr><td style="width:1.0%"></td><td style="width:28.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.069%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.339%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.069%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.339%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.995%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For&#160;the&#160;three&#160;months&#160;ended&#160;<br>December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the year ended <br>December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Per&#160;Member&#160;per&#160;Month&#160;(I)<br>For&#160;the&#160;three&#160;months&#160;ended&#160;December 31,</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Per&#160;Member&#160;per&#160;Month&#160;(I)<br>For the year ended December 31,</font></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Insurance</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Individual Medicare Advantage</font></td><td style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">21,500</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,642&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">88,019</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,837&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,264</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,210&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,307</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,246&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Group Medicare Advantage</font></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,891</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,677&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7,731</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,869&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,154</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,096&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,176</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,121&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</font></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">728</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">512&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,137</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,189&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">106</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">112</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State-based contracts and other (E)</font></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,159</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,142&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,915</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,108&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">699</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">560&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">627</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">496&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial fully-insured (F)</font></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">717&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">501</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,527&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">345</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">570&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">563</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">556&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Specialty benefits (G)</font></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">238</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">955</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,007&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">19</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Supplement</font></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">226</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">846</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">735&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">203</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">205</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Military and other (H)</font></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">246</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">920</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">794&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial ASO</font></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">50</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total </font></td><td colspan="2" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">28,002</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,399&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">113,074</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102,303&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CenterWell</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmacy solutions</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,993</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,791&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11,628</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,300&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Primary care</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,279</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,073&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,945</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,174&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Home solutions </font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">858</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">846&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,363</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,931&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,130</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,710&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">19,936</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,405&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">CenterWell Segment - Pharmacy Solutions (Unaudited)</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.062%"><tr><td style="width:1.0%"></td><td style="width:20.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.075%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.075%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.503%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:24.075%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.507%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For&#160;the&#160;three&#160;months&#160;ended<br>December 31, 2024</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">For&#160;the&#160;three&#160;months&#160;ended<br>December 31, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">For&#160;the&#160;three&#160;months&#160;ended<br>September 30, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Generic Dispense Rate</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 49.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total Medicare</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">90.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">90.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Mail-Order Penetration</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 49.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total Medicare</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">27.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.062%"><tr><td style="width:1.0%"></td><td style="width:20.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.075%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.075%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.503%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:24.075%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.507%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For&#160;the year&#160;ended<br>December 31, 2024</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">For&#160;the&#160;year&#160;ended<br>December 31, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Generic Dispense Rate</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 49.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total Medicare</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">91.0</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Mail-Order Penetration</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 49.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total Medicare</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">28.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29.7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:99pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">CenterWell Segment - Primary Care (J) (Unaudited) </font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.041%"><tr><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.336%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.336%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">As of December 31, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">As of December 31, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year-over-Year Growth</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Primary</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Primary</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Primary</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Center</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Care</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Patients</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Center</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Care</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Patients</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Center</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Care</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Patients</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Count</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Providers</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Served (K)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Count</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Providers</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Served (K)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Count</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Providers</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Served</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">De novo</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">133&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">327</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">79,400&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">108&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">274</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">43,100&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23.1&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19.3&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">84.2&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Wholly-owned</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">211</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">675</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">246,500&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">188</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">617</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">189,600&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">30.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Independent Physician Associations</font></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">64,600&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">61,500&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">344</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,002&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">390,500&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">296</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">891&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">294,200&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16.2&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12.5&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">32.7&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.020%"><tr><td style="width:1.0%"></td><td style="width:17.412%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:4.023%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.969%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">As of September 30, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Sequential Growth</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Primary</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Primary</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Center</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Care</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Patients</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Center</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Care</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Patients</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Count</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Providers</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Served (K)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Count</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Providers</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Served</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">De novo</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">120&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">295</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">64,100&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.8&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.8&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23.9&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Wholly-owned</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">181</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">658</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">217,300&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Independent Physician Associations</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">62,800&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">301</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">953&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">344,200&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14.3&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.1&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13.5&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">CenterWell Segment - Home Solutions (Unaudited) </font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.145%"><tr><td style="width:1.0%"></td><td style="width:29.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.902%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">For the three months ended<br>December 31, 2024</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">For the three months ended<br>December 31, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Year-over-Year Growth</font></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Episodic Admissions (L)</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">77,429&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">75,921&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">2.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Total Admissions - Same Store (M)</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">100,580&#160;</font></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">97,363&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">3.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.145%"><tr><td style="width:1.0%"></td><td style="width:29.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.902%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">For the year ended<br>December 31, 2024</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">For the year ended<br>December 31, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Year-over-Year Growth</font></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Episodic Admissions (L)</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">321,862&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">301,642&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">6.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Total Admissions - Same Store (M)</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">416,133&#160;</font></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">384,552&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">8.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-15</font></div></div></div><div id="i45fcfc2dae8f4d179f1cf8be997c3fd9_157"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Footnotes to Statistical Schedules and Supplementary Information</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4Q24 Earnings Release </font></div><div><font><br></font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8.87pt">Net losses</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">associated with the company's non-consolidated minority interest investments.</font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">B.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.25pt">Fully-insured dental membership as reported does not include Humana members that have a Medicare Advantage plan that includes an embedded dental benefit. </font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">C.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:9.37pt">In certain circumstances, the company contracts with providers to accept financial risk for a defined set of Medicare Advantage membership. For these Downside Risk arrangements, the provider is measured against a medical expense ratio target and the company may share savings from reduction to the total cost of care of the defined membership. The result is a high level of engagement on the part of the provider. Under these arrangements, the company may contract with providers to accept partial, full, or global financial risk. In certain instances (capitated shared risk) of these arrangements, the company may choose to prepay these providers a monthly fixed-fee per member to coordinate substantially all of the medical care for their Medicare Advantage members assigned or attributed to their provider panel, including some health benefit administrative functions and claims processing.</font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">D.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:8.47pt">A Path to Risk provider is one who has a high level of engagement and has contracted with the company to participate in an Upside Only&#47;Shared Savings total cost of care arrangement and&#47;or in one of Humana&#8217;s Quality Bonus programs (Model Practice), through which the company rewards the provider for achieving quality and utilization targets. Providers who are contracted in an Upside Only&#47;Shared Savings arrangement may receive a portion of achieved surpluses when the actual cost of the medical services provided to patients assigned or attributed to their panel is less than the agreed upon medical expense targets. These contracts may also include a Downside Risk trigger (future date or membership threshold) which has not yet been met.</font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">E.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.86pt">Per Member per Month (PMPM) shown reflects only Medicaid premiums and average Medicaid membership for the period&#59; includes impact of dual eligible demonstration members. </font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">F.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.18pt">Fully-insured commercial medical premiums also include stop-loss premiums associated with the commercial ASO product&#59; for purposes of the PMPM metric, the commercial ASO stop-loss premiums have been excluded.</font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">G.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8.3pt">Specialty per member per month is computed based on reported specialty premiums and average fully-insured specialty membership for the period.  </font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">H.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8.38pt">The amounts primarily reflect services revenues under the TRICARE East Region contract that generally are contracted on a per-member basis. </font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.46pt">Computed based on average membership for the period (i.e. monthly ending membership during the period divided by the number of months in the period).</font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">J.</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:11.73pt">De novo </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">refers to all new centers opened or acquired since 2020 under a WCAS joint venture</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.  Wholly-owned </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">refers to all centers outside a WCAS joint venture. </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">K.</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.52pt">Represents Medicare Advantage (MA) risk, MA path to risk, MA value-based, Direct Contracting Entity, and Accountable Care Organization patients. </font><font style="background-color:#ffffff;color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">L.</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.61pt">Reflects patient admissions under the Patient Driven Groupings Model (PDGM) payment model.</font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">M.</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.83pt">Reflects all patient admissions regardless of reimbursement model. Same store is defined as care centers that have been owned and operated at least the last twelve months and startups that are an expansion of a same store care center. </font></div><div style="padding-left:9pt"><font><br></font></div><div style="padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-16</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>a4q2024humanaincpostedrema.htm
<DESCRIPTION>EX-99.3
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ie13bf0ca4cce4b4b96f5b81b791b662a_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Exhibit 99.3 &#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Humana Inc. Fourth Quarter 2024 Prepared Management Remarks</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2&#47;11&#47;2025</font></div></div><div style="text-align:center"><img alt="image_0.jpg" src="image_0.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:238px"></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Please view these remarks in conjunction with our 4Q 2024 earnings release that can be found on our website at </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.humana.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> under the Investors section, or via the following link&#58;  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;humana.gcs-web.com&#47;financial-information&#47;quarterly-results.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We also invite you to listen to our live question and answer webcast with our President and Chief Executive Officer, Jim Rechtin, Chief Financial Officer, Celeste Mellet, and President of Insurance, George Renaudin, which will begin today at 9&#58;00 a.m. Eastern Time and will be available at via the following link&#58;  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;humana.gcs-web.com&#47;events-and-presentations&#47;upcoming-events</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. For those unable to listen to the live event, the archive will be available in the Historical Webcasts and Presentations section of the Investor Relations page via the following link&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;humana.gcs-web.com&#47;events-and-presentations</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Cautionary Statement </font></div><div style="margin-bottom:5pt;text-align:justify;text-indent:21.6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Certain of the matters discussed in these prepared remarks are forward-looking and are subject to a number of risks, uncertainties and assumptions.  Actual results could differ materially.</font></div><div style="margin-bottom:5pt;text-align:justify;text-indent:21.6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Investors are advised to read the detailed risk factors discussed in our latest Form 10-K, our other filings with the Securities and Exchange Commission, and our 4Q 2024 earnings release as they relate to forward-looking statements along with other risks discussed in our SEC filings. We undertake no obligation to publicly address or update any forward-looking statements in future filings or communications regarding our business or results. </font></div><div style="margin-bottom:5pt;text-align:justify;text-indent:21.6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Today&#8217;s release, our historical financial news releases and our filings with the SEC are all also available on our Investor Relations site.  </font></div><div style="margin-bottom:5pt;text-align:justify;text-indent:21.6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These remarks include financial measures that are not in accordance with generally accepted accounting principles, or GAAP. </font></div><div style="margin-bottom:5pt;text-align:justify;text-indent:21.6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Management's explanation for the use of these non-GAAP measures and reconciliations of GAAP to non-GAAP financial measures are included in today&#8217;s release which can be found via the following link&#58;  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;humana.gcs-web.com&#47;financial-information&#47;quarterly-results</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:5pt;text-align:justify;text-indent:21.6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Finally, any references to earnings per share or EPS made within these remarks refer to diluted earnings per common share. </font></div><div style="margin-bottom:5pt;text-align:justify;text-indent:21.6pt"><font><br></font></div><div style="margin-bottom:5pt;text-align:justify;text-indent:21.6pt"><font><br></font></div><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div><div><font><br></font></div></div></div><div id="ie13bf0ca4cce4b4b96f5b81b791b662a_4"></div><hr style="page-break-after:always"><div style="min-height:56.16pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Exhibit 99.3 &#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Humana Inc. Fourth Quarter 2024 Prepared Management Remarks</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2&#47;11&#47;2025</font></div></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Key Messages</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:14.33pt">Achieved 2024 Adjusted EPS of $16.21, in line with our guidance, and reaffirmed 2025 outlook of &#8216;at least in line with 2024 results&#8217;</font></div><div style="margin-bottom:6pt;padding-left:36pt;padding-right:-4.3pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:7.2pt">2025 Adjusted EPS guidance of &#8216;approximately $16.25&#8217;, inclusive of incremental investments to support operational excellence</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> as we </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">prioritize sustainable, long-term value creation</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:14.33pt">Solid finish to 2024</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">reporting 4Q Adjusted net loss per share of $2.16, in line with expectations</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> and inclusive of incremental investments in Stars </font></div><div style="margin-bottom:6pt;padding-left:36pt;padding-right:-4.3pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:7.2pt">4Q Insurance segment Adjusted benefit ratio of 91.9%,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> which includes a 20-basis point increase related to incremental Stars investments, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">was consistent with expectations </font></div><div style="margin-bottom:6pt;padding-left:40.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:11.7pt">Grew individual Medicare Advantage (MA) membership over 250,000 or approximately 5% </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">in 2024, while taking incremental pricing action to mitigate reimbursement pressure</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:14.33pt">Committed to achieving individual MA pretax margin of &#8216;at least 3%&#8217; over time</font></div><div style="margin-bottom:6pt;padding-left:36pt;padding-right:-4.3pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:7.2pt">Intend to improve underlying margins annually </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">through operational improvements and pricing strategies, including targeted Stars mitigation actions </font></div><div style="margin-bottom:6pt;padding-left:36pt;padding-right:-4.3pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:7.2pt">Acknowledge risk in achieving &#8216;at least 3%&#8217; by 2027</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> driven by uncertainty in pace of Stars recovery  </font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:14.33pt">2025 represents a critical step on our margin expansion journey, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">with a focus on</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-13.7pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:7.4pt">Resetting MA pricing and membership to improve underlying margins</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Wingdings',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:13.2pt">Remain </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">confident in our expectation </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">that</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%"> MA pricing will drive the intended underlying margin improvement</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Wingdings',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:13.2pt">Anticipate full year Individual MA membership losses of approximately 550,000, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">inclusive of impact of exiting certain unprofitable plans and counties </font></div><div style="margin-bottom:6pt;padding-left:90pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Wingdings',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:13.2pt">Remain confident in our pricing strategy </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">as we </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">prioritize membership that is expected to drive sustainable, long-term value creation   </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:11.7pt">Continue efforts to strengthen our Stars program</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> with initiatives expected to impact across key measures as we focus on a return to an industry leading position</font></div><div style="margin-bottom:6pt;padding-left:90pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Wingdings',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:13.2pt">Acknowledge that risk remains regarding our overall 2026 Star results (payment year 2027) given the limited timeframe to impact results post receipt of the 2025 Star results (payment year 2026)</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:11.7pt">Investing to improve member and patient outcomes </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">and</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%"> support operational excellence, positioning the company for long-term success</font></div><div style="margin-bottom:6pt;padding-left:36pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:11.7pt">Continue to advance Medicaid and CenterWell strategies, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">which are expected to drive increased earnings contribution over the mid and longer term as they mature through their respective J curves</font></div><div style="margin-bottom:6pt;padding-left:54pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Wingdings',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:13.2pt">Expanded Medicaid footprint, which now spans 13 states, including the recent intents to award in Georgia and Texas (subject to clearing state protest process)&#59; executed a Virginia contract with implementation expected in 2025</font></div><div style="margin-bottom:6pt;padding-left:90pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Wingdings',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:13.2pt">Medicaid progress is important for our long-term strategy given linkage of Medicare and Medicaid programs for dually eligible populations (D-SNP), and is emerging as a strong, scaled business with meaningful earnings potential</font></div><div style="padding-left:54pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Wingdings',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:13.2pt">Solid growth expected in CenterWell Primary Care through center adds and expansion of our Independent Physician Association (IPA) model, adding 20 to 30 clinics and 30,000 to 50,000 patients </font></div><div style="padding-left:72pt;padding-right:-4.3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:14.33pt">We have conviction that </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">the strong core fundamentals and growth outlook </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">for MA and value-based care </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">remain intact</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:11.7pt">Believe that</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%"> Humana&#8217;s platform, unique focus on MA, and expanding CenterWell and Medicaid capabilities </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">will allow us to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">compete effectively,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">drive better outcomes for members and patients,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> and</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%"> deliver compelling shareholder value over the long-term</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="height:55.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.16pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Exhibit 99.3 &#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Humana Inc. Fourth Quarter 2024 Prepared Management Remarks</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2&#47;11&#47;2025</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:7.2pt;padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%;text-decoration:underline">Fourth Quarter and Full Year 2024 Results</font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#160;&#160;&#160;&#160;Today, Humana reported fourth quarter Adjusted net loss per share of $2.16, consistent with expectations.  Our results were underpinned by solid performance across the Insurance and CenterWell segments and are inclusive of additional investments in Stars to support long term value creation, as previously disclosed.  The fourth quarter Insurance segment Adjusted benefit ratio of 91.9%, which includes a 20-basis point increase from incremental Stars investments, was consistent with expectations.  </font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">We are pleased to deliver full year 2024 Adjusted EPS and Insurance segment benefit ratio results in line with our initial guidance while also making incremental investments to position the company for long term success.  In addition, we grew our individual MA membership over 250,000, or approximately 5%, while taking incremental pricing action to mitigate reimbursement pressure, and further expanded our Medicaid footprint which now covers 13 states.  Finally, we advanced our integrated health strategy during 2024 with further expansion of our CenterWell platform, including the addition of 48 centers and nearly 100,000 patients in our Primary Care business representing growth of approximately 16% and 33%, respectively.  </font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%;text-decoration:underline">2025 Outlook</font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">2025 represents a critical step on our margin expansion journey.  Our 2025 MA pricing strategy was focused on resetting pricing and membership to more accurately reflect the funding and medical cost trend environment, improving underlying margins.  We assessed the needs and benefit preferences of various consumer segments, the current and expected profitability of our offerings and greatest opportunities for attractive membership growth, making targeted plan and county exits if we did not see a path to sustainable profitability over a reasonable timeframe.    Importantly, we remain confident in our expectation that our 2025 MA pricing will drive the intended underlying margin improvement contemplated in bids.  From a membership perspective, we now anticipate full year Individual MA membership losses of approximately 550,000, inclusive of plan and county exits.  See additional discussion of our 2025 MA membership expectations below.</font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">The path to achieving compelling margins in individual MA is a multi-year process. We are investing in the near term to improve member outcomes and support operational excellence which, when combined with disciplined pricing, is expected to lead to high quality membership growth that will drive compelling returns for our shareholders over the long term.   As previously discussed, we are planning to invest in 2025 to further strengthen our operating performance in areas including Stars, supporting clinical excellence and operating efficiencies, among others. These investments, while limiting margin expansion and earnings growth in the near term, position us for structural operational improvement, profitable growth and long-term value creation.  Currently, we anticipate incremental investments of &#8216;a few hundred million&#8217; dollars in these key drivers of the business in 2025.  We will be disciplined and data driven in our investment decisions.   As a result, the actual level of and timing of investments will be informed by early returns achieved and therefore may be adjusted throughout the year. </font></div><div style="height:55.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.16pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Exhibit 99.3 &#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Humana Inc. Fourth Quarter 2024 Prepared Management Remarks</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2&#47;11&#47;2025</font></div></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Accordingly, today we provided Adjusted EPS guidance for 2025 of &#8216;approximately $16.25&#8217;, inclusive of the investments described above, which is consistent with our previous commentary of &#8216;at least in line with 2024 results&#8217;.  Our guidance assumes consolidated revenue in a range of $126 to $128 billion, reflecting approximately 8% year over year growth at the midpoint.  Expected 2025 consolidated revenue growth is impacted by anticipated high single digit premium yield in our individual MA business, driven in large part by an increased direct subsidy due to the IRA, along with growth in Medicaid, Stand-Alone Part D (PDP), and agnostic activity in our CenterWell segment.  These increases are partially offset by the expected reduction in individual MA membership, reimbursement headwinds in our Primary Care business, and a reduction in investment income.  </font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">With respect to medical costs, we anticipate a full year 2025 Insurance Segment benefit ratio in a range of 90.1% to 90.5% compared to the 2024 Adjusted ratio of 90.3%.  Individual MA is expected to see an improving benefit ratio year over year, with plan exits, benefit changes, and favorable workday impacts more than offsetting the impact of IRA, our assumption of claims trend, the funding environment and incremental investments.  In PDP, we expect the benefit ratio to increase several hundred basis points year over year driven by IRA changes.  In addition, business mix puts upward pressure on the Insurance segment benefit ratio due to reductions in individual MA membership and growth in PDP and Medicaid.  (see Appendix A)     Finally, we anticipate our consolidated benefit ratio will be in line with the Insurance benefit ratio for the full year.</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> </font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">We anticipate the consolidated operating cost ratio to be in a range of 11.3% to 11.7%  for 2025, an increase of 20 basis points at the mid-point from the Adjusted operating cost ratio of 11.3% in 2024. This increase is primarily driven by business mix changes, including within our CenterWell segment which runs a significantly higher operating cost ratio than our Insurance segment, along with the incremental investments described above, a portion of which is expected to impact operating expenses.  These increases are partially offset by the impact of the IRA, as well as our ongoing focus on driving sustainable value creation from productivity and operating efficiencies. (see Appendix A)</font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Turning to earnings seasonality. As discussed above,  the actual level of and timing of incremental investments will be informed by early returns achieved and therefore may be adjusted throughout the year.   At this time, we expect first quarter earnings to be approximately 60% to 65% of expected full year 2025 Adjusted earnings and anticipate that the first quarter Insurance segment benefit ratio will be approximately 87.5%.  The higher than historical earnings contribution expected in the first quarter is primarily driven by the impacts of the IRA, benefit changes (including the addition of deductibles), and favorable year over year workday seasonality.  </font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Individual MA Membership</font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Turning to MA membership growth.  We expect full-year individual MA membership losses of approximately 550,000 in 2025, compared to our previous commentary of &#8216;down a few hundred thousand members&#8217;.   Membership losses are driven in part by our decision to exit certain unprofitable plans and counties, which impacted approximately 560,000 members.  The greater than previously anticipated full year membership loss is expected to be largely driven by a slightly lower recapture rate for members affected by plan exits, along with higher than expected D-SNP attrition.  Given the </font></div><div style="height:55.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.16pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Exhibit 99.3 &#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Humana Inc. Fourth Quarter 2024 Prepared Management Remarks</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2&#47;11&#47;2025</font></div></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">change in special election period (SEP) rules for D-SNP members in 2025, there is more uncertainty in the rest of year membership activity than is typical. We believe we have been prudent in the assumptions utilized in our full year membership outlook and will monitor actual experience closely.   </font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">As we focus our efforts on driving high quality membership growth, we have been pleased to see strong year to date performance in markets with a concentration of our best performing value-based partners including Florida, Illinois and Texas (excluding plan exits).  Further, we are seeing a higher than historical percentage of our non-DSNP sales coming from individuals switching from peer MA plans.  This activity reflects the strength of Humana&#8217;s value proposition, which goes beyond benefit value and includes our best-in-class customer service and integrated health strategy oriented to driving better health outcomes.</font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Importantly, we remain confident in our pricing strategy as we prioritize serving membership which will drive sustainable, long-term value creation.   </font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Group MA</font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">We expect group MA membership to be relatively flat year over year as we maintain pricing discipline in a competitive market. Given the group MA pricing cycles, we anticipate continued margin pressure in 2025.  We remain focused on improving Group MA margins through renewal cycles to reflect the current reimbursement levels and cost trends, with the opportunity to significantly improve performance through pricing action in 2026 and beyond.</font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Stand Alone Part D (PDP)</font></div><div style="margin-bottom:0.6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">We were disciplined in the pricing and design of our PDP products for 2025 recognizing increased plan liability due to the IRA changes. Further, we are participating in the PDP Premium Stabilization Demonstration which limits the maximum amount of member premium increase, while narrowing the risk corridors and increasing the direct subsidy paid to plan sponsors.  </font></div><div style="margin-bottom:0.6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">We now expect net PDP membership growth of approximately 200,000 versus our previous expectation of largely flat membership.  The improved expectations are largely driven by shifting competitive dynamics. </font></div><div style="margin-bottom:0.6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Turning to our PDP margin outlook, while we priced for positive margins in 2025, we are taking a conservative approach to guidance given the magnitude of IRA changes implemented this year.  We will closely monitor PDP performance over the course of the year and adjust expectations as appropriate based on performance.</font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Finally, we are enhancing enterprise value from our PDP plans by driving increased mail order pharmacy usage and conversions to MA.</font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Medicaid</font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">In our Medicaid business, we are successfully expanding our footprint organically, including our recent &#8220;intent to award&#8221; wins in Georgia and Texas (subject to clearing state protest process), which brought our total awarded footprint to 13 states. We look forward to begin serving members in Virginia later this year, bringing our total Medicaid active </font></div><div style="height:55.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.16pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Exhibit 99.3 &#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Humana Inc. Fourth Quarter 2024 Prepared Management Remarks</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2&#47;11&#47;2025</font></div></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">footprint to 10 states, with the Michigan Fully Integrated Dual Eligible (FIDE) contract on track to be implemented in January of 2026 driving our total to 11 active states.   While the Texas and Georgia awards remain under protest, we are optimistic that these programs will move forward in 2026.  Further, we have a bid outstanding in Illinois and are investing in our business development capabilities. We are pursuing priority states and advancing our Medicaid capabilities and growth prospects &#8211; leaning into enterprise innovation, existing community presence, and best practices.  For context, our recent organic growth is unprecedented within the Medicaid industry, where incumbent MCOs have historically had a strong advantage over new entrants. In the last two years, Humana has launched or been awarded Medicaid plans in eight new states. </font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">From a membership perspective, we currently anticipate growth of 175,000 to 250,000 members in 2025, representing  an increase of approximately 16% at the midpoint, largely driven by the expected implementation of the Virginia contract and an additional membership allocation in Kentucky.  </font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">While we are excited about our historical and prospective growth opportunities, we are also focused on ensuring both operational and financial discipline.  Notably, six of our ten active states have been operating less than 3 years with this cohort comprising approximately 45% of our 2025 Medicaid revenue&#59; typically, it takes a newly added state a few years to reach break-even and eventually industry-standard margins.  Florida is our most mature contract and has margins consistent with industry standards. We expect margin progression to align with industry levels as our business mix matures.  In addition, we are working closely with our state and industry partners to ensure 1) rates reflect the acuity level of members maintaining coverage, and 2) rates in newly implemented states are updated to reflect recent trend experience.  States have been generally receptive and collaborative.  All in, we anticipate modest improvement in our Medicaid margin in 2025.</font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Tricare</font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Humana Military successfully transitioned to the new T-5 contract, which went live on January 1st, 2025.&#160; We are meeting or exceeding contract expectations in critical areas such as access to care, beneficiary service, enrollment, billing, and referrals.&#160; We are pleased with our ongoing collaborative partnership with the Defense Health Agency and honored to be able to serve approximately 4.6 million active-duty military, families, and retirees in the TRICARE East Region in 2025. </font></div><div><font><br></font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%">CenterWell</font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:174%">Primary Care</font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Our multi payer Primary Care platform is key to our integrated value-based care strategy, creating value for our members and patients, and is expected to meaningfully contribute to enterprise earnings over time.  We intend to  continue to scale our platform through a combination of new center adds, patient growth and expansion of our IPA business, as we look to strategically grow our IPA affiliate footprint in additional states where we already operate centers.  </font></div><div style="height:55.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.16pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Exhibit 99.3 &#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Humana Inc. Fourth Quarter 2024 Prepared Management Remarks</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2&#47;11&#47;2025</font></div></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Our IPA business allows the Primary Care Organization (PCO) to support affiliate practices through a multi payer portfolio of senior value-based contracts, enabling these practices to succeed in value-based care by leveraging our data and analytics infrastructure, clinical programs, and engagement model.  Further, the current regulatory and funding environment has created opportunities as certain smaller provider groups have challenges adapting to the dynamic environment. We have been opportunistic,  focusing on high value transactions in 2024, as evidenced by our lease agreement with Walmart to take over certain Walmart Health locations, as well as the addition of 41 centers in the fourth quarter through multiple highly attractive acquisitions.  We anticipate exploring similar opportunities in 2025. All in, we expect to add approximately 20 to 30 centers in 2025, with a focus on scaling our Primary Care portfolio in key geographies.</font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">From a patient panel perspective, we expect 2025 net patient growth of 30,000 to 50,000, reflecting approximately 10% growth at the midpoint, driven by organic growth, M&#38;A, and additional growth with Original Medicare as a part of our ACO Reach program.  We are excited about the recent launch of a new patient onboarding experience where new PCO patients that are also Humana health plan members have a more simplified onboarding experience &#8211; both prior to and during their visit to a center, eliminating paperwork and friction for both the patient and the provider.  This is one example of our broader efforts to create a simpler experience through our integrated health strategy, contributing to 120 basis point improvement in voluntary termination rate (VTR) for Humana health plan members who are seen by the PCO across all markets. </font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Year-over-year we anticipate largely flat margins in our PCO business.&#160; The headwinds created by the continued phase in of v28 and addition of centers at various stages of maturation are expected to be offset by (1) advancement of our ongoing v28 mitigation activities, and (2) further maturation of our centers which are progressing through the J curve. &#160; We still anticipate we will largely mitigate the ultimate impact of the risk model changes over the three-year phase in through a multi-pronged plan including numerous operational efficiencies such as centralizing and streamlining administrative functions, standardizing the clinic operating model, and improving clinician productivity to increase capacity. </font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:174%">Home</font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">In the Home, we expect further expansion of our value-based home care models. During 2025, OneHome will continue to pursue novel value-based home health care with the expectation of growing members in some form of value-based home health model by greater than 15% through innovative payment models and additional expansion of our CenterWell partnerships.  These arrangements align incentives between the health plan and the home health provider, driving better coordination, lower cost, and a better experience and health outcomes for the patient. As an example, through OneHome&#8217;s collaborative value-based model with CenterWell Primary Care in Florida and Texas in 2024, CenterWell Home Health successfully drove a relative reduction in length of stay of greater than 15% and an absolute decrease in recertification rates by greater than 10% versus baseline while maintaining consistent clinical outcomes performance, such as 60-day admission rates. </font></div><div style="height:55.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.16pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Exhibit 99.3 &#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Humana Inc. Fourth Quarter 2024 Prepared Management Remarks</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2&#47;11&#47;2025</font></div></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Within our CenterWell Home Health fee for service business, we anticipate a &#8216;mid to high&#8217; single digit increase in home health admissions year over year.  Further, we continue our comprehensive initiative to drive productivity and efficiency within our home operating model to offset reimbursement pressure.  Our efforts are aimed at reducing overhead both through simplifying our home health organizational structure and centralizing and streamlining key functions. Examples of this important work include consolidating branch locations to reduce operating expense while maintaining broad geographic coverage, introducing technology to simplify the referral process, and the launching of AI solutions to improve clinical documentation and reduce administrative tasks for our clinicians.  </font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:174%">Pharmacy</font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Our CenterWell Pharmacy business expects to sustain industry leading mail order penetration for Humana health plan members in 2025.  In addition, we are focused on expanding our agnostic client base and anticipate strong growth in our agnostic volume this year driven by new and existing client growth.  </font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Within Humana Pharmacy Solutions, our Pharmacy Benefit Manager (PBM) business, we remain focused on providing convenient and affordable access to medications for Humana health plan members.  As a reminder, our PBM fees are not linked to drug prices.  Further, our PBM activity is intercompany and is reported and eliminated within our Insurance segment.  </font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Net Investment Income </font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">In 2025, we anticipate a high single digit percentage reduction in investment income driven by the cumulative impact of rate cuts in 2024 and further rate reductions expected throughout this year. In addition, we expect interest expense to be largely consistent year over year.  Collectively, net investment income is expected to be down approximately $100 million year over year.  </font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Capital Deployment</font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">We will remain prudent in our near-term capital deployment approach as we fully assess our Stars mitigation plans and until we have better visibility into the final 2026 MA funding environment and our MA pricing strategy.  As a result, our current 2025 outlook does not contemplate share repurchase activity.  We will re-evaluate our capital deployment plans throughout the year, taking a balanced approach to evaluating capital investments and returns.  </font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Further, we are evaluating optimal timing to execute on the call option for the first cohort of 18 clinics built in 2020 as part of the WCAS joint venture.  The call period begins June 30, 2025, and continues for one year. </font></div><div style="margin-bottom:7.2pt;padding-right:-4.5pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Finally, we intend to maintain our dividend flat year over year on a per share basis throughout 2025. </font></div><div style="margin-bottom:7.2pt;padding-right:-4.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%;text-decoration:underline">Stars Program </font></div><div style="margin-bottom:7.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">As previously shared, we are focused on returning to an industry leading Stars position as quickly as possible and have initiatives underway to improve performance for measures that have not kept pace with the industry.&#160; Areas of </font></div><div style="height:55.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.16pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Exhibit 99.3 &#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Humana Inc. Fourth Quarter 2024 Prepared Management Remarks</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2&#47;11&#47;2025</font></div></div><div style="margin-bottom:7.2pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">focus include enhancing member and provider engagement strategies and incentive programs, improving customer experience, optimizing vendor relationships, and strengthening technology integrations to support operational excellence. </font></div><div style="margin-bottom:7.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">2026 Stars (payment year 2027) results will be released by CMS in October 2025, with calendar year 2024 as the measurement period for most measures.&#160;&#160; As you know, our overall 2026 Star ratings will be determined by (1) our performance and (2) peer performance and the resulting industry cut points.&#160; With respect to our performance, given the higher than anticipated industry cut points for 2025 Stars (payment year 2026), we invested in the final months of 2024 to accelerate our performance on impactable 2026 Star measures through year end and were pleased to see our efforts yield positive results.  However, the industry cut points remain unknown and we had a limited timeframe to impact results post receipt of the 2025 Star results.  As a result, risk remains regarding our overall 2026 Star results.&#160; </font></div><div style="margin-bottom:7.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Looking ahead to 2027 Stars (payment year 2028), the measurement period is calendar year 2025 for most measures.&#160; We set our targets with the goal of having an appropriate buffer between our performance and the expected industry cut points to provide increased confidence in our ability to recover to an industry leading position. We are working to ensure we achieve the performance targets set for all 2027 Stars measures, and we have enhanced our internal governance and performance reporting to increase visibility across the enterprise.</font></div><div style="margin-bottom:7.2pt;padding-right:-4.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%;text-decoration:underline">Closing</font></div><div style="margin-bottom:7.2pt;padding-right:-4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> We had a solid finish to 2024 in a dynamic environment and were pleased to provide initial 2025 Adjusted EPS guidance consistent with our previous commentary.   Looking forward, we remain committed to returning to industry leading Stars performance and achieving individual MA pretax margin of &#8216;at least 3%&#8217;.  2025 represents a critical step on this margin expansion journey. We reset our MA pricing and membership to improve underlying margins and are investing to improve member outcomes and support operational excellence, positioning the company for long-term success.  In addition, we are advancing our Medicaid and CenterWell strategies which are expected to drive increased earnings contribution over the mid and longer term as they mature through their respective J curves.  </font></div><div style="margin-bottom:7.2pt;padding-right:-4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">We have conviction that the strong core fundamentals and growth outlook for MA and value-based care remain intact and that Humana&#8217;s platform, unique focus on MA, and expanding CenterWell and Medicaid capabilities will allow us to compete effective, drive better outcomes for our members and patients, and deliver compelling shareholder value over the long term.</font></div><div style="margin-bottom:7.2pt;padding-left:40.5pt;padding-right:-13.5pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">We appreciate your ongoing support and look forward to providing further updates in the coming months.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%;text-decoration:underline"> </font></div><div style="margin-bottom:7.2pt;padding-right:-13.5pt;text-align:justify"><font><br></font></div><div style="margin-bottom:7.2pt;padding-right:-13.5pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Jim Rechtin, President and Chief Executive Officer</font></div><div style="margin-bottom:7.2pt;padding-right:-43.2pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Celeste Mellet, Chief Financial Officer</font></div><div style="margin-bottom:7.2pt;padding-right:-43.2pt;text-align:justify"><font><br></font></div><div style="height:55.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.16pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Exhibit 99.3 &#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Humana Inc. Fourth Quarter 2024 Prepared Management Remarks</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2&#47;11&#47;2025</font></div></div><div style="margin-bottom:7.2pt;padding-right:-43.2pt;text-align:justify"><font><br></font></div><div style="margin-bottom:7.2pt;padding-right:-43.2pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:18pt;font-weight:700;line-height:174%">Appendix A</font></div><div style="margin-bottom:7.2pt;padding-right:-21.6pt;text-align:center"><img alt="insurancesegmentbenefitsra.jpg" src="insurancesegmentbenefitsra.jpg" style="height:443px;margin-bottom:5pt;vertical-align:text-bottom;width:777px"></div><div style="margin-bottom:7.2pt;padding-right:-43.2pt;text-align:justify"><font><br></font></div><div style="height:55.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.16pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Exhibit 99.3 &#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Humana Inc. Fourth Quarter 2024 Prepared Management Remarks</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2&#47;11&#47;2025</font></div></div><div style="margin-bottom:7.2pt;padding-right:-21.6pt;text-align:center"><img alt="consolidatedocr.jpg" src="consolidatedocr.jpg" style="height:439px;margin-bottom:5pt;vertical-align:text-bottom;width:777px"></div><div style="margin-bottom:7.2pt;padding-right:-43.2pt;text-align:justify"><font><br></font></div><div style="height:55.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>hum-20250211.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:009e4717-ec41-4801-ab4f-36ee5ab4fc59,g:ed3e948d-78e3-4427-a7bf-36efb002053c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hum="http://www.humana.com/20250211" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.humana.com/20250211">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hum-20250211_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hum-20250211_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.humana.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>hum-20250211_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:009e4717-ec41-4801-ab4f-36ee5ab4fc59,g:ed3e948d-78e3-4427-a7bf-36efb002053c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_8c0567d5-65ec-4cf5-bae4-4c1ef502f85a_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_68dbf81b-6b08-40c4-9243-d1abf67d22d5_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_ea3caa13-a01d-45c1-a60e-53419611abaa_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_7f0cb857-28ea-4f92-856e-f46ad3537bf5_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_4eafa85f-d910-452d-b32a-4aedaf9a897e_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_325f6e53-73d2-4bed-855d-a0ae62868a01_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_6a1a475a-87f0-4cf4-9105-47a3f5c239f6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_6e1d9a31-d4bb-44c2-8808-f5e1e0069af5_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_91bf6d0a-2594-4707-ba6c-8b9bfe9d4612_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_d75962c1-e9f4-4edb-a816-92052999dfb0_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_11b9d158-9bda-41f3-80f0-0750ea38a8f1_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_54f8e777-2c70-4df6-91d4-dff17a263e93_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_55a4e2ec-78e1-4a4a-ada1-a88cf2222921_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_4bd280e5-0687-46b8-a180-7f1818d84b9b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_8b57b5c6-549c-451f-bbfc-556b1488da47_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_dda158cf-6e48-4879-9eab-5718a2029789_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_c0312fd2-ef89-4166-a1f8-6913f00d20d7_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_ce6536ae-62ec-4378-868f-97d2cb002b62_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a2469a2b-8c2c-4ab6-8fc6-e46c882d1f18_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_bef9c1a7-3e73-47c7-8a98-5ee33720a03d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_3588dd2b-497e-47ae-8dc4-fecfb4083aa0_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_636ce743-1599-4062-b45d-1d921a451795_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_dde192ae-45ae-4319-8aa8-efb6949926f9_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>hum-20250211_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:009e4717-ec41-4801-ab4f-36ee5ab4fc59,g:ed3e948d-78e3-4427-a7bf-36efb002053c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.humana.com/role/CoverPage" xlink:type="simple" xlink:href="hum-20250211.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_dded21f2-9ca4-4553-9dca-1a7a683544c4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_DocumentType_dded21f2-9ca4-4553-9dca-1a7a683544c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_1039062f-4239-4e48-b68d-65a08db5d8b9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_DocumentPeriodEndDate_1039062f-4239-4e48-b68d-65a08db5d8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_20aaf493-73df-49e1-bc47-bb6d1b8aeef8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_EntityRegistrantName_20aaf493-73df-49e1-bc47-bb6d1b8aeef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a33f1fca-6ac9-44dd-b419-5dd8d1d10d03" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_EntityCentralIndexKey_a33f1fca-6ac9-44dd-b419-5dd8d1d10d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_cff9999e-12bd-491b-9cf5-39a4027791ae" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_AmendmentFlag_cff9999e-12bd-491b-9cf5-39a4027791ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_d0fa269f-b490-4f4f-9f2c-5f8b79248402" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_EntityIncorporationStateCountryCode_d0fa269f-b490-4f4f-9f2c-5f8b79248402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_7021cbb5-b503-4d56-bc0e-1de5f653c12e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_EntityFileNumber_7021cbb5-b503-4d56-bc0e-1de5f653c12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8c292007-7984-4fd4-ab64-b4f8bd9d69aa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_EntityTaxIdentificationNumber_8c292007-7984-4fd4-ab64-b4f8bd9d69aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_3fb51977-3e6b-4a81-b2d4-f3ecbfeaa9f3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_EntityAddressAddressLine1_3fb51977-3e6b-4a81-b2d4-f3ecbfeaa9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_2480edac-2b53-453f-8c6a-3f34130a2269" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_EntityAddressCityOrTown_2480edac-2b53-453f-8c6a-3f34130a2269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_52a1619c-8eac-4d1d-815e-3e6c25279593" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_EntityAddressStateOrProvince_52a1619c-8eac-4d1d-815e-3e6c25279593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_36362e44-778f-4d26-af37-48e858e2f5de" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_EntityAddressPostalZipCode_36362e44-778f-4d26-af37-48e858e2f5de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e5a456d6-2994-46d6-a6ae-1fdf5091fb41" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_CityAreaCode_e5a456d6-2994-46d6-a6ae-1fdf5091fb41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_4fb1990a-c106-48dd-9036-c072b6c9c653" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_LocalPhoneNumber_4fb1990a-c106-48dd-9036-c072b6c9c653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_5cb79f13-58b7-4d6d-a5f4-07732e32d5f5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_WrittenCommunications_5cb79f13-58b7-4d6d-a5f4-07732e32d5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_be7b27b5-dbd9-45fb-a97a-776ea4a721af" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_SolicitingMaterial_be7b27b5-dbd9-45fb-a97a-776ea4a721af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_da8f2035-429a-4154-9d12-7e77d728474a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_PreCommencementTenderOffer_da8f2035-429a-4154-9d12-7e77d728474a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_29fe70f9-aae3-40f6-890c-888ffc6cf8d2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_29fe70f9-aae3-40f6-890c-888ffc6cf8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9173ea12-2702-4b5e-9220-fafa90e989cf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_Security12bTitle_9173ea12-2702-4b5e-9220-fafa90e989cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3058bdec-b939-420b-9393-d49136547800" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_TradingSymbol_3058bdec-b939-420b-9393-d49136547800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_ce8846a0-16ef-4690-a650-12b07e79fdc6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_SecurityExchangeName_ce8846a0-16ef-4690-a650-12b07e79fdc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_278aea3f-3ff4-4aac-9393-8786a3dba2e1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b211959-df67-45a4-b92c-fb5b3436818a" xlink:to="loc_dei_EntityEmergingGrowthCompany_278aea3f-3ff4-4aac-9393-8786a3dba2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>consolidatedocr.jpg
<TEXT>
begin 644 consolidatedocr.jpg
M_]C_X  02D9)1@ ! @$ > !X  #__@ 23$5!1%1/3TQ3('8R,"XP /_; (0
M!04%" 4(# <'# P)"0D,#0P,# P-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-
M#0T-#0T-#0T-#0T-#0T-#0T-#0$%" @*!PH,!P<,#0P*# T-#0T-#0T-#0T-
M#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-_\0!H@
M 04! 0$! 0$           $" P0%!@<("0H+ 0 # 0$! 0$! 0$!
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MW#Q6\42D@2.V[W"@''YFOD\\J2A2ITXNRE)W\TDOU9P8EVBDNK/*Z_/SRPH
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M  H]E4_DE_X"_P#(.5]F'V&X_P"><G_?+?X4>RJ?R2_\!?\ D'*^S#[#<?\
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MN/\ GG)_WRW^%'LJG\DO_ 7_ )!ROLP^PW'_ #SD_P"^6_PH]E4_DE_X"_\
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M?X4>RJ?R2_\  7_D'*^S#[#<?\\Y/^^6_P */95/Y)?^ O\ R#E?9A]AN/\
MGG)_WRW^%'LJG\DO_ 7_ )!ROLP^PW'_ #SD_P"^6_PH]E4_DE_X"_\ (.5]
MF'V&X_YYR?\ ?+?X4>RJ?R2_\!?^0<K[,/L-Q_SSD_[Y;_"CV53^27_@+_R#
ME?9A]AN/^><G_?+?X4>RJ?R2_P# 7_D'*^S#[#<?\\Y/^^6_PH]E4_DE_P"
MO_(.5]F'V&X_YYR?]\M_A1[*I_)+_P !?^0<K[,/L-Q_SSD_[Y;_  H]E4_D
ME_X"_P#(.5]F'V&X_P"><G_?+?X4>RJ?R2_\!?\ D'*^S#[#<?\ /.3_ +Y;
M_"CV53^27_@+_P @Y7V8?8;C_GG)_P!\M_A1[*I_)+_P%_Y!ROLP^PW'_/.3
M_OEO\*/95/Y)?^ O_(.5]F'V&X_YYR?]\M_A1[*I_)+_ ,!?^0<K[,/L-Q_S
MSD_[Y;_"CV53^27_ ("_\@Y7V8?8;C_GG)_WRW^%'LJG\DO_  %_Y!ROLP^P
MW'_/.3_OEO\ "CV53^27_@+_ ,@Y7V8?8;C_ )YR?]\M_A1[*I_)+_P%_P"0
M<K[,/L-Q_P \Y/\ OEO\*/95/Y)?^ O_ "#E?9A]AN/^><G_ 'RW^%'LJG\D
MO_ 7_D'*^S#[#<?\\Y/^^6_PH]E4_DE_X"_\@Y7V8?8;C_GG)_WRW^%'LJG\
MDO\ P%_Y!ROLP^PW'_/.3_OEO\*/95/Y)?\ @+_R#E?9A]AN/^><G_?+?X4>
MRJ?R2_\  7_D'*^S#[#<?\\Y/^^6_P */95/Y)?^ O\ R#E?9A]AN/\ GG)_
MWRW^%'LJG\DO_ 7_ )!ROLP^PW'_ #SD_P"^6_PH]E4_DE_X"_\ (.5]F'V&
MX_YYR?\ ?+?X4>RJ?R2_\!?^0<K[,/L-Q_SSD_[Y;_"CV53^27_@+_R#E?9A
M]AN/^><G_?+?X4>RJ?R2_P# 7_D'*^S#[#<?\\Y/^^6_PH]E4_DE_P" O_(.
M5]F'V&X_YYR?]\M_A1[*I_)+_P !?^0<K[,/L-Q_SSD_[Y;_  H]E4_DE_X"
M_P#(.5]F'V&X_P"><G_?+?X4>RJ?R2_\!?\ D'*^S#[#<?\ /.3_ +Y;_"CV
M53^27_@+_P @Y7V8?8;C_GG)_P!\M_A1[*I_)+_P%_Y!ROLP^PW'_/.3_OEO
M\*/95/Y)?^ O_(.5]F'V&X_YYR?]\M_A1[*I_)+_ ,!?^0<K[,/L-Q_SSD_[
MY;_"CV53^27_ ("_\@Y7V8?8;C_GG)_WRW^%'LJG\DO_  %_Y!ROLP^PW'_/
M.3_OEO\ "CV53^27_@+_ ,@Y7V8?8;C_ )YR?]\M_A1[*I_)+_P%_P"0<K[,
M/L-Q_P \Y/\ OEO\*/95/Y)?^ O_ "#E?9A]AN/^><G_ 'RW^%'LJG\DO_ 7
M_D'*^S#[#<?\\Y/^^6_PH]E4_DE_X"_\@Y7V8?8;C_GG)_WRW^%'LJG\DO\
MP%_Y!ROLP^PW'_/.3_OEO\*/95/Y)?\ @+_R#E?9A]AN/^><G_?+?X4>RJ?R
M2_\  7_D'*^S#[#<?\\Y/^^6_P */95/Y)?^ O\ R#E?9A]AN/\ GG)_WRW^
M%'LJG\DO_ 7_ )!ROLP^PW'_ #SD_P"^6_PH]E4_DE_X"_\ (.5]F'V&X_YY
MR?\ ?+?X4>RJ?R2_\!?^0<K[,/L-Q_SSD_[Y;_"CV53^27_@+_R#E?9A]AN/
M^><G_?+?X4>RJ?R2_P# 7_D'*^S#[#<?\\Y/^^6_PH]E4_DE_P" O_(.5]F'
MV&X_YYR?]\M_A1[*I_)+_P !?^0<K[,/L-Q_SSD_[Y;_  H]E4_DE_X"_P#(
M.5]F'V&X_P"><G_?+?X4>RJ?R2_\!?\ D'*^S#[#<?\ /.3_ +Y;_"CV53^2
M7_@+_P @Y7V8?8;C_GG)_P!\M_A1[*I_)+_P%_Y!ROLP^PW'_/.3_OEO\*/9
M5/Y)?^ O_(.5]F1R6TL0RZ,H]2I _45#A.&LHM+S30K-;HAK,0Y/O#ZBJ6Z]
M4!Z5X_\ ]7;_ .])_):^XS[X*/K/\HGIXK:/J_T/,Z^%/,-'2?\ C\A_ZZ+_
M #KKPW\:G_B1</B7J?27EKZ#\A7Z_P J[+[CW[!Y:^@_(4<J[+[@L'EKZ#\A
M1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'
M*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J
M[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKL
MON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^
MX+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@
ML'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P
M>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y
M:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EK
MZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH
M/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_
M(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A
M1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'
M*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J
M[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKL
MON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^
MX+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@
ML'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P
M>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y
M:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EK
MZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH
M/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_
M(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A
M1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'
M*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J
M[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKL
MON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^
MX+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@
ML'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P
M>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y
M:^@_(4<J[+[@L'EKZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EK
MZ#\A1RKLON"P>6OH/R%'*NR^X+!Y:^@_(4<J[+[@L'EKZ#\A1RKLON"QPOQ
M15T\8 '[P=OI7S.=)+#JR^TCCQ'P?,\6K\[/)')]X?452W7J@/2O'_\ J[?_
M 'I/Y+7W&??!1]9_E$]/%;1]7^AYG7PIYAHZ1_Q^0_\ 71?YUUX;^-3_ ,2+
MA\2]3Z5K]A/H H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H R]<O%TZPN+ECM$4+MGT.TX_7%)Z(B3Y8M]D>">'+F\DDT2WFGEWM'<
MZE<%I'P5,C[%;)Y4*H 4Y'7BL%]E?,X8-^XFWLY/7S-SP9XMDL;*VN+A9+J;
M7=0E$:F0_NHBSL'&X-\BJ/NK@54967JRZ<[)-ZN<G\D=1?\ Q(AL4OY1;/(F
MFSQV^Y7&)7D#$G.T[%3 W$[NM5S6OIL:NJES.WPM(P]<^(]Z-$DU"QM#',95
MA1O-62/<^ K*P0!\DXQ@$8J7)VND1*J^3FBM;VW-B#QW>17,>E2V$DMZMNDU
MQLE7;&"5!9CLP!AMV>.F.^:KF>UM2O:-/D<=;7>NQ0MOBW;W&H1Z>;8KYTAB
M1A,I?< 3S'Y8(4XQG<:7/K:PE73ERV\M_P!#GA\0-1N+35KF^@DCLH9'MH6A
ME19$D V%58QL"^[)#$$ G&TXJ>9V;>QG[634W):)V5GJ=9#X^AT>&YM+B&7S
M=-2%%#R*TMP\N%11A%^9F(!.".^*OFMIV-?:J*::?NV]7<S[OXP6]K*T)M6/
MD;!/^^ *,^/E1?+/F;01NP5Q2Y[="772=K;;Z_U<]$OO%&F:7#%/?7$=LERH
M>,R';N! ;C\#5W2W.ASC%)R=K[$VG^(=/U:&2YL9X[B*'.]HSD+@$\_@#333
MV&I1DKQ=TCYS\.^+[_0Y;V[U&1WM-6CN'M"[,0DD+%-J9/&X.IXXX&!7.I-7
M;V>QYT)N',Y/25[?([SPUXKN-'T^STJ&WFU2_-J+N?,NTHDQ,B[G=7))#?*O
M'& *M.R2W>YO";C%02<I6N]>^I'J?Q'O=1?2UT*W+#4)"SAF 8I&C&2(94X(
MQG?[8QS0Y/3EZ@ZK?+[-;_TT;_CKQ1J>CR6%GID&Z>^F Y<=%&7C *GGD?/V
MQTYJI-JR74TJ3E'E45JW_2(KWXFBU$\T=E+-;6!"7<RR "*3:&D0#8?,,><$
M@C..@I<]NFVXG6M=J+LMWV-WQC)?:CH,KZ&VVYF1&BQP[*64LJ$\!RFX#@^W
M."*E>WNEU+N#Y-WL>7>#-7M='FNKR:XOH7LK8&[L+MC(=Y/$L;,,C)R,#@9&
M0:SB[:ZZ;IG-3DHMMN2LM8O\ST?3/&\UTX^VV$UG"\!N(Y6<.K(%+?, J[&*
MC(!)ZU:EW5CH51O>+2M>Y@:;\6[?4;IK,V_DL8II483"3_5(SG>@12F0I[GT
MI*=]#-5TWRVMHWOV,;0/&X\,:-;2W>^[NM5GN)HD>4KM3>%&YV#[%&!M&,=<
M5*ERK7J1&I[.*;U<FVM3T_PCXJA\66C74*&$QR-$Z$[L,I(.&PH93C(( R#6
ML7S'5":J*ZTZ'4U1J% !0 4 % '"?$'_ )!X_P"N@_I7S.=?[NO\2.+$_!\S
MQ2OSD\D<GWA]15+=>J ]*\?_ .KM_P#>D_DM?<9]\%'UG^43T\5M'U?Z'F=?
M"GF&CI'_ !^0_P#71?YUUX;^-3_Q(N'Q+U/I6OV$^@"@"&XN8K1#+.Z11CJS
ML%4?4L0!0!E0^)=)N7\N&]M)'_NI<1,WY!R: -OK0 4 % !0 4 % !0 4 %
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ME-@ WXR<,<9[TADNO?&./P]KC:/<VO[B,G=.LA+_ '6*XB\O!+, N-XZY[4
M8L?QY\J[2*\TZ6VMI&PLK,P?:3][RVC4'WPY^M 'J7BOQWI_A.P34)R91. 8
M$3&9,C(ZD87')/8= 3Q0!Y3JOQEU>SM#<OI+6L<PQ!.\I9=QZ%E\L$<9.,T
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M6AU;5],2;SITC:SFD("$JY#;_+SD;>FT=>M(9V>B>(K&S\.PZO)&MC:+#O\
M*0[@@!/RJ<+N)QQP,F@#RZ7X[32LTEAI<MQ:1GF4NRD#/4JL3K^&^@#U7P7X
MYL?&MN9K3,<L6!+"^-R$YP1@\J<'!XZ<@4 =I0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M <)\0?\ D'C_ *Z#^E?,YU_NZ_Q(XL3\'S/%*_.3R1R?>'U%4MUZH#TKQ_\
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M*@YZ@@8(ZXZ'-,1QC6'C#P38,L9CO]' W%0$EA9,]3QN52<<;Z .Q'B2+7O
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M&*DL&+C/7.>O;% &O\&O#=[H-]>M=26S)*@(C@F63:^_G*CE0!P"?I2&<O\
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M6(^?=Z]\YI#/&_@\?+\77L=OQ;^7/G;]W(E7;_-L?C3$?65(84 % !0 4 %
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MRG54^R=/+W3?=]-NW;^'2F!ZOX#^&]EX'1GC/GW<@P\S#! ZE5]%R!Z9QS2
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MD*Z=>ZL'TY",1!IC@#I\K+LXYQZ4P/6;7P'IUIH;>'D4_9Y$97;^)F;JY/\
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M'))Z9[]*0'H= !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M@#AKGX>Z9=:TGB)S-]LB967#@1Y4$#*[<]S_ !4 =S0 4 % !0 4 % !0 4
M% !0 4 % '/>(O"NG>*81;ZE$)54Y5NC*?53V_(T <''\$_#Z,"QNY%'_+-Y
M\I_WSL''XT >GZ;IEMH]NMI91K##&,*JC __ %GO0!>H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0!PGQ!_Y!X_ZZ#^E?,YU_NZ_Q(XL3\'S/%*_.3R1R?>'U%4MUZH#TKQ_
M_J[?_>D_DM?<9]\%'UG^43T\5M'U?Z'F=?"GF&CI'_'Y#_UT7^==>&_C4_\
M$BX?$O4^E:_83Z * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@#A/B#_R#Q_UT']*^9SK_=U_B1Q8GX/F>*5^<GDCD^\/J*I;
MKU0'I7C_ /U=O_O2?R6ON,^^"CZS_*)Z>*VCZO\ 0\SKX4\PT=(_X_(?^NB_
MSKKPW\:G_B1</B7J?2M?L)] % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M?"GF&CI'_'Y#_P!=%_G77AOXU/\ Q(N'Q+U/I6OV$^@"@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M:G_B1</B7J?2M?L)] % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MQ^0_]=%_G77AOXU/_$BX?$O4^E:_83Z * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@!"0HR>!0 M !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!PGQ!_Y!X_ZZ#^E?,YU_NZ_Q
M(XL3\'S/%*_.3R1R?>'U%4MUZH#TKQ__ *NW_P!Z3^2U]QGWP4?6?Y1/3Q6T
M?5_H>9U\*>8:.D?\?D/_ %T7^==>&_C4_P#$BX?$O4^E:_83Z * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M,#)["G!W6I=!N4+MW=V>DUH=(4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MJ?P;B>'PY$LBM&WFR?*P((^[V(%:0^$ZL/I!>K/5*U.H* "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H X3X@_\@\?]=!_2OF<Z
M_P!W7^)'%B?@^9XI7YR>2.3[P^HJENO5 >E>/_\ 5V_^])_):^XS[X*/K/\
M*)Z>*VCZO]#S.OA3S#1TC_C\A_ZZ+_.NO#?QJ?\ B1</B7J?2M?L)] % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % ')^+_":>+[5;*6XGM8LDN(&"^:I
M!1\CE?;WJ91YM#*I#VBY6VEY=3;TC2H-$M(K"T&V&W0(@SDX48&2>2?4FFE;
M1%QBH)16R-&F4% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 ?/ES^T%86TKPFQN"8W9"1)'SM)&?TH
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MMWZ55T:W6R:OZC[O4+:P -U-% #T,CJ@/TW$4;#;4=VD/6\@>+[0LD9A R9
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M /SE6V2\U=X)<['N)0<'!^\QZTQ';?\ "(V'H_\ WV?\*8@_X1&P]'_[[/\
MA0 ?\(C8>C_]]G_"@ _X1&P]'_[[/^% !_PB-AZ/_P!]G_"@ _X1&P]'_P"^
MS_A0 ?\ "(V'H_\ WV?\* #_ (1&P]'_ .^S_A0 ?\(C8>C_ /?9_P * #_A
M$;#T?_OL_P"% !_PB-AZ/_WV?\* #_A$;#T?_OL_X4 '_"(V'H__ 'V?\* #
M_A$;#T?_ +[/^% !_P (C8>C_P#?9_PH /\ A$;#T?\ [[/^% !_PB-AZ/\
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M/6UMG=;WMO"K?Q>6#M;\".M5)6Y4NYI57*Z:71I'T#6YZ 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MM_#'\STNM#I"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * /SMLO^0X?^OF7^;TQ'JM,04 % !0 4 % !0 4 %
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M (4 '_"=^+?^?V^_-_\ "@ _X3OQ;_S^WWYO_A0 ?\)WXM_Y_;[\W_PH /\
MA._%O_/[??F_^% !_P )WXM_Y_;[\W_PH /^$[\6_P#/[??F_P#A0 UO'OBQ
M 6:]O0!R22P ^O% 'L/P0\5ZMKVJW,&I74UU&EH759&W -YL0W >N"1^- SZ
M;I % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 ?G;9?\ (</_ %\R_P WIB/5:8@H * "@ H * "@ H * "@ H * "@ H
M * "@ H * /-O&W_ !\1?]<__9C0,^T?AQ_R+6F_]>L?\JD9VM !0 4 % '"
M?$'_ )!X_P"N@_I7S.=?[NO\2.+$_!\SQ2OSD\D<GWA]15+=>J ]*\?_ .KM
M_P#>D_DM?<9]\%'UG^43T\5M'U?Z'F=?"GF&CI'_ !^0_P#71?YUUX;^-3_Q
M(N'Q+U/I6OV$^@"@ H * /#OC_\ \B]%_P!?T7_HJ>@#P+P7_P >DG_74_\
MH"51)V- !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!F:U_QXS_\ 7)__
M $$T :G[//\ R&;O_KR/_HZ&D,^O*0PH * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@#\[;+_D.'_KYE_F],1ZK3$% !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0!YMXV_X^(O^N?\ [,:!GVC\./\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?G;9?\AP
M_P#7S+_-Z8CU6F(* "@ H * "@ H * "@ H * "@ H * "@ H * "@#S;QM_
MQ\1?]<__ &8T#/M'X<?\BUIO_7K'_*I&=K0 4 % !0!PGQ!_Y!X_ZZ#^E?,Y
MU_NZ_P 2.+$_!\SQ2OSD\D<GWA]15+=>J ]*\?\ ^KM_]Z3^2U]QGWP4?6?Y
M1/3Q6T?5_H>9U\*>8:.D?\?D/_71?YUUX;^-3_Q(N'Q+U/I6OV$^@"@ H *
M/#OC_P#\B]%_U_1?^BIZ / O!?\ QZ2?]=3_ .@)5$G8T % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % &9K7_ !XS_P#7)_\ T$T :G[//_(9N_\ KR/_
M *.AI#/KRD,* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H _.VR_Y#A_Z^9?YO3$>JTQ!0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 >;>-O^/B+_ *Y_^S&@9]H_#C_D6M-_Z]8_Y5(SM: "@ H
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M8$$9'(H&%  3B@!%8.,J01ZCF@!: "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * &O(L0RY"CIDD ?K0&PZ@ H * "@ H *
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M 4 % 'AWQ_\ ^1>B_P"OZ+_T5/0!X%X+_P"/23_KJ?\ T!*HD[&@ H * "@
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M?WM'TM^3/2;&S33X([:+)2)0BY.3@#')K3;0Z4N5670M4QA0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0!R7C3PJOC"P73WE-N%GBFWA _\
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MS;QM_P ?$7_7/_V8T#/M'X<?\BUIO_7K'_*I&=K0 4 % !0!PGQ!_P"0>/\
MKH/Z5\SG7^[K_$CBQ/P?,\4K\Y/)')]X?452W7J@/2O'_P#J[?\ WI/Y+7W&
M??!1]9_E$]/%;1]7^AYG7PIYAHZ1_P ?D/\ UT7^==>&_C4_\2+A\2]3Z5K]
MA/H H * "@#P[X__ /(O1?\ 7]%_Z*GH \"\%_\ 'I)_UU/_ * E42=C0 4
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M H * "@ H * "@ H \V\;?\ 'Q%_US_]F- S[1^''_(M:;_UZQ_RJ1G:T %
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0!X[\4O^/[0_P#K^;^4=93W7J<=;>'^(\Y;P]9ZN_BB
MYNU9WLWNI8?F(59$1G5]H.-P('/IQ6=D^9]KG/R*7M6^EV@?4)O"]GH_BT[W
M^U6#6ERXR69RI:#/<_.E%^5*7E8+NFH5>\;/]#.UC1;G3+'2Q=E4M+YI;N[,
MPD-N9Y6#*9O+#''E[ -PQP:35DK[;LB47%1OL[MWO:[[ENQB9O#^IP)>,EB9
MT\M[:&Y,47S+E5W1@F \[B@*A<YXIK9ZZ?,I?!)7]V_1.R_X!0T>PBOX-3TR
M*%+B-;(3++:%S;/(C#&8^%$V&8\+NP&S22W7ETV)BKJ44KZ7NMK_ .9->0Z:
M_@VQCT["EKZ,76W*L)_E#9Z$-LV?I1IRJW<;4?914?YM?4ZK_A"]-3Q@VCJL
M@L9[7S)81(^V1PG5^?F.>><\\U7*N:W0U]G'VO)T:U5SCYEO$\,Q6T+-]ABU
M:>*;=YC(L2A=BR; 6\H'.>,9QFI^SY7,=?9I+X>9I^GGY$*+Y6F:PEE/#+8F
MW3,=LDX@1\'F-I$5,GC<%.<]:71VV%M&?*U:W2]OQ.CCT.VT:\\/S6F])-1A
M5+EB[$RK)$0RMD]""0!V'2JM9QMU->51=-KJM?.Z(_">FZ;IKZY:G?:ZC&L@
M3RT<S+;%EW%%4$LN[9G;DXHBDN9;,4%&/.MI:^MAGPY,>GZ[:P6WE78EA;?/
M:F1",D_\?<>%&\="7&ZB.C5OP_4*7NS25GINOU1]3UTGJ!0 4 % 'YVV7_(<
M/_7S+_-Z8CU6F(* "@ H * "@ H * "@ H * "@ H * "@ H * "@#S;QM_Q
M\1?]<_\ V8T#/M'X<?\ (M:;_P!>L?\ *I&=K0 4 % !0!PGQ!_Y!X_ZZ#^E
M?,YU_NZ_Q(XL3\'S/%*_.3R1R?>'U%4MUZH#TKQ__J[?_>D_DM?<9]\%'UG^
M43T\5M'U?Z'F=?"GF&CI'_'Y#_UT7^==>&_C4_\ $BX?$O4^E:_83Z * "@
MH \.^/\ _P B]%_U_1?^BIZ / O!?_'I)_UU/_H"51)V- !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0!F:U_QXS_ /7)_P#T$T :G[//_(9N_P#KR/\
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MZ1HK_P!X*H/Y@9H"R70L4#"@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M !0 4 % !0!F:U_QXS_]<G_]!- &I^SS_P AF[_Z\C_Z.AI#/KRD,* "@ H
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M0!X=\?\ _D7HO^OZ+_T5/0!X%X+_ ./23_KJ?_0$JB3L: "@ H * "@ H *
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M % !0 4 % !0 4 % !0 4 % !0 4 9FM?\>,_P#UR?\ ]!- &I^SS_R&;O\
MZ\C_ .CH:0SZ\I#"@ H * "@ H * &22+"I=R%51DDG  '4DGH* /CSXM_%I
M]9=]'T9RMFIQ-*O!F(_A7T3/XMQTK:$')^1Z^"P4L7*[TIK=_HCYYKT$E%61
M^A4Z<:453@K170[7P/XYO? ]Z+FV.^%B!-"3A77O]&QT.#@]C7+4I_:C]Q\O
MF.7WOB,.O.45^:_R/O;PSXFLO%=DE_8.&1@-R_Q(W=6'8C\C7&?';:'0T %
M!0 4 % !0 4 % !0 4 % !0 4 % 'S?^T H<Z<K<@M-Q^"5S5Y.%*<HNS2T9
MG-VBVCY^^Q0_W!7RGUJM_.SS_:2[L/L4/]P4?6JW\[#VDN[#[%#_ '!1]:K?
MSL/:2[L/L4/]P4?6JW\[#VDN[#[%#_<%'UJM_.P]I+NP^Q0_W!1]:K?SL/:2
M[L]Y^ "!)]151@ 1<5]5AY.=*,I.[:U?S9Z$'>*;/IBNHT"@ H * "@ H *
M"@ H * "@#F_&'_(%OO^O6;_ - - 'PE:?ZI?I7QF*_C3]6>74^)EFN(R"@
MH * "@#0T/\ Y#%A_P!?47\Z]S+OCE_A_5'70W?H??%?2'<% !0 4 % !0 4
M % !0 4 % !0 4 ->18E+N0JJ,DDX  ZDGTH ^0/BW\6VU9GT717*VJG$TPX
M,I'\*^B>IZMQTQSM"#D_(];!X.6+EVIK=_HO,^=*]!)15D?H=.E&C%4Z:M%'
M9>"?&]]X(O5NK0[HF($T)/RR+W^C8Z''!QUZ5S5*?VHGS&8Y?S7Q&'6N\HKK
MYK_(^]_"_BBR\6627U@^Y6 W*?O(W=6'8_H:XCXW;0Z.@ H * "@ H * "@
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ML\%KXH\L* "@ H * "@#W+X!_P#'SJ/TBK[3"_P8>C_-GJ4_A1]+5V&H4 %
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MW-?$8=:_:BOS1][>%_%%EXMLDO[!PRL,.N?FC?NK#L1^HP>]<1\;MH='0 4
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M)K+Q79)?Z>X=''S+_%&W=''4$'CT/4$CFN,^/.AH * "@ H * "@ H * "@
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M?2M?L)] % !0 4 >'?'_ /Y%Z+_K^B_]%3T >!>"_P#CTD_ZZG_T!*HD[&@
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M]9_E$]/%;1]7^AYG7PIYAHZ1_P ?D/\ UT7^==>&_C4_\2+A\2]3Z5K]A/H
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MJ?$RS7$9!0 4 % !0!H:'_R&+#_KZB_G7N9=\<O\/ZHZZ&[]#[XKZ0[@H *
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M9^1ZV"P4L7*[TIK=_HO,^=J]!)15D?H=.G&C%4Z:M%"TS8* "@ H * "@ H
M* "@ H$=MX&\<7O@>]%S;$M Y FA)^5U^G3<.<&N2I3^U'[CY',,NWQ&'7G*
M*_-?J?>WAGQ-9>*[)+_3W#HX&Y?XD;NKCL0>/0]02.:XSX\Z"@ H * "@ H
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MT?>WA?Q19>+;)+^P?<K ;D/WXV[JX[$?D>H)%<1\:='0 4 % 'YVV7_(</\
MU\R_S>F(]5IB"@#K_!-H!!)>D?-<O@'_ *9IPOZEZ11VU( H * "@ H * "@
M H * "@ H * #':@#QB2U_L^YGLP,+"Y*#_IFV2GZ"J$.H$>;>-O^/B+_KG_
M .S&@9]H_#C_ )%K3?\ KUC_ )5(SM: "@ H * .$^(/_(/'_70?TKYG.O\
M=U_B1Q8GX/F>*5^<GDCD^\/J*I;KU0'I7C__ %=O_O2?R6ON,^^"CZS_ "B>
MGBMH^K_0\SKX4\PT=(_X_(?^NB_SKKPW\:G_ (D7#XEZGTK7["?0!0 4 % '
MAWQ__P"1>B_Z_HO_ $5/0!X%X+_X])/^NI_] 2J).QH * "@ H * "@ H *
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MNJ"2%C^]@-L0LB]^?M!VMZ-@X/4'I6=SSI2<FY2W>Y[G2)"@ H * "@ H *
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MA9X+7Q1Y84 % !0 4 % 'N7P#_X^=1^D5?:87^##T?YL]2G\*/I:NPU"@ H
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M6OV$^@"@ H * /#OC_\ \B]%_P!?T7_HJ>@#P+P7_P >DG_74_\ H"51)V-
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M\&'H_P V>I3^%'TM78:A0 4 % !0 4 % !0 4 % !0!S?C#_ ) M]_UZS?\
MH!H ^$K3_5+]*^,Q7\:?JSRZGQ,LUQ&04 % !0 4 :&A_P#(8L/^OJ+^=>YE
MWQR_P_JCKH;OT/OBOI#N"@ H * "@ H * "@ H * "@ H _,KQ#_ ,A2]_Z^
M[C_T:]=]'X?F?=Y-_ E_U\?_ *3$R*Z#Z0* "@ H * $H(EL_1GW7\"/^13M
M_P#KM<?^CFKR#\C/8J "@ H * "@ H _.VR_Y#A_Z^9?YO3$>JTQ#77>I4]"
M"/SH ]"\(W/VC38@3EXLQO[,IS_(BI*.EH * "@ H * &A%7H /PH  BJ<@
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M=\S\G/"HO=F/IZ#N<#(SF@#T/1_#%MIH\R4>?<'EI'&0#Z(O10/Q/O4E'34
M% !0 4 % !0 4 8&K^'+751N(\J8<K*G# ^_9AZ@]1T(/- 'F]Q#/IL_V2\
M#XRCC[LB^H]&'=<GJ.:H0Z@04 % &9K7_'C/_P!<G_\ 030!J?L\_P#(9N_^
MO(_^CH:0SZ\I#"@ H * "@ H _,;6_\ D(W7_7S-_P"C&KOH_#\S[W)_]W?_
M %\E^43,KH/H@H * "@ H 2A[&<_AEZ/\C[P^!G_ "*-K_UTN?\ THDKR#\D
M/7: "@ H * "@ H * "@ H * "@ H ^<?C[][3O]Z;^25R8G^#/T_4RJ?"SP
M6OBCRPH * "@ H * /<O@'_Q\ZC](J^TPO\ !AZ/\V>I3^%'TM78:A0 4 %
M!0 4 % !0 4 % !0!S?C#_D"WW_7K-_Z : /A*T_U2_2OC,5_&GZL\NI\3+-
M<1D% !0 4 % &AH?_(8L/^OJ+^=>YEWQR_P_JCKH;OT/OBOI#N"@ H * "@
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MP^)>I]*U^PGT 4 % !0!X=\?_P#D7HO^OZ+_ -%3T >!>"_^/23_ *ZG_P!
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M_P!'0TAGUY2&% !0 4 % !0!^8VM_P#(1NO^OF;_ -&-7?1^'YGWN3_[N_\
MKY+\HF970?1!0 4 % !0 E#V,Y_#+T?Y'WA\#/\ D4;7_KI<_P#I1)7D'Y(>
MNT % !0 4 % !0 4 % !0 4 % !0!\X_'W[VG?[TW\DKDQ/\&?I^IE4^%G@M
M?%'EA0 4 % !0 4 >Y? /_CYU'Z15]IA?X,/1_FSU*?PH^EJ[#4* "@ H *
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M-:_X\9_^N3_^@F@#4_9Y_P"0S=_]>1_]'0TAGUY2&% !0 4 % !0!^8VM_\
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M>M #8O!&FQ63Z:!(;>1PY#2$MN P,'M]* +^I>&K/5;6*QN _D6X4*JL1D(
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M 4 % !0 E#V,Y_#+T?Y'WA\#/^11M?\ KI<_^E$E>0?DAZ[0 4 % !0 4 %
M!0 4 % !0 4 % 'SC\??O:=_O3?R2N3$_P &?I^IE4^%G@M?%'EA0 4 % !0
M 4 >Y? /_CYU'Z15]IA?X,/1_FSU*?PH^EJ[#4* "@ H * "@ H * "@ H *
M .;\8?\ (%OO^O6;_P! - 'PE:?ZI?I7QF*_C3]6>74^)EFN(R"@ H * "@#
M0T/_ )#%A_U]1?SKW,N^.7^']4==#=^A]\5](=P4 % !0 4 % !0 4 % !0
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M % !0 A&>* (8H6M6WVLCV[9S^[8A2?4IG8?Q!H VH?$FJV_#-%<#_;78?\
MR&%%*PS03QG<J/WEKN/^Q(H'_CQHL \^-93TLW'UEC_H:+ 5I/%VH/Q%#%'[
MNQ8C_ODXHL!CW.HZC?#;/<,J?W8@(_\ Q]0'_6BP%2&W2#.P8)ZL>6)]68\D
M^Y-,1-0 4 % !0 4 >;>-O\ CXB_ZY_^S&@9]H_#C_D6M-_Z]8_Y5(SM: "@
M H * .$^(/\ R#Q_UT']*^9SK_=U_B1Q8GX/F>*5^<GDCD^\/J*I;KU0'I7C
M_P#U=O\ [TG\EK[C/O@H^L_RB>GBMH^K_0\SKX4\PT=(_P"/R'_KHO\ .NO#
M?QJ?^)%P^)>I]*U^PGT 4 % !0!X=\?_ /D7HO\ K^B_]%3T >!>"_\ CTD_
MZZG_ - 2J).QH * "@ H A2-[>3S[5V@E[LG0^S#^(>U '26GC&YM@%OH?-
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M;_\ 7:X_]'-7D'Y&>Q4 % !0 4 % !0!^=ME_P AP_\ 7S+_ #>F(]5IB"@
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M![E\ _\ CYU'Z15]IA?X,/1_FSU*?PH^EJ[#4* "@ H * "@ H * "@ H *
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M#OC_ /\ (O1?]?T7_HJ>@#P+P7_QZ2?]=3_Z E42=C0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 9FM?\>,_P#UR?\ ]!- &I^SS_R&;O\ Z\C_ .CH
M:0SZ\I#"@ H * "@ H _,;6_^0C=?]?,W_HQJ[Z/P_,^]R?_ '=_]?)?E$S*
MZ#Z(* "@ H * $H>QG/X9>C_ "/O#X&?\BC:_P#72Y_]*)*\@_)#UV@ H *
M"@ H * "@ H * "@ H * /G'X^_>T[_>F_DE<F)_@S]/U,JGPL\%KXH\L* "
M@ H * "@#W+X!_\ 'SJ/TBK[3"_P8>C_ #9ZE/X4?2U=AJ% !0 4 % !0 4
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M]EV);MJ<S_PO#7/^?:W_ .^C_P#$UY_UZCW?W&/M8A_PO#7?^?:W_P"^C_\
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M?4^G3.:^HPU&5*/-5;<G^!WPBXJ\GJ?8UE90Z="EM;((XH@%55&  *] W+5
M!0 4 % !0 4 % !0!^97B'_D*7O_ %]W'_HUZ[Z/P_,^[R;^!+_KX_\ TF)D
M5T'T@4 % !0 4 )01+9^C/NOX$?\BG;_ /7:X_\ 1S5Y!^1GL5 !0 4 % !0
M 4 ?G;9?\AP_]?,O\WIB/5:8@H * "@ H * "@ H * "@ H * "@ H * "@
MH * /-O&W_'Q%_US_P#9C0,^T?AQ_P BUIO_ %ZQ_P JD9VM !0 4 % '"?$
M'_D'C_KH/Z5\SG7^[K_$CBQ/P?,\4K\Y/)')]X?452W7J@/2O'_^KM_]Z3^2
MU]QGWP4?6?Y1/3Q6T?5_H>9U\*>8:.D?\?D/_71?YUUX;^-3_P 2+A\2]3Z5
MK]A/H H * "@#P[X_P#_ "+T7_7]%_Z*GH \"\%_\>DG_74_^@)5$G8T % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % &9K7_'C/\ ]<G_ /030!J?L\_\
MAF[_ .O(_P#HZ&D,^O*0PH * "@ H * /S&UO_D(W7_7S-_Z,:N^C\/S/O<G
M_P!W?_7R7Y1,RN@^B"@ H * "@!*'L9S^&7H_P C[P^!G_(HVO\ UTN?_2B2
MO(/R0]=H * "@ H * "@ H * "@# \2>&[/Q19O8WR!E8?*W\2-V93V(_(T
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M * "@ H \.^/_P#R+T7_ %_1?^BIZ / O!?_ !Z2?]=3_P"@)5$G8T % !0
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M/H H * "@#P[X_\ _(O1?]?T7_HJ>@#P+P7_ ,>DG_74_P#H"51)V- !0 4
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M1>B_Z_HO_14] '@7@O\ X])/^NI_] 2J).QH * "@ H * "@ H * "@ H *
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M+:U18HHP%55&  *]4Z2U0 4 % !0 4 % !0 4 % !0 4 % 'YE>(?^0I>_\
M7W<?^C7KOH_#\S[O)OX$O^OC_P#28F170?2!0 4 % !0 E!$MGZ,^Z_@1_R*
M=O\ ]=KC_P!'-7D'Y&>Q4 % !0 4 % !0!^=ME_R'#_U\R_S>F(]5IB"@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H \V\;?\?$7_7/_ -F- S[1^''_
M "+6F_\ 7K'_ "J1G:T % !0 4 <)\0?^0>/^N@_I7S.=?[NO\2.+$_!\SQ2
MOSD\D<GWA]15+=>J ]*\?_ZNW_WI/Y+7W&??!1]9_E$]/%;1]7^AYG7PIYAH
MZ1_Q^0_]=%_G77AOXU/_ !(N'Q+U/I6OV$^@"@ H * /#OC_ /\ (O1?]?T7
M_HJ>@#P+P7_QZ2?]=3_Z E42=C0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M1%&  /85ZITEJ@ H * "@ H * "@ H * "@ H * "@#\RO$/_(4O?^ONX_\
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M_P"^HO\ XY1[;R_'_@!_;3_Y\K_P/_[4/^%3>+/^@;-_WU%_\<H]MY?C_P
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MD!I&93\I(Y!SUKD/DSTV@ H * "@ H * /SMLO\ D.'_ *^9?YO3$>JTQ!0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 >;>-O\ CXB_ZY_^S&@9]H_#
MC_D6M-_Z]8_Y5(SM: "@ H * .$^(/\ R#Q_UT']*^9SK_=U_B1Q8GX/F>*5
M^<GDCD^\/J*I;KU0'I7C_P#U=O\ [TG\EK[C/O@H^L_RB>GBMH^K_0\SKX4\
MPT=(_P"/R'_KHO\ .NO#?QJ?^)%P^)>I]*U^PGT 4 % !0!X=\?_ /D7HO\
MK^B_]%3T >!>"_\ CTD_ZZG_ - 2J).QH * "@ H * "@ H * "@ H * "@
MH * "@ H * ,S6O^/&?_ *Y/_P"@F@#4_9Y_Y#-W_P!>1_\ 1T-(9]>4AA0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MV$^@"@ H * /#OC_ /\ (O1?]?T7_HJ>@#P+P7_QZ2?]=3_Z E42=C0 4 %
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M9)+7S?<^CJZ#T0H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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ML: "@ H * "@ H * "@ H * "@ H * "@ H * "@#,UK_CQG_P"N3_\ H)H
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MVMXI$&%=(8U91Z!@H('L#19+H)12U27W&E3*"@ H * "@ H * "@ H * "@
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M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!^=ME_P AP_\
M7S+_ #>F(]5IB"@ H * "@ H * "@ H * "@ H * "@ H * "@ H \V\;?\
M'Q%_US_]F- S[1^''_(M:;_UZQ_RJ1G:T % !0 4 <)\0?\ D'C_ *Z#^E?,
MYU_NZ_Q(XL3\'S/%*_.3R1R?>'U%4MUZH#TKQ_\ ZNW_ -Z3^2U]QGWP4?6?
MY1/3Q6T?5_H>9U\*>8:.D?\ 'Y#_ -=%_G77AOXU/_$BX?$O4^E:_83Z * "
M@ H \.^/_P#R+T7_ %_1?^BIZ / O!?_ !Z2?]=3_P"@)5$G8T % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % &9K7_'C/_P!<G_\ 030!J?L\_P#(9N_^
MO(_^CH:0SZ\I#"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M:DQ?+[)MV6MR6?Q!>2GQ'=Z3-(Z[X C+N.V,J!(R*?N]#R![\T[_ !- Y/\
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MVL[M;WO^B/H"MST H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M5(I;BTDNZ([+1['326L[>"W)ZF**.,GZ[%%%DM@45'9)>BL:-,H* "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#\W;R66TU"6:+*ND
M\I4XSCYV[$$4Q%K_ (234_\ GH?^_:?_ !- !_PDFI_\]#_W[3_XF@ _X234
M_P#GH?\ OVG_ ,30 ?\ "2:G_P ]#_W[3_XF@ _X234_^>A_[]I_\30 ?\))
MJ?\ ST/_ '[3_P")H /^$DU/_GH?^_:?_$T '_"2:G_ST/\ W[3_ .)H /\
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M _X3>7_GBG_?1_PH /\ A-Y?^>*?]]'_  H /^$WE_YXI_WT?\* #_A-Y?\
MGBG_ 'T?\* #_A-Y?^>*?]]'_"@"O>>+I+N%X#$JB12N0QXR,9Z4@/3OV>?^
M0S=_]>1_]'0T ?7E(84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 >&>(OB-J&G>(!;VH1M)M98+>[)4%A+.)-N'ZJ
M!L_QK%R:>FW4X9U91G9?"FD_5GJ>M^*=,\.JC:A.L7F_< 5I&;W"1JS$>^,>
M]:-J.YU2G&'Q.W]>1QOB7XJ:;H]A!J%DPO$N)5C&T2# SAB?ERI7D[6 )Q@
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M6?W'J=:'4% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M6>%_^@?#^<G_ ,70 ?\ "K/"_P#T#X?SD_\ BZ #_A5GA?\ Z!\/YR?_ !=
M!_PJSPO_ - ^'\Y/_BZ #_A5GA?_ *!\/YR?_%T '_"K/"__ $#X?SD_^+H
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@#A/B#_R#Q_UT']*^9SK
M_=U_B1Q8GX/F>*5^<GDCD^\/J*I;KU0'I7C_ /U=O_O2?R6ON,^^"CZS_*)Z
M>*VCZO\ 0\SKX4\PT=(_X_(?^NB_SKKPW\:G_B1</B7J?2M?L)] % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M@"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
MX3X@_P#(/'_70?TKYG.O]W7^)'%B?@^9XI7YR>2.3[P^HJENO5 >E>/_ /5V
M_P#O2?R6ON,^^"CZS_*)Z>*VCZO]#S.OA3S#1TC_ (_(?^NB_P ZZ\-_&I_X
MD7#XEZGTK7["?0!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 <)\0?\ D'C_ *Z#^E?,YU_NZ_Q(XL3\'S/%*_.3R1R?>'U%
M4MUZH#TKQ_\ ZNW_ -Z3^2U]QGWP4?6?Y1/3Q6T?5_H>9U\*>8:.D?\ 'Y#_
M -=%_G77AOXU/_$BX?$O4^E:_83Z * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@#A/B#_P @\?\ 70?TKYG.O]W7^)'%B?@^
M9XI7YR>2.3[P^HJENO5 >E>/_P#5V_\ O2?R6ON,^^"CZS_*)Z>*VCZO]#S.
MOA3S#1TC_C\A_P"NB_SKKPW\:G_B1</B7J?2M?L)] % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M+^WV_P#SUC_[Z'^-?K7MJ?\ /'_P)'N\T>Z^\/M]O_SUC_[Z'^-'MJ?\\?\
MP)!S1[K[P^WV_P#SUC_[Z'^-'MJ?\\?_  )!S1[K[P^WV_\ SUC_ .^A_C1[
M:G_/'_P)!S1[K[P^WV__ #UC_P"^A_C1[:G_ #Q_\"0<T>Z^\/M]O_SUC_[Z
M'^-'MJ?\\?\ P)!S1[K[P^WV_P#SUC_[Z'^-'MJ?\\?_  )!S1[K[P^WV_\
MSUC_ .^A_C1[:G_/'_P)!S1[K[P^WV__ #UC_P"^A_C1[:G_ #Q_\"0<T>Z^
M\/M]O_SUC_[Z'^-'MJ?\\?\ P)!S1[K[P^WV_P#SUC_[Z'^-'MJ?\\?_  )!
MS1[K[P^WV_\ SUC_ .^A_C1[:G_/'_P)!S1[K[P^WV__ #UC_P"^A_C1[:G_
M #Q_\"0<T>Z^\/M]O_SUC_[Z'^-'MJ?\\?\ P)!S1[K[P^WV_P#SUC_[Z'^-
M'MJ?\\?_  )!S1[K[P^WV_\ SUC_ .^A_C1[:G_/'_P)!S1[K[P^WV__ #UC
M_P"^A_C1[:G_ #Q_\"0<T>Z^\/M]O_SUC_[Z'^-'MJ?\\?\ P)!S1[K[P^WV
M_P#SUC_[Z'^-'MJ?\\?_  )!S1[K[P^WV_\ SUC_ .^A_C1[:G_/'_P)!S1[
MK[P^WV__ #UC_P"^A_C1[:G_ #Q_\"0<T>Z^\/M]O_SUC_[Z'^-'MJ?\\?\
MP)!S1[K[P^WV_P#SUC_[Z'^-'MJ?\\?_  )!S1[K[P^WV_\ SUC_ .^A_C1[
M:G_/'_P)!S1[K[P^WV__ #UC_P"^A_C1[:G_ #Q_\"0<T>Z^\/M]O_SUC_[Z
M'^-'MJ?\\?\ P)!S1[K[P^WV_P#SUC_[Z'^-'MJ?\\?_  )!S1[K[P^WV_\
MSUC_ .^A_C1[:G_/'_P)!S1[K[P^WV__ #UC_P"^A_C1[:G_ #Q_\"0<T>Z^
M\/M]O_SUC_[Z'^-'MJ?\\?\ P)!S1[K[P^WV_P#SUC_[Z'^-'MJ?\\?_  )!
MS1[K[P^WV_\ SUC_ .^A_C1[:G_/'_P)!S1[K[P^WV__ #UC_P"^A_C1[:G_
M #Q_\"0<T>Z^\/M]O_SUC_[Z'^-'MJ?\\?\ P)!S1[K[P^WV_P#SUC_[Z'^-
M'MJ?\\?_  )!S1[K[P^WV_\ SUC_ .^A_C1[:G_/'_P)!S1[K[P^WV__ #UC
M_P"^A_C1[:G_ #Q_\"0<T>Z^\/M]O_SUC_[Z'^-'MJ?\\?\ P)!S1[K[P^WV
M_P#SUC_[Z'^-'MJ?\\?_  )!S1[K[P^WV_\ SUC_ .^A_C1[:G_/'_P)!S1[
MK[P^WV__ #UC_P"^A_C1[:G_ #Q_\"0<T>Z^\/M]O_SUC_[Z'^-'MJ?\\?\
MP)!S1[K[P^WV_P#SUC_[Z'^-'MJ?\\?_  )!S1[K[P^WV_\ SUC_ .^A_C1[
M:G_/'_P)!S1[K[P^WV__ #UC_P"^A_C1[:G_ #Q_\"0<T>Z^\/M]O_SUC_[Z
M'^-'MJ?\\?\ P)!S1[K[P^WV_P#SUC_[Z'^-'MJ?\\?_  )!S1[K[P^WV_\
MSUC_ .^A_C1[:G_/'_P)!S1[K[P^WV__ #UC_P"^A_C1[:G_ #Q_\"0<T>Z^
M\/M]O_SUC_[Z'^-'MJ?\\?\ P)!S1[K[P^WV_P#SUC_[Z'^-'MJ?\\?_  )!
MS1[K[P^WV_\ SUC_ .^A_C1[:G_/'_P)!S1[K[P^WV__ #UC_P"^A_C1[:G_
M #Q_\"0<T>Z^\/M]O_SUC_[Z'^-'MJ?\\?\ P)!S1[K[P^WV_P#SUC_[Z'^-
M'MJ?\\?_  )!S1[K[P^WV_\ SUC_ .^A_C1[:G_/'_P)!S1[K[P^WV__ #UC
M_P"^A_C1[:G_ #Q_\"0<T>Z^\/M]O_SUC_[Z'^-'MJ?\\?\ P)!S1[K[P^WV
M_P#SUC_[Z'^-'MJ?\\?_  )!S1[K[P^WV_\ SUC_ .^A_C1[:G_/'_P)!S1[
MK[P^WV__ #UC_P"^A_C1[:G_ #Q_\"0<T>Z^\/M]O_SUC_[Z'^-'MJ?\\?\
MP)!S1[K[P^WV_P#SUC_[Z'^-'MJ?\\?_  )!S1[K[P^WV_\ SUC_ .^A_C1[
M:G_/'_P)!S1[K[P^WV__ #UC_P"^A_C1[:G_ #Q_\"0<T>Z^\/M]O_SUC_[Z
M'^-'MJ?\\?\ P)!S1[K[P^WV_P#SUC_[Z'^-'MJ?\\?_  )!S1[K[P^WV_\
MSUC_ .^A_C1[:G_/'_P)!S1[K[P^WV__ #UC_P"^A_C1[:G_ #Q_\"0<T>Z^
M\/M]O_SUC_[Z'^-'MJ?\\?\ P)!S1[K[P^WV_P#SUC_[Z'^-'MJ?\\?_  )!
MS1[K[P^WV_\ SUC_ .^A_C1[:G_/'_P)!S1[K[P^WV__ #UC_P"^A_C1[:G_
M #Q_\"0<T>Z^\/M]O_SUC_[Z'^-'MJ?\\?\ P)!S1[K[P^WV_P#SUC_[Z'^-
M'MJ?\\?_  )!S1[K[P^WV_\ SUC_ .^A_C1[:G_/'_P)!S1[K[P^WV__ #UC
M_P"^A_C1[:G_ #Q_\"0<T>Z^\/M]O_SUC_[Z'^-'MJ?\\?\ P)!S1[K[P^WV
M_P#SUC_[Z'^-'MJ?\\?_  )!S1[K[P^WV_\ SUC_ .^A_C1[:G_/'_P)!S1[
MK[P^WV__ #UC_P"^A_C1[:G_ #Q_\"0<T>Z^\/M]O_SUC_[Z'^-'MJ?\\?\
MP)!S1[K[P^WV_P#SUC_[Z'^-'MJ?\\?_  )!S1[K[P^WV_\ SUC_ .^A_C1[
M:G_/'_P)!S1[K[P^WV__ #UC_P"^A_C1[:G_ #Q_\"0<T>Z^\/M]O_SUC_[Z
M'^-'MJ?\\?\ P)!S1[K[P^WV_P#SUC_[Z'^-'MJ?\\?_  )!S1[K[P^WV_\
MSUC_ .^A_C1[:G_/'_P)!S1[K[P^WV__ #UC_P"^A_C1[:G_ #Q_\"0<T>Z^
M\/M]O_SUC_[Z'^-'MJ?\\?\ P)!S1[K[P^WV_P#SUC_[Z'^-'MJ?\\?_  )!
MS1[K[P^WV_\ SUC_ .^A_C1[:G_/'_P)!S1[K[P^WV__ #UC_P"^A_C1[:G_
M #Q_\"0<T>Z^\/M]O_SUC_[Z'^-'MJ?\\?\ P)!S1[K[P^WV_P#SUC_[Z'^-
M'MJ?\\?_  )!S1[K[P^WV_\ SUC_ .^A_C1[:G_/'_P)!S1[K[P^WV__ #UC
M_P"^A_C1[:G_ #Q_\"0<T>Z^\/M]O_SUC_[Z'^-'MJ?\\?\ P)!S1[K[P^WV
M_P#SUC_[Z'^-'MJ?\\?_  )!S1[K[P^WV_\ SUC_ .^A_C1[:G_/'_P)!S1[
MK[P^WV__ #UC_P"^A_C1[:G_ #Q_\"0<T>Z^\/M]O_SUC_[Z'^-'MJ?\\?\
MP)!S1[K[P^WV_P#SUC_[Z'^-'MJ?\\?_  )!S1[K[P^WV_\ SUC_ .^A_C1[
M:G_/'_P)!S1[K[P^WV__ #UC_P"^A_C1[:G_ #Q_\"0<T>Z^\/M]O_SUC_[Z
M'^-'MJ?\\?\ P)!S1[K[P^WV_P#SUC_[Z'^-'MJ?\\?_  )!S1[K[P^WV_\
MSUC_ .^A_C1[:G_/'_P)!S1[K[P^WV__ #UC_P"^A_C1[:G_ #Q_\"0<T>Z^
M\/M]O_SUC_[Z'^-'MJ?\\?\ P)!S1[K[P^WV_P#SUC_[Z'^-'MJ?\\?_  )!
MS1[K[P^WV_\ SUC_ .^A_C1[:G_/'_P)!S1[K[P^WV__ #UC_P"^A_C1[:G_
M #Q_\"0<T>Z^\/M]O_SUC_[Z'^-'MJ?\\?\ P)!S1[K[P^WV_P#SUC_[Z'^-
M'MJ?\\?_  )!S1[K[P^WV_\ SUC_ .^A_C1[:G_/'_P)!S1[K[P^WV__ #UC
M_P"^A_C1[:G_ #Q_\"0<T>Z^\/M]O_SUC_[Z'^-'MJ?\\?\ P)!S1[K[P^WV
M_P#SUC_[Z'^-'MJ?\\?_  )!S1[K[P^WV_\ SUC_ .^A_C1[:G_/'_P)!S1[
MK[P^WV__ #UC_P"^A_C1[:G_ #Q_\"0<T>Z^\/M]O_SUC_[Z'^-'MJ?\\?\
MP)!S1[K[P^WV_P#SUC_[Z'^-'MJ?\\?_  )!S1[K[P^WV_\ SUC_ .^A_C1[
M:G_/'_P)!S1[K[P^WV__ #UC_P"^A_C1[:G_ #Q_\"0<T>Z^\/M]O_SUC_[Z
M'^-'MJ?\\?\ P)!S1[K[P^WV_P#SUC_[Z'^-'MJ?\\?_  )!S1[K[P^WV_\
MSUC_ .^A_C1[:G_/'_P)!S1[K[P^WV__ #UC_P"^A_C1[:G_ #Q_\"0<T>Z^
M\XCQY=136 6-U8[QP"">WI7S><5(3PZ4))OF6S3.3$-..CZGC=?GQY0Y/O#Z
MBJ6Z]4!Z5X__ -7;_P"])_):^XS[X*/K/\HGIXK:/J_T/,Z^%/,#I3 =O;U/
MYT[ONP#>WJ?SHN^[ -[>I_.B[[L WMZG\Z+ONP#>WJ?SHN^[ -[>I_.B[[L
MWMZG\Z+ONP#>WJ?SHN^[ -[>I_.B[[L WMZG\Z+ONP#>WJ?SHN^[ -[>I_.B
M[[L WMZG\Z+ONP#>WJ?SHN^[ -[>I_.B[[L WMZG\Z+ONP#>WJ?SHN^[ -[>
MI_.B[[L WMZG\Z+ONP#>WJ?SHN^[ -[>I_.B[[L WMZG\Z+ONP#>WJ?SHN^[
M -[>I_.B[[L WMZG\Z+ONP#>WJ?SHN^[ -[>I_.B[[L WMZG\Z+ONP#>WJ?S
MHN^[ -[>I_.B[[L WMZG\Z+ONP#>WJ?SHN^[ -[>I_.B[[L WMZG\Z+ONP#>
MWJ?SHN^[ -[>I_.B[[L WMZG\Z+ONP#>WJ?SHN^[ -[>I_.B[[L WMZG\Z+O
MNP#>WJ?SHN^[ -[>I_.B[[L WMZG\Z+ONP#>WJ?SHN^[ -[>I_.B[[L WMZG
M\Z+ONP#>WJ?SHN^[ -[>I_.B[[L WMZG\Z+ONP#>WJ?SHN^[ -[>I_.B[[L
MWMZG\Z+ONP#>WJ?SHN^[ -[>I_.B[[L WMZG\Z+ONP#>WJ?SHN^[ -[>I_.B
M[[L WMZG\Z+ONP#>WJ?SHN^[ -[>I_.B[[L WMZG\Z+ONP#>WJ?SHN^[ -[>
MI_.B[[L WMZG\Z+ONP#>WJ?SHN^[ -[>I_.B[[L WMZG\Z+ONP#>WJ?SHN^[
M -[>I_.B[[L WMZG\Z+ONP#>WJ?SHN^[ -[>I_.B[[L WMZG\Z+ONP#>WJ?S
MHN^[ -[>I_.B[[L WMZG\Z+ONP#>WJ?SHN^[ -[>I_.B[[L WMZG\Z+ONP#>
MWJ?SHN^[ -[>I_.B[[L WMZG\Z+ONP#>WJ?SHN^[ -[>I_.B[[L WMZG\Z+O
MNP#>WJ?SHN^[ -[>I_.B[[L WMZG\Z+ONP#>WJ?SHN^[ -[>I_.B[[L WMZG
M\Z+ONP#>WJ?SHN^[ -[>I_.B[[L WMZG\Z+ONP#>WJ?SHN^[ -[>I_.B[[L
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * +EA:27LZ0Q#+,P_ 9[UTT*4J]2-.FKMM%QBY
M-)'T ZAE((R",$'I7["TFFGMV/?/!-718[N15 4!C@ 8 _ 5^1XM*-::BDDF
M]%HCP:FDFD9U<)F% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0!Z?X%B3RG?:-V[&[ SC'3/7%?>9)&/)*=ES7M>RO
+;UW/3PR5F^I__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>humanalogoa051.jpg
<TEXT>
begin 644 humanalogoa051.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "D B$# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS3$XZI.->5TB<OQ-2O)\[NCJJ***^\/;"BDI: "BBB@ HHHH **** "BBB@
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MHHH **** "BBB@ HHHH ^8_VW/\ D$^%_P#KXF_]!6ODVOK+]MS_ )!/A?\
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M!(PQ^)J.V_X^(O\ >']*DO\ _C_NO^NK_P#H1J.V_P"/B+_>']*_GO\ Y?\
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MN7CMQ/\ A&RR']%-?GTO05S<61:Q<7T:,\T3]JF>E?LZL%^,7A[)Q^]8#/\
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M7XKQ!_R,:G]=#X_,/]XD?4'[$/\ Q^>+_P#=M/YS5]%_$*,R^!O$"(,LVGW
M ]_+:OG3]B'_ (^_&&?[MI_.:OJ6]MUN[6:&0;DD0HR^H(((K]$R*//E48KL
MSZ#!*^%2/R[]N]7_  _,EOX@TR5SA$NHF8^P8$FD\0:3+X?US4=,G!$MG</
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MY!%>E&I&;M%W.I23V):***V&%%%% !1110 4444 %%%% 'S'^VW_ ,@?PO\
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M_7 _X5YG$V'JU,:I0BVK'/F4)2K*RN=5^S/_ ,EFT/\ [:?^BVK[Z["OBO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>humanalogoa05b.jpg
<TEXT>
begin 644 humanalogoa05b.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "D B$# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS3$XZI.->5TB<OQ-2O)\[NCJJ***^\/;"BDI: "BBB@ HHHH **** "BBB@
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MHHH **** "BBB@ HHHH ^8_VW/\ D$^%_P#KXF_]!6ODVOK+]MS_ )!/A?\
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M!(PQ^)J.V_X^(O\ >']*DO\ _C_NO^NK_P#H1J.V_P"/B+_>']*_GO\ Y?\
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MN7CMQ/\ A&RR']%-?GTO05S<61:Q<7T:,\T3]JF>E?LZL%^,7A[)Q^]8#/\
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M7XKQ!_R,:G]=#X_,/]XD?4'[$/\ Q^>+_P#=M/YS5]%_$*,R^!O$"(,LVGW
M ]_+:OG3]B'_ (^_&&?[MI_.:OJ6]MUN[6:&0;DD0HR^H(((K]$R*//E48KL
MSZ#!*^%2/R[]N]7_  _,EOX@TR5SA$NHF8^P8$FD\0:3+X?US4=,G!$MG</
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MY!%>E&I&;M%W.I23V):***V&%%%% !1110 4444 %%%% 'S'^VW_ ,@?PO\
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M_7 _X5YG$V'JU,:I0BVK'/F4)2K*RN=5^S/_ ,EFT/\ [:?^BVK[Z["OBO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
M_]C_X  02D9)1@ ! @$!] 'T  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" %U!-4# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ML#[E-7!#D4Z@# HIK5#"BBBF V0 CFF!0.E2,,C%-*%14M1OJ)J^IQ7QY/\
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M>/0TKJ]ABT44A< XHN@%HI-XI00>AI@%%)NP<&@L!WH"XM%-#^HI2P'>DFF
MM%-9^.,T!L#DTP'44A<=J9YV/>DW8:5R2BF[SZ4X'(S36JN*^M@HHHH ***0
MD 9-#=D M%)O6@.#2335P%HI-ZTH(/2DIQ86"BBDW*>]5<!:*,@]#12YD 44
MA.!D4F\^@I[@.HINY_[OZ4I8 XH%="T4TN.PI00>E2Y)#%HI"P7K06P,BG=7
M 6BF[SZ"@.<]*8FTAU%(S;3C%"ODXQ0',KV%HI"X% <&CI<+J]A:*,CUHR#T
M-)23&%%%(S@<4P%HIOF'T%.H ***,@=32<D@"BDW+ZT;ESC-.X"T4A< XHW
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MJ>K/R_-_]ZEZB4J]1]:2E7J/K7R<CS:>S'0_\?*?]=!_.OU\_8#_ .2$6/\
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M^,^];2;2YKE:VN/('8TH( Y;-1">$C(E7\Z#-'CB0?G252.S:%>ZO<>3DT$
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M4WHBK*PE'2@\\XI'SCBK2;=Q)*3%SGO2-N XI8B,X].M(S@\C!IR:V&[1=[
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ML<&GT@ W9!I:I;!>X4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?>GQ?ZK\*_F26[1^;R]UJPUA@@COUK7\!*&\6VF>TZX_,5D.0,9]:V/ ./\
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M'05)MS^%)*0BAS^(J.;W_0Q;;1TOPG^)&M?#3Q);Z_H]\\(24%]AZ@&OU?\
MV//V@M/^,O@6VN&O ]Q'$HE!;))ZU^/#EX' 3E2*^F/^"=OQSNO 7Q-M] O+
MTK:W4G*LW P *_1>".(ZF!QL:,WH]#Z;)<:Z511DS]6H2VS<QZDU(@/)]:IZ
M/?1ZEI\5W"X*R1JP(]QFKB'C:37](1J*I&+CU/O(OFU!F(.!36)88)I[,.1[
M4PL%&XBM&T5HT4M:U2#2-.>_NI %B4L237P'^WA^W!>+=S>"O!NH%7(*2O$_
MO@C\C7MO_!0']HM/ACX&FT?3[L+=W*-& IY'&17Y;>(_$%]XEU>;7+R=I'D<
MERQS@FOQ_CWB98=/#TY'RN=9I[->RBR'4+VXU*Z:[NY"\C,6+'U-5S'AMV,G
MUH#$'-/&#S7X57K2KS<Y.Y\34FW[SU& -O&Y<C/-.E0@Y5>*1B[@JO&!UI"H
M6'+N2<]C40IREKU(?+-JP#Y?OG'M2EE'(;%3VNE:G>1@V&F3RD]<(35D>#?%
MN,_\(_<X/_3$UTTL#BZJ^%G0\/.2]U&=(Z-("II#+&YX7I6H/!GBY#SX>N?;
M]R:C?PAXIB&9-#N!D_\ /(UJ\IQBVBROJ53J4G+@%1WZ"F'T-6I-$U:U+&YT
M^9?+ZY4U6(P2,8KEJT*\-)*QE*A[+XAH50<@4_:6'/6D3[U29&,8K%2E8R:C
MT&KO_B-?3_\ P2JC4_'6^)'/V%/_ $(U\PU]/_\ !*@Y^.M]_P!>*?\ H1KZ
MGA'3/:7J>MDVF*B?J?%_JE'M3Q@XSUS3(O\ 5+]*>O4?6OZOI?PT?IL?A&2H
MHC;:*_-?_@K0@7QY;\?\M%_]!-?I5+]QOK7YK?\ !6HC_A/8!_TT7_T$U\'Q
M\E_94CQL];^HL^-@"Q!:E**3DBE7H/I17\RO23L?FSW$VRCE$R*:S'H6VTXH
M&.XEN!T!ILLJXP%P?4U*][<A1BDV&X$8//N:$D.Y<=SS1"MS(P$,1;/H*N1^
M'->N3O@TR9O]V,UU4<%6JKW8LVC1E.14)<J05[]<T+Y:+@')K3_X0GQ6Y54T
M&[.X\$1&K3_"OQQ;VSRRZ%<<+_SR-;+*<?-_ ]#9X&KHT888A<D4BID%P!D]
MJOS>#_$MF<W6CW"@+DYC-9\T;QMM>!T/<-7-6H8FEI.+1SU:$Z;NT(@R2)%Q
M0J /E6X'2E\M5&6;\C3MHQQWKGFJD+7ZC@X-<R8UE*\J>O6NI^$_Q-USX7^)
MK?7-#OG@:-P24.*Y=,[N?2@J"<*0#7=@L34PF)52+M8O"U94I[GZ_P#['G[1
MNG?&3P/ TERK7"+MD&[). !FO<4VK& 3C/2OR3_8%^.M[\./B-!I-S>$6URX
MCVEN,EJ_5_PYJT.LZ7#?Q,&26/*D5_2O!F=QS;";ZH_1LIQRQ-!1OJC04MD<
MT^HQP:?D8W5]S/X=#V6M2/+B4@CM39YA&C22, %'-.)(<MGKVKSW]HOXJ:=\
M+O %YK=S<JCK&0H)')(-<..QL,)A75D[6,:M14H.3/%OVX_VPK/X7Z)-X<T&
M]'VR0%24?!''%?FCXX\::WX]UV;7M;O'E=W)4N<]:VOCI\5-8^*7C2\UJ[NV
M9&E(0,QQP37%1HV!YK\>QK^9N+>(ZV98MJ,O=N?GF8YA4Q%9J+T'+N!!C?&#
M0Z8.\\GUIP52Q"GC'6C@#%?&SF^:Z/$<(U9:D08DX IQ*/UEZ4.>,QC-26=G
M?7[;+2S=S_LK6D,-*JKI7+Y97LM1K. N,Y^M"S#'RKBM"/P=XHE'RZ!=,/:$
MTJ>"/%L:D)X?NASWA-='U#&M>[!E*A5?0SB-YW,>*"T4?W5S6E_PB'BM#^]T
M*Y _ZY&H)M UF$$RZ1< >\=3_9U:*O.+&Z%1="GEF.YQD>E(R%2'*\=J)+5X
MG\J4%6]&-*LI)$+KTYZ5S5*#INZ,9-I6:'%5/.*50%^Z,44?6I;<5H2HWU/0
M/V5\#XX:05X/FG^8K]FO!:@^';(D<_98_P#T$5^,G[+"Y^.&D-G_ ):G^E?L
M[X*_Y%JR_P"O:/\ ]!%?O'ADVL(S[GAE?NV:T8ZGUI"2>IIR]_K3*_8>B/K$
MK#U4#FEH7H/I15 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4RX_U3?0T^F7'^J;Z&LZO\-B>Q^4?_  4]_P"2ZWG_ %]-
M7S6W;Z5]*?\ !3W_ )+K>?\ 7TU?-;=OI7\H<7?\C>IZL_+\W_WJ7J)2,NX8
MSBEHKY21YD%=-#&CW(!G##^+UKJOA?\ %CQ1\*];BU70;V13&X8HK8S@YKF*
M, ]:ZZ>+J8>K&I2=FBZ%2>&J<R9]W_"7_@J5;V.EK#XQB02 #.^0FNXC_P""
MKWPT1<L(OS;_ !K\U3$-^58^V#2!I_,RQ&WW%?;83CK-J--4Y2T/;IY[5I'Z
M6#_@K%\,CR5A]OF;_&E_X>Q?#'^[#_WTW^-?FJV[.5(Q28?UKI_XB#F2V-?]
M8L2S]*_^'L7PQ_NP_P#?3?XT?\/8OAC_ '8?^^F_QK\U0'/\0HVO_>%'_$0L
MR#_6'%'Z5I_P5@^&3' 6$?\  F_QI#_P5?\ AF8R=L.?]YO\:_-5CL&YC0J!
M& YYI/C_ #-[,?\ K)66DC]#/B'_ ,%./AOXF\'WNDQ-$'N+:2-0">I4CU]Z
M_/S7KQ=2U.:\B/\ K)68?0DU5="9-IY% VH,+S7S.<Y[BLV:]J]CS<;F4L:U
M?H-163@D\FI#[4PJ['>>!BG*<C-?.K<\VSW%KWK_ ()Y_P#);[#_ *^5KP6O
M>O\ @GG_ ,EOL/\ KY6OIN&/^1K#U/1RW_>XGZW:/_R"X?\ KFO\JM+]\?2J
MNC_\@N'_ *YK_*K2_?'TK^K<)_!CZ'ZC'X4)<?<_"OSF_P""P'_(UZ'_ -<Y
M?YFOT9N/N?A7YS?\%@/^1KT/_KG+_,U\7Q__ ,B.9XN>_P"Z,^)'^X?K3XO]
M5^%,?[A^M/B_U7X5_,DOC9^;3^)>HA3>1SWK7\ ?\C;:?]?"_P Q64O4?6M7
MP!_R-MI_U\+_ #%=>6?[Y#U1T4?XR]4?LU^S7S\*]-_ZXK_Z"M>B#I^->=_L
MU?\ )*]-_P"N*_\ H*UZ(.GXU_6^2_[C#T1^J8;_ '>'H@'3\:*!T_&BO2.D
M*,<YHHJD)GG'[5/_ "0;Q'_V#V_F*_&#Q-_R,-[_ -?#5^S_ .U3_P D&\1_
M]@]OYBOQ@\3?\C#>_P#7PU?AOBG_ !X>A\=Q+_$7H4:***_&>Y\7'=A7W'_P
M2/\ ^0A<_63^1KX<K[C_ ."1_P#R$+GZR?R-?:<#?\C:)[N2_P"^Q]#]#H/]
M4*5OOBD@_P!4*5OOBOZBI?PT?I"$D'7Z5^6G_!6O_DY8?]@F#_T&OU+E_I7Y
M:?\ !6O_ ).6'_8)@_\ 0:_/O$;_ )$;]3P^(/\ <6?*^T-SGK3@,#&:1/NB
ME R<5_-+YV['YPH_$P*AN&7/M6KX%T:W\3>.M,T.ZXBNKI(F'7&:R@<<UTGP
M=.?BOH.?^@C'_.O1RV$:F,A"6S:-\)[]:*D?I-\&/V _A38>'+/4KG2X;AY8
M@Q+Q<FO6=*_96^$>F6JVZ>#[0E3G.PUUGPL5?^$$TT@#_CW'\S70U_3V6\-Y
M92PL9<B;:1^FT,#A8TD['GEQ^S7\)[B,)+X-M" .Z&N-\>?L-_"'Q;:21KX=
MMK?<I *19Q7NASCBHGC8-QSG@BNZOP[EU6%G!&CR[!UE9H_,;]JS_@GKJOPU
MM9O$O@^)Y;93DJL8  _+VKY/N;*:SG:VGBVNK$-FOW0\=^%],\3^'[C2KZ!)
M%DC88*@\X-?D?^VK\*!\+?BY>6MO#LAD<% !QSDU^,\<\,4\ME[6C&T3Y#.,
MJIX:\H;'C^TXSBD!!&<TOF!ABFHNTC)K\HFK,^6EH*.03Z&D"&5@J\YI-Q#8
M-6]*C4ZE&C]"W-=.&I\\TF737-)(]Y_9L_89\4_&+R=9O+:2.T+C+;01C\J^
MU_A?_P $[OA=X3@C:_L8KIU SYD.,UU?[%&FV\7P:L6BMHU8QIDA!D_+7M R
M5$:8]S7]$\,<)Y>L+&K4C>Z/T'+LFPU.G&3UN>?V/[,OPBL$5(?!UH"%QD(?
M\:H:W^RE\(M9BD@?P;:!F&-^PY%>H?*GW3FG*LF=P%?8/),JG%Q4$>M+ X22
MM8^'/VD_^":>BRZ+<ZYX&3;<H&?RXH@,@<XKX#\:^$]3\$>()]!U>V:*Y@?:
MZ,.]?NOJ5NMS T,JJ01A@1UK\VO^"HWP5M_"'C&+QMI5DJQWS/),57@<X_"O
MRSCKA6A1POM\.MMSYG.\LA2I\]-'QYGC);'M2;24*.<@]/:DC)#ESR#3Z_$4
MO8R;9\;RVB(PR,;L<5J^ ->NO#'BFTU:WD(>.=<'/0;A62^:=;MY<\;9QAP?
MUKNP%:,,5&IM8K#RE&JF?ME^SKXH3Q7\,M,U%9<DVZ X/H@KOL8]\U\Z_P#!
M.#Q%+XB^ =E>RR[ML\D><_W<"OHG[PX[U_5O#E>6)RVE4EV/U/!5.?"Q8,WS
M8Z^]4?$>IC2M)GO&; CB9LY] 35U@%&5ZUY9^UOX['@/X/ZEK<DVS">6#G'+
M!A79FN*^IX&=7LB\54]A0E+L?FK^WC\8]0^)7Q=N[-;PFWMW&P!L@$9%>$J"
MK;$& >6'J?6M'Q%J<VM^(K[5;N4LSS,<D_[1J@J_/N'>OY1SG%SS',)RD^I^
M99A4]O5YF "]S^%*'YQCBA\CGUIM>-2C>\>QQP3F]1\?[QS&@)9N !7TA^RQ
M^PEXF^+Z1:UK-I)%:,X.XH#D=>XKE/V+O@)+\9OB7;)) 6MK696N,CC:>*_6
M?P!X#TGP5X<MM(TFTBA6*-5)" 9P/:OU#@CA.&:OV]5:(^GRC)J59\\MCQ_X
M;_L ?"GP;9I'/I,%TP W,\6,UW4?[+/P?1 K>"+,X_V#_C7I*J-H"-Q[4X<+
MBOVFEPYE=&FG&"/KXY=@Z:LHGG#?LN_!X\'P/9?]\G_&J6I_LF?!^]4 >"[-
M<'J$/^->I@L3]VE<-MZ=ZZ?[#R]P^!!]2PT]T?.OCK]A/X3:C97ES%HEO"9%
M)&V+IQ7Y5>.M-BT?QKJVDVX^2VU&:)..RN0/Y5^Z'B2,'1K@X_Y9-_*OPX^*
M8/\ PL_Q !T.LW/_ *-:OQWQ%RS#8",)4E:Y\MQ%AJ&'C!Q5C"9=M/'3K37'
M2G5^.M0Z,^/35] KZ?\ ^"5'_)=;['_/BG_H1KY@KZ?_ ."4_P#R76__ .O%
M/_0C7U7"/_(]I>I[&3?[W _4^$YB'TJ15SSFHH/]4*F3[HK^KZ/\-'Z9'89+
M]QOK7YJ_\%:TSX]@)/\ RT7_ -!-?I5+]QOK7YK_ /!6K_D?+?\ ZZ+_ .@F
MOA./O^15(\;/?]P9\;KT'THH7H/I17\QR^-GYN]Q#N4B0$\=JFTZS-]JT,,@
MRKO@@_2HF)VX]ZM>&R__  DEL#R/-%:X:G%UXJ6S95!1E42D?H1^SS_P3N^'
M/B3P1I_BC42CR7,"2,K0CC(Z5[=X<_8=^$>AQ!6\.VTN!U,>*Z?]E< ?![1@
M!_RXQ_RKT<*1U-?T[DO#F5+!4Y\JNTC]*P>6X3V"E;H>;0?LN_"*(+M\%6GR
M]#L-6IOV<?A;-"T,GA"U(8=U->@CGFBO?CD6 C.\8(ZU@\,H['DGB/\ 8]^$
M&O6K6X\)6D1*XWB/FOG/]H/_ ()D:3)83:GX)_UFTGRXX@,5]SL U5[F'SD:
M/:I!'(89S7G9APGE6+@TXI,RKY5A*])JQ^&7Q ^'^N_#OQ!<:%KEHR-"[#+#
ML#6#"?,3>KY!Z5][?\%2OV?;.TTI/B#HEH%9Y5CE"+^?2O@F)5C_ '*GA:_G
M'B7)ZF58^5-[=#\^S# QP=1Q0^FLISN%.I'8JN:^=D_=2[GGZ7T+_A+6'T+Q
M#::M VQH9@PQ[5^PG[&OCU_''P=TB_EFWN+1=Q)SW-?C2SJ6* X)'!K],/\
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MM3?^6E2/U_"OPQ12U/BV]!M?3_\ P2G_ .2ZW_\ UXI_Z$:^8*^G_P#@E/\
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M +![?S%?C!XF_P"1AO?^OAJ_"O%/_>:?H?'\2_&O0HT445^-=SXN.["ON/\
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M7\*C_P"6E22<M^%?AWV3XKHAM?3_ /P2G_Y+K?\ _7BG_H1KY@KZ?_X)3_\
M)=;_ /Z\4_\ 0C7U/"/_ "/*7J>MDW^]P/U.@_U0J9/NBH8/]4*F3[HK^KZ/
M\-'Z6OA&2_<;ZU^:_P#P5J_Y'RW_ .NB_P#H)K]*)?N-]:_-?_@K5_R/EO\
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M(_"C]"MJ%%%%4,*CNO\ 4M_NFI*CNO\ 4M_NFLJW\)B>Q^2G_!23_DXO6/\
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M1>@^E*WWC7\O5?XC/S66LV(/O_\  :LZ'_R$8?\ >JL/O_\  :LZ)_R$H?\
M>KIP'^]Q]2Z'\0_83]BG_DCVG_\ 7!/_ $&O9!]TUXW^Q3_R1[3_ /K@G_H-
M>R#[IK^M,A_Y%E/T/U7 _P"Z1] _@_&A/O"C^#\:$^\*]CJCJ^P*.I^AKYG_
M ."G?_)M>M?]<?ZFOI@=3]#7S1_P4\ '[-FM#_IB/YU\]Q7_ ,B>IZ'GYBKX
M.?H?E"/N?\"I],'W/^!4^OY.Q?\ $9^6OXPH Q10?ND@\UG33<D$-9'ZB_\
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M#]X4OM".+^.QV_"[6R?^@;-_Z :_%/QB0?$UV1_STK]K/CUS\+]:'_4.F_\
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M4O42E7J/K24J]1]:^3D>;3V8Z'_CY3_KH/YU^OG[ ?\ R0>Q_P!]OY"OR$B
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M_K3(O^193]#]5P/^Z1] _@_&A/O"C^#\:$^\*]CJCJ^P*.I^AKYI_P""GO\
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MHDXK5BCL/ZT4T2*>,')[4K/M .T\TDXRV&+13?,]J<#D9JDK %%%%, HHHH
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M\HV7[C?6OS7_ ."M7_(^6_\ UT7_ -!-?I/+]QJ_-?\ X*UD#QY;DG_EHO\
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M &@/VO/ /PLT:9TUN"2Y52!"LGS9KR\PS+#8:A*4YI:=S&KB*-.+YI'Y]?\
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M!-?!>(&F4RU/'SSF>"9\<@X I:11\HI:_F1M-L_.9I\]V)@9S5[PS_R'K?\
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MJ4'#2,CS9JK.>A:TC7M4T&_2^TN\>-U.00V*]W^%7_!0#XJ^"$CM+S4'GBB
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MV2?A3W\.VWU\E:]6VC^^*0@#HU8+(,N<K^S0+!89?9/.M"_9I^&GA^\6^L=
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M'^&$"NV;<!UH3H:[Z.1Y=0^&"-E@\.E;E,K3_!VAV"@6^G1*/9!6C#86L/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "DVC.<TM%)M@(R[J%7 Y I:*2;
M,#T%-921\H%.HJ@$5<4%03FEHH **** "BBB@ HHHH ****  \C%(J!>]+10
M $ C!H P,444M "C'.?2BBC0!&7)S1MY! I:*8!1110 4444 -=23D4FQJ?1
M4N:0#0A'IFEVY'('X4M(Q('%*[EL FQ1W-(,9]J 23@DTX*!R!1R6W8-"D>E
M,P1D[N_K3Z0JI[4<@#23TS2ITQ04(Z<TJ @<BJ2L-M6%HHHIB"BBB@ HHHH
M#GMBDQG[P%+10 8'I1@>@HHH 0J#VH  Z4M%3<!&!/0TM%%";8!1115 %!&>
M]%% "; >I- 0 YI:*FX!1111< HHHJ@"BBB@ HP#U%%%)L P/048'H***5P#
M ]!1@=Q1133N 4  <CO113 ****FVH!1115 %%%% "%@#@TA 8?**5MF>:
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M, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+"BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>insurancesegmentbenefitsra.jpg
<TEXT>
begin 644 insurancesegmentbenefitsra.jpg
M_]C_X  02D9)1@ ! @$ > !X  #__@ 23$5!1%1/3TQ3('8R,"XP /_; (0
M!04%" 4(# <'# P)"0D,#0P,# P-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-
M#0T-#0T-#0T-#0T-#0T-#0T-#0$%" @*!PH,!P<,#0P*# T-#0T-#0T-#0T-
M#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-_\0!H@
M 04! 0$! 0$           $" P0%!@<("0H+ 0 # 0$! 0$! 0$!
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M_P!,O^^#_C1_;6*_N?\ @+_S#ZS/R^X/^$WU#_IE_P!\'_&C^VL5_<_\!?\
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M?\)OJ'_3+_O@_P"-']M8K^Y_X"_\P^LS\ON#_A-]0_Z9?]\'_&C^VL5_<_\
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M'_3+_O@_XT?VUBO[G_@+_P P^LS\ON#_ (3?4/\ IE_WP?\ &C^VL5_<_P#
M7_F'UF?E]P?\)OJ'_3+_ +X/^-']M8K^Y_X"_P#,/K,_+[@_X3?4/^F7_?!_
MQH_MK%?W/_ 7_F'UF?E]P?\ ";ZA_P!,O^^#_C1_;6*_N?\ @+_S#ZS/R^X/
M^$WU#_IE_P!\'_&C^VL5_<_\!?\ F'UF?E]P?\)OJ'_3+_O@_P"-']M8K^Y_
MX"_\P^LS\ON#_A-]0_Z9?]\'_&C^VL5_<_\  7_F'UF?E]P?\)OJ'_3+_O@_
MXT?VUBO[G_@+_P P^LS\ON#_ (3?4/\ IE_WP?\ &C^VL5_<_P# 7_F'UF?E
M]P?\)OJ'_3+_ +X/^-']M8K^Y_X"_P#,/K,_+[@_X3?4/^F7_?!_QH_MK%?W
M/_ 7_F'UF?E]P?\ ";ZA_P!,O^^#_C1_;6*_N?\ @+_S#ZS/R^X/^$WU#_IE
M_P!\'_&C^VL5_<_\!?\ F'UF?E]P?\)OJ'_3+_O@_P"-']M8K^Y_X"_\P^LS
M\ON#_A-]0_Z9?]\'_&C^VL5_<_\  7_F'UF?E]P?\)OJ'_3+_O@_XT?VUBO[
MG_@+_P P^LS\ON#_ (3?4/\ IE_WP?\ &C^VL5_<_P# 7_F'UF?E]P?\)OJ'
M_3+_ +X/^-']M8K^Y_X"_P#,/K,_+[@_X3?4/^F7_?!_QH_MK%?W/_ 7_F'U
MF?E]P?\ ";ZA_P!,O^^#_C1_;6*_N?\ @+_S#ZS/R^X/^$WU#_IE_P!\'_&C
M^VL5_<_\!?\ F'UF?E]P?\)OJ'_3+_O@_P"-']M8K^Y_X"_\P^LS\ON#_A-]
M0_Z9?]\'_&C^VL5_<_\  7_F'UF?E]P?\)OJ'_3+_O@_XT?VUBO[G_@+_P P
M^LS\ON#_ (3?4/\ IE_WP?\ &C^VL5_<_P# 7_F'UF?E]P?\)OJ'_3+_ +X/
M^-']M8K^Y_X"_P#,/K,_+[@_X3?4/^F7_?!_QH_MK%?W/_ 7_F'UF?E]P?\
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M<_\  7_F'UF?E]P?\)OJ'_3+_O@_XT?VUBO[G_@+_P P^LS\ON#_ (3?4/\
MIE_WP?\ &C^VL5_<_P# 7_F'UF?E]P?\)OJ'_3+_ +X/^-']M8K^Y_X"_P#,
M/K,_+[@_X3?4/^F7_?!_QH_MK%?W/_ 7_F'UF?E]P?\ ";ZA_P!,O^^#_C1_
M;6*_N?\ @+_S#ZS/R^X/^$WU#_IE_P!\'_&C^VL5_<_\!?\ F'UF?E]P?\)O
MJ'_3+_O@_P"-']M8K^Y_X"_\P^LS\ON#_A-]0_Z9?]\'_&C^VL5_<_\  7_F
M'UF?E]P?\)OJ'_3+_O@_XT?VUBO[G_@+_P P^LS\ON#_ (3?4/\ IE_WP?\
M&C^VL5_<_P# 7_F'UF?E]P?\)OJ'_3+_ +X/^-']M8K^Y_X"_P#,/K,_+[@_
MX3?4/^F7_?!_QH_MK%?W/_ 7_F'UF?E]P?\ ";ZA_P!,O^^#_C1_;6*_N?\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M_P"^O_K4?V1BOY5]X?5Y]@_X0;4_[B_]]?\ UJ/[(Q7\J^\/J\^P?\(-J?\
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M_P#6H_LC%?RK[P^KS[!_P@VI_P!Q?^^O_K4?V1BOY5]X?5Y]@_X0;4_[B_\
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MM1_9&*_E7WA]7GV#_A!M3_N+_P!]?_6H_LC%?RK[P^KS[!_P@VI_W%_[Z_\
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ML<YJ%A+IDQMYP Z]0#GK7D5J,\--TJNDD<\HN#Y7N4JYB0H U]?_ .0A<?\
M75_YUZ6._P!ZK?\ 7R7YFM7XY>K,BO-,CT_X;_?G_P!T?S%?:9%\57T7YGH8
M7=GJ]?<'IA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M0 4 % !0 4 -9UC&YB% ZDG 'XF@ 1UD&Y"&!Z$'(_,4 .H * "@ H * "@
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M !0 4 % !0 4 % !0 4 % '@WC;_ )"DGT7^M?F&;?[U/T1XM?XV<E7A',%
M&OK_ /R$+C_KJ_\ .O2QW^]5O^ODOS-:OQR]69%>:9'I_P -_OS_ .Z/YBOM
M,B^*KZ+\ST,+NSU>ON#TSRWXR_\ (L7/^]'_ .A4 <K\,_\ D0;G_KGJ'_H#
MT >;_"/P#9>,89Y=3:1H(' 6%'*+N8<L2"#G  ]^],1-X4M1X1\>G3;)F%N7
M,6TG.4=00#GKMW<$\]Z &_%BSN;+Q,-0U2"2ZTWY2H&=A0#E-PX4@XX)&<4
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MB?8[O:MVL8=7. $G"C/(X"EN#CC'M0!\G6FK:GXECL_!C2*L4=P5W;A@A0<
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MCI3 W_@7KUQJ^D2VURQD^PR+&C-R=K*2!GT4# ]!2 ]NH * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * /!O&W_(4D^B_P!:_,,V_P!ZGZ(\
M6O\ &SDJ\(Y@H U]?_Y"%Q_UU?\ G7I8[_>JW_7R7YFM7XY>K,BO-,CT_P"&
M_P!^?_='\Q7VF1?%5]%^9Z&%W9ZO7W!Z9YC\7X)+CPU<1PJTCEH\*@+$_-Z
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M6UF%;+2M&^S7C%0TAB!&1U"AHD')SR6X]Z8'5>.M-U)/!(M[Y?-O2T;2+"G
M)=20%4?P]SBD!UGPP@D@\*0QRJR.(Y?E92K=^Q - 'E'P;TV>+7M0^T0R)&Z
MR#+HRJ<R/T) !XH$9MKI^I_"G5KAFL/[2L)\A&"[LJ3E2/E<JPP 1MQSUI@=
M)I&M^(?&&L1-8V*:;IZ;?,WQ#@ DD[BB'<W0 +QC.:!E+X_6-Q=WUF;>*24+
M"02B,P'[QNNT'% CUCXI023^$KN*)6=S'!A5!9CB>$G  )Z"D,Q?ACILLWA
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M9:E#'I.GKIMHI42M)$.F?F8ED0Y R  #GCD4#&_&:PN9]:TQHHI)0FW<R(S
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M]1H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MT_X;_?G_ -T?S%?:9%\57T7YGH87=GJ]?<'IA0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 >#>-O^0I)]%_K7YAFW^]3]$>+
M7^-G)5X1S!0!KZ__ ,A"X_ZZO_.O2QW^]5O^ODOS-:OQR]69%>:9'I_PW^_/
M_NC^8K[3(OBJ^B_,]#"[L]7K[@],* "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M_ WC.?Q5<W\,R1(EC.8XVCW?.O9FW,PR?; J(RO?R,J=1S<D[:.R/1JT.@*
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MO((GMDMEA:+;)$!_RTD7/RH3DEO4U,7:6B9G3DE5TBTK6M;;S9[%\7]=;1M
MEBA)\^^/V:,#J?,^5\>^TDUM-V1V5Y<L&EN]$>&WL.O^%UTG4;S35L(-)98_
MM"SQR-(DN%<NJL2"5SSCKQ6&L;-JUCA:G3Y).-E'K?N=GXIEM-4\:Z>=7\MM
M,ELDDA$I'DEF9S\V?DSCKGL!GM5NSDK[6-IVE5CS_#;2^Q-X'CTV'QUJ":/L
M^R"!-OE_<#;1Y@7'&T/N QQCH<41MSNVPZ?*JTN3:W0X>S4GP#J6!G%Z2?\
MOZ*C[#]3!?P9>OZG4>/=?T^_TS0[6UGBFF5H"R1L&*[4C4[L9VG((PV#5R:L
MDC6K*+C!)J^GZ&IX]TI+OQ)]HL+JT.H10#?9WR$1LA3&8W=/*)*\GYL@^].2
M][1J_9EU8WJ7BUS6VE_5C%TDVNM^"M3A2T6%[1]VT-YD?F[N9(B>%.W<#MZ
MX[U*UB]#.-I4I)*UONOY%'4UBB^'MNVEB(/(Z"\,6-V/,<?OMO(&,9W=L4G\
M&GS%+2BN6WG;]1J:9]GOM(N4O=)MI!+#Y2V:S-+*I*YCD\J XW#@^85&3R:+
M6:U7R#ELX-2BM5:U[O[D;=G#IEYXTU0>)/)*I&?(%P0$$>1RF_ S@G;CGKCO
M5:<SYBURNK+VEO*YJ_! 6ZSZL+/FW%T?*QTV?PXSVQT]J=/K8K#VO/EVOH?0
M-;GH!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M%]N\_P D;MWWL9.S/OLVUO'97/1I7Y(\V]CKJLV"@ H * "@ H * "@ H *
M/!O&W_(4D^B_UK\PS;_>I^B/%K_&SDJ\(Y@H U]?_P"0A<?]=7_G7I8[_>JW
M_7R7YFM7XY>K,BO-,CT_X;_?G_W1_,5]ID7Q5?1?F>AA=V>KU]P>F% !0 4
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M;G%V35K6+OP]\%GP-IYT]IQ=;I"^\1^7U[;=[_GFG&/*K%4J?LH\M[_@<_\
M%OS=1M;30[9&>74+I V <"),M(Q(&!CY>N,U,^D5U,Z^J4%NW^!ZG9VXLX([
M=>D,:1CZ(H4?RK38ZDK)+L6:8PH * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M?S%?:9%\57T7YGH87=GJ]?<'IA0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M])/YK0,^N?A)_P BII_^Y+_Z/EJ1GHU !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'YZ>(X%N?$MY"^0LFHSJ<=<&X<
M''O3$=#_ ,(;9?WI?^^E_P#B*8@_X0VR_O2_]]+_ /$4 '_"&V7]Z7_OI?\
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M@#SWQO\ ?@^DG\UH&?7/PD_Y%33_ /<E_P#1\M2,]&H * "@ H * "@ H *
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M@DEM6"S* <H2,@'( Y'IFE=;(2DFVD]5N:5,H* "@ H * "@ H * "@ H *
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M>^-_OP?23^:T#/KGX2?\BII_^Y+_ .CY:D9Z-0 4 % !0 4 % !0 4 % !0
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M)-OSM"&3+,5S]Y>,$5:?PI;&\)_PU%^ZUK\BX?%6MW)\0K83K(]E=P1V@;8
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MU8,P..0Q(/>CE6GD4Z47:Z^';4G@\%Z3;_:]L.X:CM^TAV9U?:,#AB0N!_=
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M=N XZ X]J.56MT'[./+R6TO?<FE\&:7+>P:D8F%S:*B1NLCK\L8 4. P#@
M?.#3Y5>X_9QNI6U6QBGX6>'CN'V=@K.)-@FE"*X8-N1-^U"2.=H&1D'@FIY$
M1[&';\6;C>#M,;4(]7$16\@4(KJ[KE5Z!U!"OC_:!JN57OU+]G'F4[:HZ>J-
M0H * "@ H * /SZUO_D:;K_L)S?^E+4Q'I%,04 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % 'EGC#_C^_P"V:_S:D,^]?#/_ "";+_KTM_\ T2E(9MT
M% !0 4 >#>-O^0I)]%_K7YAFW^]3]$>+7^-G)5X1S!0!KZ__ ,A"X_ZZO_.O
M2QW^]5O^ODOS-:OQR]69%>:9'I_PW^_/_NC^8K[3(OBJ^B_,]#"[L]7K[@],
M* "@ H ^&/C/_P C7>?[MO\ ^D\5,1U"?='T%,0Z@ H * "@ H * "@ H *
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MEL;E99B"P7;(FY1U*%T4. .<J3QS0I)Z(4:D9.T7J=-5&H4 % !0 4 % !0
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M[L<'8SHJOC_9)JE)/1&BJ1D[1>IU%4:A0 4 % !0 4 ?GUK?_(TW7_83F_\
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M@ H * "@ H * /+/&'_']_VS7^;4AGWKX9_Y!-E_UZ6__HE*0S;H * "@ H
M\&\;?\A23Z+_ %K\PS;_ 'J?HCQ:_P ;.2KPCF"@#7U__D(7'_75_P"=>ECO
M]ZK?]?)?F:U?CEZLR*\TR/3_ (;_ 'Y_]T?S%?:9%\57T7YGH87=GJ]?<'IA
M0 4 % 'PQ\9_^1KO/]VW_P#2>*F(ZA/NCZ"F(=0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 >>^-_OP?23^:T#/KGX2?\BII_\ N2_^CY:D9Z-0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MKGB:]UV^;4;J1FF9L@YQM / 7^Z!VQ7;&DK>]O\ D?:X?*H*DU7_ (DE_P"
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M^1KO/]VW_P#2>*F(ZA/NCZ"F(=0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M^1KO/]VW_P#2>*F(ZA/NCZ"F(=0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M?NR+W5A_(]0?QKFJ4[^]'<^6S#+_ &EZ]!6E]J*Z^:\S[T\(>+[+QC9+=V;
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M;OQ)=O>WKF220]^BCLJCH /05WTZ?+J]S[[ 8!89>UJ*]1_^2^2\S!K<]\*
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MO7W!Z84 % !0!\,?&?\ Y&N\_P!VW_\ 2>*F(ZA/NCZ"F(=0 4 % !0 4 %
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MPDW3FM.CZ-'T54'$% !0 4 % !0 4 ?GUK?_ "--U_V$YO\ TI:F(](IB"@
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MKX*6[]3R'N.J1!0 4 % 'N7P#_X^=1^D5?9X7^##T?YL].G\*/I:NTV"@ H
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M+RY^VO%P)3'Y;%1T##>^2/7(R,<<5!RFW0 4 % !0 4 % 'Y]:W_ ,C3=?\
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M\C@CH0?0CL:8B>@ H * "@ H \L\8?\ ']_VS7^;4AGWKX9_Y!-E_P!>EO\
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M1!0 4 % 'N7P#_X^=1^D5?9X7^##T?YL].G\*/I:NTV"@ H * "@ H * "@
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M *^2_,UJ_'+U9D5YID>G_#?[\_\ NC^8K[3(OBJ^B_,]#"[L]7K[@],* "@
MH ^&/C/_ ,C7>?[MO_Z3Q4Q'4)]T?04Q#J "@ H * "@!.E $,ES%%P[*OU-
M $#:G:IUE0?\"%  NI6K=)4/_ A0!8CGCE^XP;Z&@":@ H * "@ H * "@#S
MWQO]^#Z2?S6@9]<_"3_D5-/_ -R7_P!'RU(ST:@ H * "@ H \I^,_\ R+,_
M_72/^9I/83/DM>@^E?!2W?J>0]QU2(* "@ H ]R^ ?\ Q\ZC](J^SPO\&'H_
MS9Z=/X4?2U=IL% !0 4 % !0 4 % !0 4 % !0!P/Q0_Y%F^_P"N:_\ HU*
M/SR;J:]6.R/U7#_PH?X5^0E4=04 % !0!]*?LY_\A"[_ .O;_P!J1UY]7XC\
MZS3_ 'F7HCZXK \4* "@ H * "@ H * "@ H * "@#E/'/\ R ;[_KWD_E0!
M^<,GWC]:]2'PKT/T[!?[O2_P+\AE6>B% !0 4 >]?L_?\AYO^N$G\JX:WQ?(
M^!S?_>%_@7YL^TJYCYX* "@ H * "@ H * "@ H * "@ H X+XH_\BOJ/_7#
M_P!G2@#\\6ZGZFO5CLO1'ZKA_P"#3_Z]P_\ 24)5'4% !0 4 ?4_[-W74O\
M=M?YW%>;4^)GYGF'^]5?\2_)'U+61Y@4 % !0 4 % !0 4 % 'Y]:W_R--U_
MV$YO_2EJ8CTBF(* (F66XD2UM^9ISM7_ &1_$Y]D&6_"@#UG2M,BTBW6WA&
MOWCW9N[,>Y-24:- 'FWB72+]-7AU;3/(DECC*F*9@HQ@@L,D'&/3!S0!YIB[
MFM=9N#MPS1^9Y7^KW%Q]TC/ QV-,1U/B5K:33=)6UV[BR;0OWNBA\=_O YH
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M ,BOJ/\ UP_]G2@#\\6ZGZFO5CLO1'ZKA_X-/_KW#_TE"51U!0 4 % 'U/\
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M>^-_OP?23^:T#/KGX2?\BII_^Y+_ .CY:D9Z-0 4 % !0 4 >4_&?_D69_\
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MXP3D\X)-,#?;3K74=.M]725K$1VIC)*A\QG@H<D<D@X/7FD!S>C&>PEMY8X
M\C0N;6.9BHC@C5CO. Q\R4 G&,#=R13$>M:)J8UBSCO NSS!DKZ'N*0S5H *
M /,_%JA=3A*]6MY-W_ 7BV_H330C&IB"@#SWQO\ ?@^DG\UH&?7/PD_Y%33_
M /<E_P#1\M2,]&H * "@ H * /*?C/\ \BS/_P!=(_YFD]A,^2UZ#Z5\%+=^
MIY#W'5(@H * "@#W+X!_\?.H_2*OL\+_  8>C_-GIT_A1]+5VFP4 % !0 4
M% !0 4 % !0 4 % ' _%#_D6;[_KFO\ Z-2@#\\FZFO5CLC]5P_\*'^%?D)5
M'4% !0 4 ?2G[.?_ "$+O_KV_P#:D=>?5^(_.LT_WF7HCZXK \4* "@ H *
M"@ H * "@ H * "@#E/'/_(!OO\ KWD_E0!^<,GWC]:]2'PKT/T[!?[O2_P+
M\AE6>B% !0 4 >]?L_?\AYO^N$G\JX:WQ?(^!S?_ 'A?X%^;/M*N8^>"@ H
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MKCS/Y/30BE3$>6>,/^/[_MFO\VI#/O7PS_R";+_KTM__ $2E(9MT % !0 4
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M-_P(X_*F(BIB"@#SWQO]^#Z2?S6@9]<_"3_D5-/_ -R7_P!'RU(ST:@ H *
M"@ H \I^,_\ R+,__72/^9I/83/DM>@^E?!2W?J>0]QU2(* "@ H ]R^ ?\
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M H X+XH_\BOJ/_7#_P!G2@#\\6ZGZFO5CLO1'ZKA_P"#3_Z]P_\ 24)5'4%
M!0 4 ?4_[-W74O\ =M?YW%>;4^)GYGF'^]5?\2_)'U+61Y@4 % !0 4 % !0
M 4 % 'Y]:W_R--U_V$YO_2EJ8CTBF(0C<"/6@#MO!=WYMD;5C\]JYCQ_L9S'
M_P".;:DH["@ H * "@ H * "@ H * "@ H * (IYEMXVE?A44L?H!F@#Q>&0
MW#273?>N)&D_X"3A/_' M426* /+/&'_ !_?]LU_FU(9]Z^&?^039?\ 7I;_
M /HE*0S;H * "@ H \&\;?\ (4D^B_UK\PS;_>I^B/%K_&SDJ\(Y@H U]?\
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M$?JN'_@T_P#KW#_TE"51U!0 4 % 'U/^S=UU+_=M?YW%>;4^)GYGF'^]5?\
M$OR1]2UD>8% !0 4 % !0 4 % !0!^?6M_\ (TW7_83F_P#2EJ8CTBF(* )M
M-U'^Q;Q;EN()<1S>P)PK^P4XW'^Z#2&>O AAD=#R*0Q: .3\9Z_)X>T]KF
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M6@$]P1V/R1^[D?\ H(Z^HH X3][-(;BY<RS-U8C  _NJ/X5'U)]2:HDDH *
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ML8"CKP,<^I]2?6F(EH * "@ H \L\8?\?W_;-?YM2&?>OAG_ )!-E_UZ6_\
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M * "@ H * "@ H * .4\<_\ (!OO^O>3^5 'YPR?>/UKU(?"O0_3L%_N]+_
MOR&59Z(4 % !0![U^S]_R'F_ZX2?RKAK?%\CX'-_]X7^!?FS[2KF/G@H * "
M@ H * "@ H * "@ H * "@#@OBC_ ,BOJ/\ UP_]G2@#\\6ZGZFO5CLO1'ZK
MA_X-/_KW#_TE"51U!0 4 % 'U/\ LW==2_W;7^=Q7FU/B9^9YA_O57_$OR1]
M2UD>8% !0 4 % !0 4 % !0!^?6M_P#(TW7_ &$YO_2EJ8CTBF(* "@ H *
M"@ H C:)'X8 _A0!7;3[=NJ"@!HTVV7I&OZ_XT 3I;11_=4#\* )@,=* %H
M* "@ H * "@#RSQA_P ?W_;-?YM2&?>OAG_D$V7_ %Z6_P#Z)2D,VZ "@ H
M* /!O&W_ "%)/HO]:_,,V_WJ?HCQ:_QLY*O".8* -?7_ /D(7'_75_YUZ6._
MWJM_U\E^9K5^.7JS(KS3(]/^&_WY_P#='\Q7VF1?%5]%^9Z&%W9ZO7W!Z84
M% !0!\,?&?\ Y&N\_P!VW_\ 2>*F(ZA/NCZ"F(=0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 >>^-_OP?23^:T#/KGX2?\ (J:?_N2_^CY:D9Z-0 4
M% '-^*?"MEXLLVLKU<Y'R2#[\;=F4^QZCH>E 'QAXB\.WGA"\-A?C*G)AF ^
M61?\?45\[B\)RWJTEIU7;S1PU*=O>C]QE5X)R!0 4 % !0 4 % #H()[^=+*
MR0S7$Q"HH]^Y] .I->CAL,Z[N](+=]_)&U.GSOR/KCX=_#NW\'V_GS@3:A,
M9)2/N?[">@'<]37UL8J"48JR1Z25M$>G50PH * "@ H * "@ H * "@#@?BA
M_P BS??]<U_]&I0!^>3=37JQV1^JX?\ A0_PK\A*HZ@H * "@#Z4_9S_ .0A
M=_\ 7M_[4CKSZOQ'YUFG^\R]$?7%8'BA0 4 % !0 4 % !0 4 % !0 4 <IX
MY_Y -]_U[R?RH _.&3[Q^M>I#X5Z'Z=@O]WI?X%^0RK/1"@ H * />OV?O\
MD/-_UPD_E7#6^+Y'P.;_ .\+_ OS9]I5S'SP4 % !0 4 % !0 4 % !0 4 %
M !0!P7Q1_P"17U'_ *X?^SI0!^>+=3]37JQV7HC]5P_\&G_U[A_Z2A*HZ@H
M* "@#ZG_ &;NNI?[MK_.XKS:GQ,_,\P_WJK_ (E^2/J6LCS H * "@ H * "
M@ H * /SZUO_ )&FZ_["<W_I2U,1Z13$% !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0!Y9XP_P"/[_MFO\VI#/O7PS_R";+_ *]+?_T2E(9MT % !0 4
M >#>-O\ D*2?1?ZU^89M_O4_1'BU_C9R5>$<P4 :^O\ _(0N/^NK_P Z]+'?
M[U6_Z^2_,UJ_'+U9D5YID>G_  W^_/\ [H_F*^TR+XJOHOS/0PN[/5Z^X/3"
M@ H * /ACXS_ /(UWG^[;_\ I/%3$=0GW1]!3$.H * "@ H * "@ H * "@
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M_P A"[_Z]O\ VI'7GU?B/SK-/]YEZ(^N*P/%"@ H * "@ H * "@ H * "@
MH Y3QS_R ;[_ *]Y/Y4 ?G#)]X_6O4A\*]#].P7^[TO\"_(95GHA0 4 % 'O
M7[/W_(>;_KA)_*N&M\7R/@<W_P!X7^!?FS[2KF/G@H * "@ H * "@ H * "
M@ H * "@#@OBC_R*^H_]</\ V=* /SQ;J?J:]6.R]$?JN'_@T_\ KW#_ -)0
ME4=04 % !0!]3_LW==2_W;7^=Q7FU/B9^9YA_O57_$OR1]2UD>8% !0 4 %
M!0 4 % !0!^?6M_\C3=?]A.;_P!*6IB/2*8@H * "@ H * "@ H * "@ H *
M "@ H * "@ H * /+/&'_']_VS7^;4AGWKX9_P"039?]>EO_ .B4I#-N@ H
M* "@#P;QM_R%)/HO]:_,,V_WJ?HCQ:_QLY*O".8* -?7_P#D(7'_ %U?^=>E
MCO\ >JW_ %\E^9K5^.7JS(KS3(]/^&_WY_\ ='\Q7VF1?%5]%^9Z&%W9ZO7W
M!Z84 % !0!\,?&?_ )&N\_W;?_TGBIB.H3[H^@IB'4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % 'GOC?[\'TD_FM SZY^$G_(J:?_N2_P#H^6I&>C4
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M%\4?^17U'_KA_P"SI0!^>+=3]37JQV7HC]5P_P#!I_\ 7N'_ *2A*HZ@H *
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M "@ H * //?&_P!^#Z2?S6@9]<_"3_D5-/\ ]R7_ -'RU(ST:@ H * "@ H
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M0!^?6M_\C3=?]A.;_P!*6IB/2*8@H * "@ H * "@ H * "@ H * "@ H *
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M^+H /^%)>%?^?>3_ ,")O_BZ #_A27A7_GWD_P# B;_XN@ _X4EX5_Y]Y/\
MP(F_^+H W_#GPXT3PI<_;-,A>.8J4RTLCC!Z\,Q% '=4 % !0 4 % !0 4 %
M !0 4 % !0 4 9VKZ5;ZY:2Z?>*7@N%VR*&*DC(/#*01R!T- 'F__"DO"O\
MS[R?^!$W_P 70 ?\*2\*_P#/O)_X$3?_ != !_PI+PK_ ,^\G_@1-_\ %T '
M_"DO"O\ S[R?^!$W_P 70 ?\*2\*_P#/O)_X$3?_ != '5^%_ ^E>#C*=*C:
M(W(02;I'DSLW;<;R<8WMTZ]Z .NH * "@ H * "@ H * "@#\^M;_P"1INO^
MPG-_Z4M3$>D4Q!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 >6>,/\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 ?GUK?\ R--U_P!A.;_TI:F(](IB"@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H \L\8?\?W_;-?YM2&?>OAG_D$V7_7I;_^B4I#-N@ H * "@#P
M;QM_R%)/HO\ 6OS#-O\ >I^B/%K_ !LY*O".8* -?7_^0A<?]=7_ )UZ6._W
MJM_U\E^9K5^.7JS(KS3(]/\ AO\ ?G_W1_,5]ID7Q5?1?F>AA=V>KU]P>F%
M!0 4 ?#'QG_Y&N\_W;?_ -)XJ8CJ$^Z/H*8AU !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0!Y[XW^_!])/YK0,^N?A)_R*FG_P"Y+_Z/EJ1GHU !0 4
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MB9B>  YR>E+F6Q"K0;LGY;.WW[%+P1XCO=;U#5;:[96CL;A(X0%52JL&)!(
M+=!R:46VVGT)IS<I33Z/0]'K0Z0H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H _/K6
M_P#D:;K_ +"<W_I2U,1Z13$% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0!Y9XP_X_O^V:_S:D,^]?#/_()LO^O2W_\ 1*4AFW0 4 % !0!X-XV_Y"DG
MT7^M?F&;?[U/T1XM?XV<E7A',% &OK__ "$+C_KJ_P#.O2QW^]5O^ODOS-:O
MQR]69%>:9'I_PW^_/_NC^8K[3(OBJ^B_,]#"[L]7K[@],* "@ H ^&/C/_R-
M=Y_NV_\ Z3Q4Q'4)]T?04Q#J "@ H * "@ H * "@ H * "@ H * "@ H *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H _/K6_\ D:;K_L)S?^E+4Q'I%,04 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % 'EGC#_ (_O^V:_S:D,^]?#/_()LO\ KTM_
M_1*4AFW0 4 % !0!X-XV_P"0I)]%_K7YAFW^]3]$>+7^-G)5X1S!0!KZ_P#\
MA"X_ZZO_ #KTL=_O5;_KY+\S6K\<O5F17FF1Z?\ #?[\_P#NC^8K[3(OBJ^B
M_,]#"[L]7K[@],* "@ H ^&/C/\ \C7>?[MO_P"D\5,1U"?='T%,0Z@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H \]\;_?@^DG\UH&?7/PD_P"14T__
M ')?_1\M2,]&H * "@ H RH-=L+F[?3HKB)[N$9>$,#(H& 25ZCDC\Z5UMU(
M4DWRIJZZ#6U_3UO1IAN(A>$;A!N'F8]=O7%%U>W4.:-^6ZOV->F6,DD6%&DD
M(5$!9B>@ &23[ <T!L95MXATZ\2&2"XBD2[)$!5P1*5)5MG][# @X[BE=$*4
M79IK7;S-BF6% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M)\RX^8*P! (([>M:Q=U=G53DYQ3:LSK:HV"@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@#\^M;_P"1INO^PG-_Z4M3$>D4Q!0 4 % !0 4 % !0 4 % !0 4 % !0
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M!$4?3<2S$GJ6)ZDU25M$:1BH+E6QITR@H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MOKO?YZ'V)76>P% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * /SZUO\ Y&FZ_P"PG-_Z4M3$>D4Q!0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 >6>,/^/[_MFO\VI#/O7PS_R";+_KTM__ $2E(9MT % !
M0 4 >#>-O^0I)]%_K7YAFW^]3]$>+7^-G)5X1S!0!KZ__P A"X_ZZO\ SKTL
M=_O5;_KY+\S6K\<O5F17FF1Z?\-_OS_[H_F*^TR+XJOHOS/0PN[/5Z^X/3"@
M H * /ACXS_\C7>?[MO_ .D\5,1U"?='T%,0Z@ H * "@ H * "@ H * "@
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MZ7/_ 'Z;_P"(H /MFN>ES_WZ;_XB@ ^V:YZ7/_?IO_B* #[9KGI<_P#?IO\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % 'Y]>*[&]37KZ:&&;(OKAD81N?^6SD$';@^HIB*7VS7/2Y_[]
M-_\ $4 'VS7/2Y_[]-_\10 ?;-<]+G_OTW_Q% !]LUSTN?\ OTW_ ,10 ?;-
M<]+G_OTW_P 10 ?;-<]+G_OTW_Q% !]LUSTN?^_3?_$4 'VS7/2Y_P"_3?\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@#P;QM_R%)/HO]:_,,V_W
MJ?HCQ:_QLY*O".8* -?7_P#D(7'_ %U?^=>ECO\ >JW_ %\E^9K5^.7JS(KS
M3(]/^&_WY_\ ='\Q7VF1?%5]%^9Z&%W9ZO7W!Z84 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '@WC;_D*2?1?ZU^89M_O4_1
M'BU_C9R5>$<P4 :^O_\ (0N/^NK_ ,Z]+'?[U6_Z^2_,UJ_'+U9D5YID>G_#
M?[\_^Z/YBOM,B^*KZ+\ST,+NSU<D 9/ %?<'IF;:ZQ:W<\MK%(#+ RJZ].6C
M24;?[PV.IR..: -*@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MP;J44D4]S>Q2R6L#V\.VW*J%<8W.IF?<PP.X4\_+0!47X?W<RW'VFZB#7(A
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MG) Z], #9/!NHPR2M8WD4*W,$4$@>W9V"Q1+'NC(F0*YVDY8.!D#!QD@$S>
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MF.YT6?S H1FR>82PS]Z@"_>>#VNH[^,3!?[2ECD!V$^7L"C!^8;LXZ_+CTH
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M. 0#D@D@'4Z9HITZ>\G\S=]NE$@ 7!CPI&,DD$\YS@?2@#BK/X?W5O/#,US
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M18/)W;LC;C! ,-OA^\4,!MYH/M5M)<,'GM_.A>.>0R%'B\Q3E<X5ED7N2#D
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M _M.Y%P#L/[L"&*+:1N^;_5;L_+UQCC) ()_!L\5]+=V,EH(KF59I$N;3SY
MV<OY4@ECV!^3AE?!/![4 69O![36E_:><H.HW*SAA&<1X:([=N_YO]7C.1C/
M3CD MV?A^ZT_5);^&>/[/=!/-B:)C)NC14!202!5!"@D&-CG/- '6T % !0
M4 >#>-O^0I)]%_K7YAFW^]3]$>+7^-G)5X1S!0!KZ_\ \A"X_P"NK_SKTL=_
MO5;_ *^2_,UJ_'+U9D5YID>G_#?[\_\ NC^8K[3(OBJ^B_,]#"[L]7K[@],*
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0!UOC#3_ +)>&8'(G^;'<'O7T6;T/8XAU$]*GO6[/J==>'+*
M_?4Y*OG3D"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * .CTS0#J$/G;PN21CGMCVKV\-@'B*?M>9+5JQT0I<ZO<
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45935812916464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Feb. 11, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 11,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Humana Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000049071<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-5975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">61-0647538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 West Main Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Louisville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">KY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">40202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">580-1000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HUM<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>15
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0
M   ( "DU2UJ]OUS![@   "L"   1              "  :\   !D;V-0<F]P
M<R]C;W)E+GAM;%!+ 0(4 Q0    ( "DU2UJ97)PC$ 8  )PG   3
M      "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ *35+
M6H-F/UHI!   61   !@              ("!#0@  'AL+W=O<FMS:&5E=',O
M<VAE970Q+GAM;%!+ 0(4 Q0    ( "DU2UJ?H!OPL0(  .(,   -
M      "  6P,  !X;"]S='EL97,N>&UL4$L! A0#%     @ *35+6I>*NQS
M    $P(   L              ( !2 \  %]R96QS+RYR96QS4$L! A0#%
M  @ *35+6AE%%?4W 0  )P(   \              ( !,1   'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    ( "DU2UHD'INBK0   /@!   :
M  "  941  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M "DU2UIED'F2&0$  ,\#   3              "  7H2  !;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@     )  D /@(  ,03      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="hum-20250211.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="hum-20250211.htm">hum-20250211.htm</File>
    <File>hum-20250211.xsd</File>
    <File>hum-20250211_lab.xml</File>
    <File>hum-20250211_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>21
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "hum-20250211.htm": {
   "nsprefix": "hum",
   "nsuri": "http://www.humana.com/20250211",
   "dts": {
    "inline": {
     "local": [
      "hum-20250211.htm"
     ]
    },
    "schema": {
     "local": [
      "hum-20250211.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "hum-20250211_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hum-20250211_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.humana.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hum-20250211.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hum-20250211.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>22
<FILENAME>0000049071-25-000004-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000049071-25-000004-xbrl.zip
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MAXX+@NJ.I0QKQ:#=%AMC#G96ZZZL%B6Y('9E%",ZZ#$F7A!\ HYNZ5 C8K#
MX84AH';X'3[-]>+NO?'5$TGNMXK&1=S8J,W_?-F0@$KZGZ0>-]"$C__$FO $
MW_TWD,R:$BOD/XE;#(8M</-OM-*W7:'3D]NID\Z\O(?;X2WMITK\-O993V<<
MLVG"NB/H@NWL.0C!Q]S=()C%( ;?FA>FZNU,1K@C",U/]I=@48;<5VQ9[>^'
MT$/<DINPVY&?R8K+CCS/P6*;$I,#XP;$8*$5 CW#P#-0EIB/U@30ZV5#.$VR
M+9/>S3QG8+BH@TE?&U+^XDZ"/,.8QZ8F3"LB%3G*87RFOGVX\O3P,WJ4W[K
MB0E84L:]6'-;<?%74KH,'13$'!LKUHIS1*RL-ZIO1K>/E#;S,W?)Y8L"\=TP
MYWH\+BJIR]>5SB=@3J4]@H)74#^32GWF[N/-ZRD8^)@<!(S@D5V)$JVIX@I+
MCE=Z$>"L:4NX> E"ITK7$,%1KC+')"6(!03DJ5:4%G*@RITV_0(.=9CK(45!
M"9^*=&R_%P;S)MC< 7'[&0FD[]%Z5*H%503(^F,2:"^:4#J&FT S0U)B,CT&
M\=6!O+@[P*+C'[$V9>W:T2@_</-SSO9VNNEN=1/W[%"ZM@UTV;IPBA=T 35\
M-W5<9($3](7-;IYL*0ZZ&4 U\.J,IA"D&F:IE#:UP.;:)HZUO76^X!,2WCL1
M]^87#1*6<V,M]5V3,%,"P;+?PY)V*AE;2C\2J@%+S\L.G4,T!-T@X"?7E1DU
MW"\_$P*13-X,!1 _0A%T;9T0DF&'I"OPP&>&-# ^#!_R:Q0WU>SV4&&*I'?V
M>3/[_!*SWIA+\0(Y+HH:&P%KQZ(!]CNRF!N/AL?<[-JMLDTU&5:*E&H'^U38
M(HNA$U%S&$72\$Y?@Q \"MJW8W#**M]$B_XG-1O#?U%;[7W_W>G3YR"'2"&"
MK8K1_QA<>K@=B1T:>'8:LS)E= &)H1=<QB*<[CR]+R!)7H HB,"69H@)86'
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MHP53!^K>E0=%$59KL+=A(P2EY8L5PG*K+@$J).NL9((&^&YD$E+/Z(&H<+[
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MJ$(;0OFIRX%U>QB3!5Y'J,/\LZFSE KJ1BHP/WL:DEUU ,9RLJL.[*H#N^K
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MW;9-2R=%7 6:=O4W7?5Z_'2G7K]B]3J\G7K]ZZA(%O"?:9VE/_X_4$L#!!0
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M$0'TYZ.BE3:\3]C2M*,(QF."/;(P(93]3-W(G9JQ "9WX7_.0B86:%5#__F
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MI!<_^1ZXV7^[N_O(>CR48>52]GW7_R,.,9170 ,URVXI*1,D@ND_2A@!-WM
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M!'&D%I!%BGQDGS!R3^['[\#3L%+T[H> 'B6#E/Y2:K ?(/X3!=F?F4F@]*)
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ML+S0!#3.0_T;O^A$M+]!E.%B0QSEX6*[^KR*PA,P@<XZO'$_XMX0ZZK9@,N
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MC@MP?1 ?D0C& -$ "&4XI?%P+;!+H*4>O,@</&3&?E? =A-\-1!13 1"*7J
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MZ%YH&105USW+NBIC&=1ZM4)V)T&+]#")X/5-U]0.Y=0.%>9HST&SN]=2E2W
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M6*)$_B/V%,=E$L#!%PQ!\9,"IN.QV1BZ?P!I^#&,!4.&R!X3$81H3>/O(##
MW2,U$P>*M53W$:&M9C#V_RMR37('W_-A,)5O#K^0N4JR_0&C4^ &6.!<>J$
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MLT)9K^4I/ \ZYRG)&\UE25Y8W%!T=+156'TN/G^2D?8#K&F#$/P:?> .?UR
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MHX3(5"#$%9S"1G-/LROM\N=';Q,I,3/<TY%1D_P92Q;Q<38[LA?X,6P&#SH
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M:_"(;!:#IW/:HG6D6F).%6OUOG('Z1'=8E<&3KJS+W!Z;,>@K1.U,@K)@:
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M'2;66X+:ZVD*K#]'4G5M!=#3,)@S;=B0T7A&4=M@&_KTYP@?XD8@C2BB]!O
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MVPFW%+,_DB[X3A?J(XV)%T299F#7V&Y1.E4%#J<ZJ(C?%T2<(F_<4BVY52G
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MKNR)"SCN,%BG'GU@/-W3)G-CP:H>XI#Z$R8M;/*P$",<',N<K,OWL72C>5(
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M;[YC0:9A,!?Q. P>\"RM>Q]N/1&A$>O4>3Y\UI1S3<H;[;.CQ-$8][)G]LH
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M)>(EB?'3JD@E%2<EK14</V4ZL2VH3^-P:?Z$4(A,;;2,F5+&E8EC91TD+>M
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MLCP#)9NCX=5<L LB2[Z$=9XL!5D%@^/2Y1*-A&$TST!<>D;^<0M7ST#9YD!
MOQH$7!!=\D6NKW>=+D4FX\@"<XDV0]?[S3,:%[^K.%H95Z=]QHURB*X29V<I
M4=>)<T;)N4CSH?6:9S[6#;HL;:C!*SH-$9L#"%<O>X.>)%R5HPRSOUT )@E7
MY@#$&E8[RJ^'<)=HGEX:RG!49E?8Z 3<&WU89=8"7E5XGPT.4&H,#*M>L=9[
MP(%E"M:)V,X>.KXF/&VAA[&V_U('[>'2,(8T2KPX@LV4XR432N(9)=,D3D)*
MW&4TSXWI/(*/[)@XMN\',1E30J/8G;,]&?PYGKGP!7=.U1K8<22V'HW"5\XU
M^12Z04@^P0V""7E+'Z@7+%@&;V8_B[2M$!#]_KO><.F-GS@?MZ=:>K]*/FY/
M5_5>_?FX0W4PJC_!=:CV>T:G[SI0K3-F^#9BHW34', 3S"@IYUF]MQ^"D&'(
MU;_\:?I+,7YU-)VR)#'=,(K)/Q,[A!5)2NV@U!UU G^"=OVHU*KFHC>(3E]F
M;C@YKD2UGD;O@R2,9R>3I?JV@DVBX7^.O@^\]+SHHBT)JYS+WJ7NNL-R>\W"
M#0DK%5JP3Y^H'4:P0W&">Q]N/2&NS^H#-DJ%3IB#N[^*'"\&99;*1KM< ER]
M')TC#;M1%"@7O;UD"FSW^CUS'GJ#J//2*)-]U%8SVH"SPL;8V/S WP$VUMS;
MQIZ&'6?1KJ+SBE(G0!VESM5+0]L#FKM('TF>'<JU1Y9/4XY2FT2^%AO^<F>S
MJY.U-0M;\=#N[*;Z:G)-OLPHN64R]#OU/!*)'CO+L]""7AKP9SP:C8CM$YM]
MEUT6!_#;A&!DB4SH BR\*RKC_ FQLZ5R(E$U/0(4S_US1# AJ>BID8M]@*+$
MF6T\UXW8J6'@>T\DB5V/.153\#0>;"_A#UPDX2*(8,58F0?^!CYU1FTOGCEV
M2&&UG@M*] 2/GL!=PR=UU\'T\4[#MSN2I(]>/ZIDQ?EKPFFH1F\K=T#\,:\=
MENQBU+)V0[*+43>Z&'W(!S]R0V[???SR[O/O[W[Y)6U@)/L7-?804/8ODOV+
M3D$@V;](]B]J<KU!Y_L7O32-4G6G%T" @L" .>P* 0I3]TU#]BXJ#APIEM;M
MWD5PAQ,3_6V9\(R<^5JLU+UAZZ8VU-\GO]N"D<^BWF%3$"233J&]QFK')-6W
MHY)1T"1+UP[BTFD'E33'6Y)%]37,"SP)$1NC@$7[Y6&O!=B\!ZNJJ/U.T98R
MM>\6T[)ZDK^7P-_""$NO9TK4D%)5<V"JKUO'XW#=KN)^W#]R I4[^>L+U^I-
MG:EC3&PZG%H3?3":ZLYT.*:CT< QIY/1_XT&+XIS71@-\G.N:I,$_3E\>68^
MV:V=X)_L\(G<Q79,UPJ$3YCRM?D>^?/HOF!/"I\^8O:U1^V(KC*YID'X:(>3
M&R\(OH*4P8K$V^!W[^$3_.//R=SV[6P.U9S:/GX23-FOGT+W :XC=]1)0C=V
MX<:_K-H3?J;PE#EYPUMHZ*-13R6_SZA/DHAG@;O^ XWB("2+D$;P;)[[H+!?
MEVN&WS.WQ]CENV_.S/;O*;D-YG,WBO!95W?O;J_)U 4BW,,5^#5X '#0R[[:
MW)Y0,GZ"O_.6[?@.]F(1!@_P/5@CR#G^P]^;Y8<.7F-G$'@^SBR$SZ:N0T-X
M %[Y"+H;X;T6LQ 72CSW*R5XF:&]QIBJ$T<*^U5_G?YY3#V7PEMO_GW5X7'[
MHRA*YMM_=OV8^I.M/^,:O"=X/<\3K4TVOY&V+=FZ5#1'B=(_LXRZT!49*4 7
MEHO'WQH)'+D@JW:(X6-D&/L69M?QE?&.'Z(I_A._MECJU!VY<&6R,D^L6<6+
M/?O2OLQ EW;I-[((.]C<)W8(8D<IXZUH>;.@(2HM&\'(S@E"3,$<HUP@.T,W
M^@K2G_BB,RGJ)-<V)J4+H< <9N"Y"AXT(%Z OH38(X=II^NS9S"0B&B,B\7Y
M"1QBA#!^AB>1][8#\+ 4R A6@=<(]'&".1BLIZ6> @1D$ "6/9\C4,.W'V>N
M,UN!WSAA2:1(! ]D.-.<9AIX7O (=V M9TKG9QJJM9F@66L7GI)"65*%!L9^
MB<VG6C]C<_]UO7Y]F4=O<,Y0>R:^_(?4$I!)0+FX@/0 Q9C +T(P!<0%A5KV
M*X(?0'\ ??%SE$X:NV@WO">0>2ZS@)1S-YE'Z9U#ZE#X1@J<48(6QA79U4[P
MP+0&13UB1C23PPQO^@ KB-)D9H&W:.7H?,R,E+NF)RCRB<_R@/&+\X7' ($X
M0 [6=PG^B5TVG#?";Z!9!/@&31K3.(:%9!Z.UBV$93H,:=:?"@H$7\85<S/!
M#.P"[0@:IDG@)#Q['%:&<(+/ :VEO,U6YCYX7_ZGI<7"[XRI3Z?LKR*IG%,.
M+/L?"7Q'V;3>[/;@KP(PQ$^PK,2;8/,NO!^LR4-N38!\$2[.GDY9=S U9<_J
MR2D7HG2=8AW+92SL)X:O' ZYH$0K28G61<5VP+U$F4/9P#97]_"G.$%SBXVP
MXED@C&P&5\G81L<I603^.JZBI_1@8]4=QTL%>&J[\W1)\"_R#X$Y;;'%Y E@
MV&,@S)<,SB)<S#Z>K"KY(I&!'XE[HL_FP_>>B(=?XHOD'S%97JP>I[)Z@U3Z
M'%!"UT\8Q4/ZX*);NL;8U ().O*^84@8D,64V'+6= J6NKZ1;]N$6=-ES,R)
MC4K:(YWAU!(SP15(PI#O0IAFXV^P**&NZ-.SFE8NWG/[*^(_B'<4H4>QJD6)
M4LS%#4R(?OW*]TFQ'K2)8[KSE/G:(R@NS6(CTY:(9G0"5"WP'A!LP9^.</_Q
MWV3"*F>$PMH/J%[P$>Q/Q=0IO"N\!_/;!>2-J6,G$6ML^$0X>,>P,L2["._+
M=C9H;=BF"A]; !^<%ED$@?O %D2%+5X&S3AT_GE%$Z ?KF+-O)7V]Z6SLJ^S
M,K5=C\DE9=:,^1\9<X_2NBPT $:RG5P,O])[U\GZ %E1QHM^99QGQC;S'>Y:
MXY\!PA<V1J,2W!3" \&K9_N(>_BF4+/ 1]#DS]YPXYG P!<3+H(Q4X;47BI\
M W/#+2":DA [<XIU/_']^'T8/,(^0MCG3)U;VD=2Q 7BB&U1[T/6EG*](&P>
MP(]*[O8BO4LJSL]X$.V5;]TXFWS#HPOD&UT)/T'7,"="LQ3--Q/T@\#HD84'
M*R"<Q=8-2$^(#N4,'D-#'AU!!\T%.((+T"^EZ =3T9R@!_P3ZC0#UP?]4W#%
MB&<_1@FX(1&E7X5G@OM7.V)^,LC6@^U@/ S%A_6;O</G?F9NS-)Q+%JLPO:E
M,;,+;'?*?+^0J1#K/)OUY=D;@(%Y &7GZ@*7B.6IY,.6XX^;%W#DT()-$R'@
MF5=>6R>[MT_O[15VH++AVN&E^@3\;&Y8 C^)5OX:*V&Z_?5.F$S0!2\*-JB\
MJ2BYBI;"@)+B%%!:=.GE&NS8T8Q,89\!IN<#EH9.7.[&<N+!LU _LP2,MHDW
MIAF"( WF&,^ _['X)@,PW  )\%LC$'Q9.*NLMX7:7E5OMBEC>T!D7(Q- 6_0
MNCRE/ERZ/0U!K_PTP,.:#;.0U-((+O?D*7O9#3G^HQ +I9S8,3P.]3DUA0S8
MEQ?1;[ [6DF&L*4^^/)KP:RG"!M%*^+!,4KX]G84_#T:HQ_)3H26+N3R8GSI
M +U&BON_>W@\N%K.$T ?D)E%PD%]XMAV,!2'MA 7R'=I_*_H7/K<WPL<N(#=
M<L'4*A9;Q@5&[AT6"<=7)\L;@\UG,5O1[9KK'4K\\ANXG7!F5'QAXD9ALH@W
M+'FFDA$)QHF>^"PR+/P.N# "_]A?^@(K9Q0NCMAWLK1EK["B78 A!G_*X\OK
M7^VX^6ZD3@MCZBYW-6SKA=N4 &R(!\;&PP (#Q^C4+K1(HE3(>-1&X_:+,:U
M]FUR)>(3^:'F%"56/N/RSFA)_DA<$MOS[%"M<1@D\#)X3 3\<^%J,'<,9,9T
M9GO3U&V]Q^"<CS!PK61^$1XU2GK(11C/N,3-A?V")\3<\(HO\7@(BVZE4@H+
M1]O$UKF*8;.8'N@DIV"R[%_\E :PA=0K@F09]4W&X 1Q70$Z<26:V',;MWRH
M3*O=GYMIO0[K0$+#4M#4.B%E#GB&7/@^J:] %LG8@_W=,L[&/ !77):KE6E@
M<Q(@N*9/E>I7L_J] 3'*".E2&X(PW:^C:M)OV#1CLCSHX<J'>+D#+-?%102#
MT<."5:1_2D,1:!;9%I&==**L9=:4"2^#\,/N;!Z19PZ2O"!B;G6ZO+Q7Q.D!
MH]<;&@KW%-'I=?WDWUT$\=*J\+BRPU0P<_<)A2>"]0)JI6$2]!NV;@ *&(>N
M@"IL3)*-1F=WV.,GKAM >&X.U^/6!4=>.7N))2N V)B>NN,K?+' 'T[5# 2L
M QR?R9!R1#A;0FPR_ 2UO16W$&B$4G23Z=S"=M>KGBWPSKA?8'UD\#NKTY&%
M[3(Q+-S8!1CUCL,@6O 0!^LOQW;PXJ:,@@"K8%Y 5-G]EG>W41L$- K"3EV&
MPXE'-^=5L#.*S#LP=^D!-'4B !!E283L0;7OGS@*1K/5"\*W_F[["2*NJ2F\
M^=W5>_;$SV_>_IM\AL=>*^MT31,%5IXL*#;+BTA/.A#TL9E.;,<)"\B'\'<W
MY)XIO-;J/ '_#BNFZ:$N4,5;'FJ\F8 8N\SM13I^0KLSP;T-YFU,$IJZI[@.
M_',<I >I0,3OOS.MU^\I/P6Z$YZY2(\.V8?"$K!8I;U25($B(D:%%,IU(+,[
M/V21SP:%I-'ZK<V@-!KU^VQ_SJ [N@(/(A%G/3$@ZUYD8#*D]PD_8P*3CB<?
M&*+@RIM^P/T]\.G<B)_6*!CF=I'12N:;*. 9@%KNQW)N*':-;@CBYOL\8&0O
M%N"9<(WE$IGGEORYR"%9Q=MWRO#&7B\=+8291:L-T=4*])?6@?W,HAX*H7X8
M>-Y\=1S!3Q%$=!.C\V(J[.HPD05<PJ\T3EMK 5&S]\XS'1F;#'9?^*P!V]+R
M>_$ ,-*HZ!;I60!>O%)8?DHZ?LHWV1RDV'DG0>"9PZNEIWN,0DA'/"G TYE5
M^)<=*A>M8VDEUDRQ,.\[WV!Y.F1'48#UL?!0EAEF,]LYH?AX%X]6N'?"5\9"
M<FGK,#*E'%7Y>]KHLT>,!]?<ON8]-P?+,F+Q#+O6(AG8\VQY=GX?!!-TO<23
M<56Y3G<&,B5F'@$S5WQ>&4W\.[@OM@/RSUD.8CUQF?>)L<0H(T29H"D!P^Q'
MZ69W%;%DP:FG_>SJ;F#*L[#;\59Y K\\@3=:>@(OE?;YLU.1 2-,J\#;"&0Y
MXCDV3R(]!?1FYBZB53IQ)BP]Y6>+FUE998*3EQ61U 9G8SH\>G=$$MA)HS7
M72;N,4<$8^HL!(8>"\;N:'I&%..."AT&,=$0][_O<3 /#16.]BSQEB,VWFR*
MT19Q#QX&!QE1R%?ZM$HQCUAW4TQV1\=*;$%O-Z1%W'-UG)TQ,Q/PQ8,T_)9W
MVK9YLU3T<L_;\ G??V<-7H-+O9TA7'+490,ELI$PM'E2-+.!S,[3"AQ -/
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MD+O\S@7S_1C^[NG?Y'T0Q'X0YW45;O6Y<$TG 48M)P%Z[_PG 3LF09UIZ,K
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MU_3Z%0<M2I!J"DC]% 1?20"KF(3VM#.)U98F#\XN!(7,GBDQJ-T8]"\?QWB
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M4N^S1<9:%LC8,UQ%.YKP*=8,H\NAECS[;#-&>'L%8)53PO1O-*73F-D>"_+
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MKJHY#[/YG.9AS,;,ZUY3D';$W2I7LVQ3-T33:Y!W=$:$6[9NCQKAAUDYLA%
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M'JMF;I>+14+G:W=U*F7DMG@F)J0VJY,9MBOO'_+"SG\2:8^)H>3"6,M!I.6
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MJQL5/)+/06DJ QZRM&]P3"EP;GL*W ^3+'I@OV;E/'G[_P%02P,$%     @
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M?<I&]OLOANY3OO<17>H1L407'&Y]@F3NZG'WJUO[,F;C>GUL]P1G?7.@AKJ
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M=EZY-C5Y3<A1?]E)<WF;R^6JG7'*U;;9]M]\2*D%J9DF$"0CTE!&G)>)B )
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M/>[UPX@>YS!K<H2,H\?6G,OAJ^@^YO:^Q?S29;P1":NRBMNK4V[6NXA5V^Q
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M2P$"% ,4    "  J-4M:JEWET/DM  #@#@$ '@              @ $
M831Q,C R-&AU;6%N86EN8W!O<W1E9')E;6$N:'1M4$L! A0#%     @ *C5+
M6L?M7MW$-@  '0X# !P              ( !-2X  &AU;2TR,#(T<30X:WAE
M>#DY>#%B<FEE9BYH=&U02P$"% ,4    "  J-4M:/5:.) ^V  "[Z@X 'P
M            @ $S90  :'5M+3(P,C1Q-#AK>&5X.3EX,F1E=&%I;&5D+FAT
M;5!+ 0(4 Q0    ( "HU2UK&?E[N]0\  .1V   0              "  7\;
M 0!H=6TM,C R-3 R,3$N:'1M4$L! A0#%     @ *C5+6M9L"S-= @  _08
M !               ( !HBL! &AU;2TR,#(U,#(Q,2YX<V102P$"% ,4
M"  J-4M:D]X902(*  !]50  %               @ $M+@$ :'5M+3(P,C4P
M,C$Q7VQA8BYX;6Q02P$"% ,4    "  J-4M:GNUX(K$&  #E,   %
M        @ &!. $ :'5M+3(P,C4P,C$Q7W!R92YX;6Q02P4&      < !P#C
) 0  9#\!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>hum-20250211_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hum-20250211.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <startDate>2025-02-11</startDate>
            <endDate>2025-02-11</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0000049071</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-02-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Humana Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">1-5975</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">61-0647538</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">500 West Main Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Louisville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">KY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">40202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">502</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">580-1000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">HUM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
